TWI822746B - Cured film forming composition, alignment material and retardation material - Google Patents
Cured film forming composition, alignment material and retardation material Download PDFInfo
- Publication number
- TWI822746B TWI822746B TW108110676A TW108110676A TWI822746B TW I822746 B TWI822746 B TW I822746B TW 108110676 A TW108110676 A TW 108110676A TW 108110676 A TW108110676 A TW 108110676A TW I822746 B TWI822746 B TW I822746B
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- cured film
- component
- polymer
- forming composition
- Prior art date
Links
- 239000000463 material Substances 0.000 title claims abstract description 105
- 239000000203 mixture Substances 0.000 title claims abstract description 94
- 239000010408 film Substances 0.000 claims abstract description 143
- 229920000642 polymer Polymers 0.000 claims abstract description 94
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 41
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 22
- 239000003054 catalyst Substances 0.000 claims abstract description 16
- 238000004132 cross linking Methods 0.000 claims abstract description 15
- 239000012788 optical film Substances 0.000 claims abstract description 15
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 43
- 125000000524 functional group Chemical group 0.000 claims description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 16
- 125000004432 carbon atom Chemical group C* 0.000 claims description 15
- 238000011907 photodimerization Methods 0.000 claims description 15
- 125000003277 amino group Chemical group 0.000 claims description 12
- 125000003368 amide group Chemical group 0.000 claims description 11
- 239000004202 carbamide Substances 0.000 claims description 10
- 125000000490 cinnamyl group Chemical group C(C=CC1=CC=CC=C1)* 0.000 claims description 9
- 125000005370 alkoxysilyl group Chemical group 0.000 claims description 7
- 125000002947 alkylene group Chemical group 0.000 claims description 6
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical group C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 claims description 4
- 125000000332 coumarinyl group Chemical group O1C(=O)C(=CC2=CC=CC=C12)* 0.000 claims description 3
- 150000008064 anhydrides Chemical class 0.000 claims description 2
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 claims description 2
- DMLAVOWQYNRWNQ-UHFFFAOYSA-N azobenzene Chemical group C1=CC=CC=C1N=NC1=CC=CC=C1 DMLAVOWQYNRWNQ-UHFFFAOYSA-N 0.000 claims description 2
- 238000007699 photoisomerization reaction Methods 0.000 claims description 2
- 239000004973 liquid crystal related substance Substances 0.000 abstract description 79
- 239000000178 monomer Substances 0.000 description 69
- -1 acrylyl group Chemical group 0.000 description 63
- 239000002904 solvent Substances 0.000 description 44
- 150000001875 compounds Chemical class 0.000 description 40
- 125000003700 epoxy group Chemical group 0.000 description 37
- 238000000034 method Methods 0.000 description 29
- 229920001577 copolymer Polymers 0.000 description 27
- 239000010410 layer Substances 0.000 description 21
- 229920000058 polyacrylate Polymers 0.000 description 19
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 15
- 229920000858 Cyclodextrin Polymers 0.000 description 14
- 239000011248 coating agent Substances 0.000 description 14
- 238000000576 coating method Methods 0.000 description 14
- 229920005862 polyol Polymers 0.000 description 13
- 239000000758 substrate Substances 0.000 description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 239000002253 acid Substances 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 150000003077 polyols Chemical class 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 12
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 11
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 11
- 239000000654 additive Substances 0.000 description 10
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 10
- 238000010438 heat treatment Methods 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 230000035945 sensitivity Effects 0.000 description 10
- 238000003786 synthesis reaction Methods 0.000 description 10
- 229920003270 Cymel® Polymers 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 9
- 229920006243 acrylic copolymer Polymers 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 9
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 9
- 125000000217 alkyl group Chemical group 0.000 description 8
- 150000001412 amines Chemical class 0.000 description 8
- 125000006267 biphenyl group Chemical group 0.000 description 8
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 7
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 7
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 7
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 7
- 239000006185 dispersion Substances 0.000 description 7
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 125000006850 spacer group Chemical group 0.000 description 7
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 6
- 125000004093 cyano group Chemical group *C#N 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 5
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 5
- 239000005022 packaging material Substances 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
- 229920001610 polycaprolactone Polymers 0.000 description 5
- 239000004632 polycaprolactone Substances 0.000 description 5
- 239000003505 polymerization initiator Substances 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- YMBCJWGVCUEGHA-UHFFFAOYSA-M tetraethylammonium chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC YMBCJWGVCUEGHA-UHFFFAOYSA-M 0.000 description 5
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- 229930185605 Bisphenol Natural products 0.000 description 4
- 229920002284 Cellulose triacetate Polymers 0.000 description 4
- 239000004593 Epoxy Substances 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 229920000877 Melamine resin Polymers 0.000 description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 4
- BUCJGDQWMGOWHV-UHFFFAOYSA-N acetylene;urea Chemical class C#C.NC(N)=O BUCJGDQWMGOWHV-UHFFFAOYSA-N 0.000 description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 4
- 229940097362 cyclodextrins Drugs 0.000 description 4
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 4
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 4
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 4
- 125000005843 halogen group Chemical group 0.000 description 4
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 4
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 4
- 230000001771 impaired effect Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 229920005906 polyester polyol Polymers 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 230000000379 polymerizing effect Effects 0.000 description 4
- 235000013824 polyphenols Nutrition 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- HWCKGOZZJDHMNC-UHFFFAOYSA-M tetraethylammonium bromide Chemical compound [Br-].CC[N+](CC)(CC)CC HWCKGOZZJDHMNC-UHFFFAOYSA-M 0.000 description 4
- 239000010409 thin film Substances 0.000 description 4
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 3
- STMDPCBYJCIZOD-UHFFFAOYSA-N 2-(2,4-dinitroanilino)-4-methylpentanoic acid Chemical compound CC(C)CC(C(O)=O)NC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O STMDPCBYJCIZOD-UHFFFAOYSA-N 0.000 description 3
- RKYJPYDJNQXILT-UHFFFAOYSA-N 2-(2-prop-2-enoyloxyethoxycarbonyl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1C(=O)OCCOC(=O)C=C RKYJPYDJNQXILT-UHFFFAOYSA-N 0.000 description 3
- MUUOUUYKIVSIAR-UHFFFAOYSA-N 2-but-3-enyloxirane Chemical compound C=CCCC1CO1 MUUOUUYKIVSIAR-UHFFFAOYSA-N 0.000 description 3
- UKTHULMXFLCNAV-UHFFFAOYSA-N 2-hex-5-enyloxirane Chemical compound C=CCCCCC1CO1 UKTHULMXFLCNAV-UHFFFAOYSA-N 0.000 description 3
- SLJFKNONPLNAPF-UHFFFAOYSA-N 3-Vinyl-7-oxabicyclo[4.1.0]heptane Chemical compound C1C(C=C)CCC2OC21 SLJFKNONPLNAPF-UHFFFAOYSA-N 0.000 description 3
- GZVHEAJQGPRDLQ-UHFFFAOYSA-N 6-phenyl-1,3,5-triazine-2,4-diamine Chemical class NC1=NC(N)=NC(C=2C=CC=CC=2)=N1 GZVHEAJQGPRDLQ-UHFFFAOYSA-N 0.000 description 3
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 3
- 239000001116 FEMA 4028 Substances 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 3
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000004721 Polyphenylene oxide Substances 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 125000004849 alkoxymethyl group Chemical group 0.000 description 3
- AOJOEFVRHOZDFN-UHFFFAOYSA-N benzyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC1=CC=CC=C1 AOJOEFVRHOZDFN-UHFFFAOYSA-N 0.000 description 3
- 229960004853 betadex Drugs 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- JHYNXXDQQHTCHJ-UHFFFAOYSA-M ethyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(CC)C1=CC=CC=C1 JHYNXXDQQHTCHJ-UHFFFAOYSA-M 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000001678 irradiating effect Effects 0.000 description 3
- 150000007974 melamines Chemical class 0.000 description 3
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical group CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- UGVYTRVYOYKZSO-UHFFFAOYSA-N n-butoxy-2-methylprop-2-enamide Chemical compound CCCCONC(=O)C(C)=C UGVYTRVYOYKZSO-UHFFFAOYSA-N 0.000 description 3
- 150000007530 organic bases Chemical class 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- RPQRDASANLAFCM-UHFFFAOYSA-N oxiran-2-ylmethyl prop-2-enoate Chemical compound C=CC(=O)OCC1CO1 RPQRDASANLAFCM-UHFFFAOYSA-N 0.000 description 3
- 229920000515 polycarbonate Polymers 0.000 description 3
- 239000004417 polycarbonate Substances 0.000 description 3
- 229920000570 polyether Polymers 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- WGTYBPLFGIVFAS-UHFFFAOYSA-M tetramethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)C WGTYBPLFGIVFAS-UHFFFAOYSA-M 0.000 description 3
- 229920001187 thermosetting polymer Polymers 0.000 description 3
- DMFAHCVITRDZQB-UHFFFAOYSA-N 1-propoxypropan-2-yl acetate Chemical compound CCCOCC(C)OC(C)=O DMFAHCVITRDZQB-UHFFFAOYSA-N 0.000 description 2
- AENZGWONVTXLRC-UHFFFAOYSA-N 2-(2,5-dioxopyrrol-1-yl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1N1C(=O)C=CC1=O AENZGWONVTXLRC-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- GHGCHYOFZGPCNY-UHFFFAOYSA-N 2-(2-methylprop-2-enoylamino)benzoic acid Chemical compound CC(=C)C(=O)NC1=CC=CC=C1C(O)=O GHGCHYOFZGPCNY-UHFFFAOYSA-N 0.000 description 2
- UECGJSXCVLTIMQ-UHFFFAOYSA-N 2-(2-prop-2-enoyloxyethoxycarbonyl)cyclohexane-1-carboxylic acid Chemical compound OC(=O)C1CCCCC1C(=O)OCCOC(=O)C=C UECGJSXCVLTIMQ-UHFFFAOYSA-N 0.000 description 2
- JFWFAUHHNYTWOO-UHFFFAOYSA-N 2-[(2-ethenylphenyl)methoxymethyl]oxirane Chemical compound C=CC1=CC=CC=C1COCC1OC1 JFWFAUHHNYTWOO-UHFFFAOYSA-N 0.000 description 2
- OCKQMFDZQUFKRD-UHFFFAOYSA-N 2-[(3-ethenylphenyl)methoxymethyl]oxirane Chemical compound C=CC1=CC=CC(COCC2OC2)=C1 OCKQMFDZQUFKRD-UHFFFAOYSA-N 0.000 description 2
- ZADXFVHUPXKZBJ-UHFFFAOYSA-N 2-[(4-ethenylphenyl)methoxymethyl]oxirane Chemical compound C1=CC(C=C)=CC=C1COCC1OC1 ZADXFVHUPXKZBJ-UHFFFAOYSA-N 0.000 description 2
- GWFCWZQFUSJPRE-UHFFFAOYSA-N 2-[2-(2-methylprop-2-enoyloxy)ethoxycarbonyl]cyclohexane-1-carboxylic acid Chemical compound CC(=C)C(=O)OCCOC(=O)C1CCCCC1C(O)=O GWFCWZQFUSJPRE-UHFFFAOYSA-N 0.000 description 2
- GWZMWHWAWHPNHN-UHFFFAOYSA-N 2-hydroxypropyl prop-2-enoate Chemical compound CC(O)COC(=O)C=C GWZMWHWAWHPNHN-UHFFFAOYSA-N 0.000 description 2
- LBLYYCQCTBFVLH-UHFFFAOYSA-M 2-methylbenzenesulfonate Chemical compound CC1=CC=CC=C1S([O-])(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 description 2
- UIHCLUNTQKBZGK-UHFFFAOYSA-N 3-methyl-2-pentanone Chemical compound CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- ZEWLHMQYEZXSBH-UHFFFAOYSA-N 4-[2-(2-methylprop-2-enoyloxy)ethoxy]-4-oxobutanoic acid Chemical compound CC(=C)C(=O)OCCOC(=O)CCC(O)=O ZEWLHMQYEZXSBH-UHFFFAOYSA-N 0.000 description 2
- YKXAYLPDMSGWEV-UHFFFAOYSA-N 4-hydroxybutyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCO YKXAYLPDMSGWEV-UHFFFAOYSA-N 0.000 description 2
- UZDMJPAQQFSMMV-UHFFFAOYSA-N 4-oxo-4-(2-prop-2-enoyloxyethoxy)butanoic acid Chemical compound OC(=O)CCC(=O)OCCOC(=O)C=C UZDMJPAQQFSMMV-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- MRABAEUHTLLEML-UHFFFAOYSA-N Butyl lactate Chemical compound CCCCOC(=O)C(C)O MRABAEUHTLLEML-UHFFFAOYSA-N 0.000 description 2
- 101150061050 CIN1 gene Proteins 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- UJVHVMNGOZXSOZ-VKHMYHEASA-N L-BMAA Chemical compound CNC[C@H](N)C(O)=O UJVHVMNGOZXSOZ-VKHMYHEASA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- 229920004552 POLYLITE® Polymers 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- 229920001807 Urea-formaldehyde Polymers 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000003926 acrylamides Chemical class 0.000 description 2
- 239000001361 adipic acid Substances 0.000 description 2
- 235000011037 adipic acid Nutrition 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N anhydrous diethylene glycol Natural products OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 230000003667 anti-reflective effect Effects 0.000 description 2
- 150000008366 benzophenones Chemical class 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 239000001191 butyl (2R)-2-hydroxypropanoate Substances 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 2
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 2
- 229960004132 diethyl ether Drugs 0.000 description 2
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- IJUHLFUALMUWOM-UHFFFAOYSA-N ethyl 3-methoxypropanoate Chemical compound CCOC(=O)CCOC IJUHLFUALMUWOM-UHFFFAOYSA-N 0.000 description 2
- 229940116333 ethyl lactate Drugs 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 2
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- ZFSLODLOARCGLH-UHFFFAOYSA-N isocyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 description 2
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 2
- 125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- HSDFKDZBJMDHFF-UHFFFAOYSA-N methyl 3-ethoxypropanoate Chemical compound CCOCCC(=O)OC HSDFKDZBJMDHFF-UHFFFAOYSA-N 0.000 description 2
- 125000006501 nitrophenyl group Chemical group 0.000 description 2
- 229920003986 novolac Polymers 0.000 description 2
- 238000000059 patterning Methods 0.000 description 2
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 2
- 150000004714 phosphonium salts Chemical class 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920001721 polyimide Polymers 0.000 description 2
- 239000002685 polymerization catalyst Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- YKYONYBAUNKHLG-UHFFFAOYSA-N propyl acetate Chemical compound CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 2
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000010526 radical polymerization reaction Methods 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 2
- 150000003672 ureas Chemical class 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- FDYDISGSYGFRJM-UHFFFAOYSA-N (2-methyl-2-adamantyl) 2-methylprop-2-enoate Chemical compound C1C(C2)CC3CC1C(OC(=O)C(=C)C)(C)C2C3 FDYDISGSYGFRJM-UHFFFAOYSA-N 0.000 description 1
- YRPLSAWATHBYFB-UHFFFAOYSA-N (2-methyl-2-adamantyl) prop-2-enoate Chemical compound C1C(C2)CC3CC1C(C)(OC(=O)C=C)C2C3 YRPLSAWATHBYFB-UHFFFAOYSA-N 0.000 description 1
- MCVVDMSWCQUKEV-UHFFFAOYSA-N (2-nitrophenyl)methyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCC1=CC=CC=C1[N+]([O-])=O MCVVDMSWCQUKEV-UHFFFAOYSA-N 0.000 description 1
- LAXOSKGHJOPZMF-UHFFFAOYSA-N (2-propyl-2-adamantyl) 2-methylprop-2-enoate Chemical compound C1C(C2)CC3CC1C(CCC)(OC(=O)C(C)=C)C2C3 LAXOSKGHJOPZMF-UHFFFAOYSA-N 0.000 description 1
- AURQHUVLTRSLGM-UHFFFAOYSA-N (2-propyl-2-adamantyl) prop-2-enoate Chemical compound C1C(C2)CC3CC1C(CCC)(OC(=O)C=C)C2C3 AURQHUVLTRSLGM-UHFFFAOYSA-N 0.000 description 1
- ZYMCBJWUWHHVRX-UHFFFAOYSA-N (4-nitrophenyl)-phenylmethanone Chemical compound C1=CC([N+](=O)[O-])=CC=C1C(=O)C1=CC=CC=C1 ZYMCBJWUWHHVRX-UHFFFAOYSA-N 0.000 description 1
- RUEBPOOTFCZRBC-UHFFFAOYSA-N (5-methyl-2-phenyl-1h-imidazol-4-yl)methanol Chemical compound OCC1=C(C)NC(C=2C=CC=CC=2)=N1 RUEBPOOTFCZRBC-UHFFFAOYSA-N 0.000 description 1
- ZISCOWXWCHUSMH-VOTSOKGWSA-N (E)-4-nitrostilbene Chemical compound C1=CC([N+](=O)[O-])=CC=C1\C=C\C1=CC=CC=C1 ZISCOWXWCHUSMH-VOTSOKGWSA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- SDTWGJXOIOEDAV-WAYWQWQTSA-N (z)-n'-(2-hydroxyphenyl)but-2-enediamide Chemical compound NC(=O)\C=C/C(=O)NC1=CC=CC=C1O SDTWGJXOIOEDAV-WAYWQWQTSA-N 0.000 description 1
- GKNWQHIXXANPTN-UHFFFAOYSA-N 1,1,2,2,2-pentafluoroethanesulfonic acid Chemical compound OS(=O)(=O)C(F)(F)C(F)(F)F GKNWQHIXXANPTN-UHFFFAOYSA-N 0.000 description 1
- RJGUAQKOHAABLK-UHFFFAOYSA-N 1,1,2,2-tetrafluoro-2-(1,1,2,2,2-pentafluoroethoxy)ethanesulfonic acid Chemical compound OS(=O)(=O)C(F)(F)C(F)(F)OC(F)(F)C(F)(F)F RJGUAQKOHAABLK-UHFFFAOYSA-N 0.000 description 1
- GIWQSPITLQVMSG-UHFFFAOYSA-N 1,2-dimethylimidazole Chemical compound CC1=NC=CN1C GIWQSPITLQVMSG-UHFFFAOYSA-N 0.000 description 1
- ZVEMLYIXBCTVOF-UHFFFAOYSA-N 1-(2-isocyanatopropan-2-yl)-3-prop-1-en-2-ylbenzene Chemical compound CC(=C)C1=CC=CC(C(C)(C)N=C=O)=C1 ZVEMLYIXBCTVOF-UHFFFAOYSA-N 0.000 description 1
- FBHPRUXJQNWTEW-UHFFFAOYSA-N 1-benzyl-2-methylimidazole Chemical compound CC1=NC=CN1CC1=CC=CC=C1 FBHPRUXJQNWTEW-UHFFFAOYSA-N 0.000 description 1
- XZKLXPPYISZJCV-UHFFFAOYSA-N 1-benzyl-2-phenylimidazole Chemical compound C1=CN=C(C=2C=CC=CC=2)N1CC1=CC=CC=C1 XZKLXPPYISZJCV-UHFFFAOYSA-N 0.000 description 1
- JNNFEXRDINXHRQ-UHFFFAOYSA-N 1-benzylsulfonyloxyethyl phenylmethanesulfonate Chemical compound C(C1=CC=CC=C1)S(=O)(=O)OC(C)OS(=O)(=O)CC1=CC=CC=C1 JNNFEXRDINXHRQ-UHFFFAOYSA-N 0.000 description 1
- BQTPKSBXMONSJI-UHFFFAOYSA-N 1-cyclohexylpyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1CCCCC1 BQTPKSBXMONSJI-UHFFFAOYSA-N 0.000 description 1
- HIDBROSJWZYGSZ-UHFFFAOYSA-N 1-phenylpyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1=CC=CC=C1 HIDBROSJWZYGSZ-UHFFFAOYSA-N 0.000 description 1
- FENFUOGYJVOCRY-UHFFFAOYSA-N 1-propoxypropan-2-ol Chemical compound CCCOCC(C)O FENFUOGYJVOCRY-UHFFFAOYSA-N 0.000 description 1
- IGGDKDTUCAWDAN-UHFFFAOYSA-N 1-vinylnaphthalene Chemical compound C1=CC=C2C(C=C)=CC=CC2=C1 IGGDKDTUCAWDAN-UHFFFAOYSA-N 0.000 description 1
- QTKPMCIBUROOGY-UHFFFAOYSA-N 2,2,2-trifluoroethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(F)(F)F QTKPMCIBUROOGY-UHFFFAOYSA-N 0.000 description 1
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- QRIMLDXJAPZHJE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(O)CO QRIMLDXJAPZHJE-UHFFFAOYSA-N 0.000 description 1
- OWPUOLBODXJOKH-UHFFFAOYSA-N 2,3-dihydroxypropyl prop-2-enoate Chemical compound OCC(O)COC(=O)C=C OWPUOLBODXJOKH-UHFFFAOYSA-N 0.000 description 1
- LXFQSRIDYRFTJW-UHFFFAOYSA-N 2,4,6-trimethylbenzenesulfonic acid Chemical compound CC1=CC(C)=C(S(O)(=O)=O)C(C)=C1 LXFQSRIDYRFTJW-UHFFFAOYSA-N 0.000 description 1
- IRLYGRLEBKCYPY-UHFFFAOYSA-M 2,5-dimethylbenzenesulfonate Chemical compound CC1=CC=C(C)C(S([O-])(=O)=O)=C1 IRLYGRLEBKCYPY-UHFFFAOYSA-M 0.000 description 1
- IRLYGRLEBKCYPY-UHFFFAOYSA-N 2,5-dimethylbenzenesulfonic acid Chemical compound CC1=CC=C(C)C(S(O)(=O)=O)=C1 IRLYGRLEBKCYPY-UHFFFAOYSA-N 0.000 description 1
- 150000003923 2,5-pyrrolediones Chemical class 0.000 description 1
- BRETYAHLENMEAI-UHFFFAOYSA-N 2,6-dimethylbenzenesulfonic acid Chemical compound CC1=CC=CC(C)=C1S(O)(=O)=O BRETYAHLENMEAI-UHFFFAOYSA-N 0.000 description 1
- OLQFXOWPTQTLDP-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCO OLQFXOWPTQTLDP-UHFFFAOYSA-N 0.000 description 1
- RWXMAAYKJDQVTF-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl prop-2-enoate Chemical compound OCCOCCOC(=O)C=C RWXMAAYKJDQVTF-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- DIZBQMTZXOUFTD-UHFFFAOYSA-N 2-(furan-2-yl)-3h-benzimidazole-5-carboxylic acid Chemical compound N1C2=CC(C(=O)O)=CC=C2N=C1C1=CC=CO1 DIZBQMTZXOUFTD-UHFFFAOYSA-N 0.000 description 1
- KJOLAZDWVDOTSF-UHFFFAOYSA-N 2-(prop-2-enoylamino)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1NC(=O)C=C KJOLAZDWVDOTSF-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- PTTPXKJBFFKCEK-UHFFFAOYSA-N 2-Methyl-4-heptanone Chemical compound CC(C)CC(=O)CC(C)C PTTPXKJBFFKCEK-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- JQCWCBBBJXQKDE-UHFFFAOYSA-N 2-[2-(2-hydroxyethoxy)ethoxy]-1-methoxyethanol;2-methylprop-2-enoic acid Chemical compound CC(=C)C(O)=O.COC(O)COCCOCCO JQCWCBBBJXQKDE-UHFFFAOYSA-N 0.000 description 1
- COORVRSSRBIIFJ-UHFFFAOYSA-N 2-[2-(2-hydroxyethoxy)ethoxy]-1-methoxyethanol;prop-2-enoic acid Chemical compound OC(=O)C=C.COC(O)COCCOCCO COORVRSSRBIIFJ-UHFFFAOYSA-N 0.000 description 1
- FIQBJLHOPOSODG-UHFFFAOYSA-N 2-[2-(2-methylprop-2-enoyloxy)ethoxycarbonyl]benzoic acid Chemical compound CC(=C)C(=O)OCCOC(=O)C1=CC=CC=C1C(O)=O FIQBJLHOPOSODG-UHFFFAOYSA-N 0.000 description 1
- UGIJCMNGQCUTPI-UHFFFAOYSA-N 2-aminoethyl prop-2-enoate Chemical compound NCCOC(=O)C=C UGIJCMNGQCUTPI-UHFFFAOYSA-N 0.000 description 1
- UHNKYAXFKWTNAA-UHFFFAOYSA-N 2-benzylsulfonyloxypropan-2-yl phenylmethanesulfonate Chemical compound C(C1=CC=CC=C1)S(=O)(=O)OC(C)(C)OS(=O)(=O)CC1=CC=CC=C1 UHNKYAXFKWTNAA-UHFFFAOYSA-N 0.000 description 1
- SBYMUDUGTIKLCR-UHFFFAOYSA-N 2-chloroethenylbenzene Chemical compound ClC=CC1=CC=CC=C1 SBYMUDUGTIKLCR-UHFFFAOYSA-N 0.000 description 1
- WBIQQQGBSDOWNP-UHFFFAOYSA-N 2-dodecylbenzenesulfonic acid Chemical compound CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O WBIQQQGBSDOWNP-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- SVONRAPFKPVNKG-UHFFFAOYSA-N 2-ethoxyethyl acetate Chemical compound CCOCCOC(C)=O SVONRAPFKPVNKG-UHFFFAOYSA-N 0.000 description 1
- ABLCFODXAYBNID-UHFFFAOYSA-N 2-heptyl-1h-imidazole Chemical compound CCCCCCCC1=NC=CN1 ABLCFODXAYBNID-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- VHSHLMUCYSAUQU-UHFFFAOYSA-N 2-hydroxypropyl methacrylate Chemical compound CC(O)COC(=O)C(C)=C VHSHLMUCYSAUQU-UHFFFAOYSA-N 0.000 description 1
- YXYJVFYWCLAXHO-UHFFFAOYSA-N 2-methoxyethyl 2-methylprop-2-enoate Chemical compound COCCOC(=O)C(C)=C YXYJVFYWCLAXHO-UHFFFAOYSA-N 0.000 description 1
- HFCUBKYHMMPGBY-UHFFFAOYSA-N 2-methoxyethyl prop-2-enoate Chemical compound COCCOC(=O)C=C HFCUBKYHMMPGBY-UHFFFAOYSA-N 0.000 description 1
- LWRBVKNFOYUCNP-UHFFFAOYSA-N 2-methyl-1-(4-methylsulfanylphenyl)-2-morpholin-4-ylpropan-1-one Chemical compound C1=CC(SC)=CC=C1C(=O)C(C)(C)N1CCOCC1 LWRBVKNFOYUCNP-UHFFFAOYSA-N 0.000 description 1
- QXSNXUCNBZLVFM-UHFFFAOYSA-N 2-methyl-1h-imidazole;1,3,5-triazinane-2,4,6-trione Chemical compound CC1=NC=CN1.O=C1NC(=O)NC(=O)N1 QXSNXUCNBZLVFM-UHFFFAOYSA-N 0.000 description 1
- IFDUTQGPGFEDHJ-UHFFFAOYSA-N 2-methylprop-2-enoic acid;oxolan-2-one Chemical compound CC(=C)C(O)=O.O=C1CCCO1 IFDUTQGPGFEDHJ-UHFFFAOYSA-N 0.000 description 1
- BNCADMBVWNPPIZ-UHFFFAOYSA-N 2-n,2-n,4-n,4-n,6-n,6-n-hexakis(methoxymethyl)-1,3,5-triazine-2,4,6-triamine Chemical compound COCN(COC)C1=NC(N(COC)COC)=NC(N(COC)COC)=N1 BNCADMBVWNPPIZ-UHFFFAOYSA-N 0.000 description 1
- NXKOSHBFVWYVIH-UHFFFAOYSA-N 2-n-(butoxymethyl)-1,3,5-triazine-2,4,6-triamine Chemical class CCCCOCNC1=NC(N)=NC(N)=N1 NXKOSHBFVWYVIH-UHFFFAOYSA-N 0.000 description 1
- KFVIYKFKUYBKTP-UHFFFAOYSA-N 2-n-(methoxymethyl)-1,3,5-triazine-2,4,6-triamine Chemical class COCNC1=NC(N)=NC(N)=N1 KFVIYKFKUYBKTP-UHFFFAOYSA-N 0.000 description 1
- ZCUJYXPAKHMBAZ-UHFFFAOYSA-N 2-phenyl-1h-imidazole Chemical compound C1=CNC(C=2C=CC=CC=2)=N1 ZCUJYXPAKHMBAZ-UHFFFAOYSA-N 0.000 description 1
- RJIQELZAIWFNTQ-UHFFFAOYSA-N 2-phenyl-1h-imidazole;1,3,5-triazinane-2,4,6-trione Chemical compound O=C1NC(=O)NC(=O)N1.C1=CNC(C=2C=CC=CC=2)=N1 RJIQELZAIWFNTQ-UHFFFAOYSA-N 0.000 description 1
- XLLXMBCBJGATSP-UHFFFAOYSA-N 2-phenylethenol Chemical compound OC=CC1=CC=CC=C1 XLLXMBCBJGATSP-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- LLEASVZEQBICSN-UHFFFAOYSA-N 2-undecyl-1h-imidazole Chemical compound CCCCCCCCCCCC1=NC=CN1 LLEASVZEQBICSN-UHFFFAOYSA-N 0.000 description 1
- WANXHMXXVLVMSK-UHFFFAOYSA-N 2h-benzotriazole;tetrabutylphosphanium Chemical compound C1=CC=CC2=NNN=C21.CCCC[P+](CCCC)(CCCC)CCCC WANXHMXXVLVMSK-UHFFFAOYSA-N 0.000 description 1
- VIONGDJUYAYOPU-UHFFFAOYSA-N 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctane-1-sulfonic acid Chemical compound OS(=O)(=O)CCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F VIONGDJUYAYOPU-UHFFFAOYSA-N 0.000 description 1
- SCJHPUGWYHCYAZ-UHFFFAOYSA-N 3,5-diethyl-2-propylpyridine Chemical compound CCCC1=NC=C(CC)C=C1CC SCJHPUGWYHCYAZ-UHFFFAOYSA-N 0.000 description 1
- UIDDPPKZYZTEGS-UHFFFAOYSA-N 3-(2-ethyl-4-methylimidazol-1-yl)propanenitrile Chemical compound CCC1=NC(C)=CN1CCC#N UIDDPPKZYZTEGS-UHFFFAOYSA-N 0.000 description 1
- SESYNEDUKZDRJL-UHFFFAOYSA-N 3-(2-methylimidazol-1-yl)propanenitrile Chemical compound CC1=NC=CN1CCC#N SESYNEDUKZDRJL-UHFFFAOYSA-N 0.000 description 1
- BVYPJEBKDLFIDL-UHFFFAOYSA-N 3-(2-phenylimidazol-1-yl)propanenitrile Chemical compound N#CCCN1C=CN=C1C1=CC=CC=C1 BVYPJEBKDLFIDL-UHFFFAOYSA-N 0.000 description 1
- SZUPZARBRLCVCB-UHFFFAOYSA-N 3-(2-undecylimidazol-1-yl)propanenitrile Chemical compound CCCCCCCCCCCC1=NC=CN1CCC#N SZUPZARBRLCVCB-UHFFFAOYSA-N 0.000 description 1
- WADSJYLPJPTMLN-UHFFFAOYSA-N 3-(cycloundecen-1-yl)-1,2-diazacycloundec-2-ene Chemical compound C1CCCCCCCCC=C1C1=NNCCCCCCCC1 WADSJYLPJPTMLN-UHFFFAOYSA-N 0.000 description 1
- IFVJFNADUNPGRA-UHFFFAOYSA-N 3-benzylsulfonyloxybutan-2-yl phenylmethanesulfonate Chemical compound C(C1=CC=CC=C1)S(=O)(=O)OC(C(C)OS(=O)(=O)CC1=CC=CC=C1)C IFVJFNADUNPGRA-UHFFFAOYSA-N 0.000 description 1
- NPYMXLXNEYZTMQ-UHFFFAOYSA-N 3-methoxybutyl prop-2-enoate Chemical compound COC(C)CCOC(=O)C=C NPYMXLXNEYZTMQ-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- JLBJTVDPSNHSKJ-UHFFFAOYSA-N 4-Methylstyrene Chemical compound CC1=CC=C(C=C)C=C1 JLBJTVDPSNHSKJ-UHFFFAOYSA-N 0.000 description 1
- NFVPEIKDMMISQO-UHFFFAOYSA-N 4-[(dimethylamino)methyl]phenol Chemical compound CN(C)CC1=CC=C(O)C=C1 NFVPEIKDMMISQO-UHFFFAOYSA-N 0.000 description 1
- BRIXOPDYGQCZFO-UHFFFAOYSA-N 4-ethylphenylsulfonic acid Chemical compound CCC1=CC=C(S(O)(=O)=O)C=C1 BRIXOPDYGQCZFO-UHFFFAOYSA-N 0.000 description 1
- NDWUBGAGUCISDV-UHFFFAOYSA-N 4-hydroxybutyl prop-2-enoate Chemical compound OCCCCOC(=O)C=C NDWUBGAGUCISDV-UHFFFAOYSA-N 0.000 description 1
- LYWVNPSVLAFTFX-UHFFFAOYSA-N 4-methylbenzenesulfonate;morpholin-4-ium Chemical compound C1COCCN1.CC1=CC=C(S(O)(=O)=O)C=C1 LYWVNPSVLAFTFX-UHFFFAOYSA-N 0.000 description 1
- XCGKPXUJHRZWBX-UHFFFAOYSA-N 4-oxo-4-(2-prop-1-enoxyethoxy)butanoic acid Chemical compound C(=CC)OCCOC(CCC(=O)O)=O XCGKPXUJHRZWBX-UHFFFAOYSA-N 0.000 description 1
- FVCSARBUZVPSQF-UHFFFAOYSA-N 5-(2,4-dioxooxolan-3-yl)-7-methyl-3a,4,5,7a-tetrahydro-2-benzofuran-1,3-dione Chemical compound C1C(C(OC2=O)=O)C2C(C)=CC1C1C(=O)COC1=O FVCSARBUZVPSQF-UHFFFAOYSA-N 0.000 description 1
- VSYIJNDEXXBJFH-UHFFFAOYSA-N 5-isocyanato-2-methylpent-1-en-3-one Chemical compound CC(=C)C(=O)CCN=C=O VSYIJNDEXXBJFH-UHFFFAOYSA-N 0.000 description 1
- FOMNBFSRHKJALH-UHFFFAOYSA-N 5-isocyanatopent-1-en-3-one Chemical compound C=CC(=O)CCN=C=O FOMNBFSRHKJALH-UHFFFAOYSA-N 0.000 description 1
- TYOXIFXYEIILLY-UHFFFAOYSA-N 5-methyl-2-phenyl-1h-imidazole Chemical compound N1C(C)=CN=C1C1=CC=CC=C1 TYOXIFXYEIILLY-UHFFFAOYSA-N 0.000 description 1
- OZFPSOBLQZPIAV-UHFFFAOYSA-N 5-nitro-1h-indole Chemical compound [O-][N+](=O)C1=CC=C2NC=CC2=C1 OZFPSOBLQZPIAV-UHFFFAOYSA-N 0.000 description 1
- ULKLGIFJWFIQFF-UHFFFAOYSA-N 5K8XI641G3 Chemical compound CCC1=NC=C(C)N1 ULKLGIFJWFIQFF-UHFFFAOYSA-N 0.000 description 1
- JKYIMLJYCNYGBH-UHFFFAOYSA-N 6-[2-(2-undecyl-1h-imidazol-5-yl)ethyl]-1,3,5-triazine-2,4-diamine Chemical compound N1C(CCCCCCCCCCC)=NC=C1CCC1=NC(N)=NC(N)=N1 JKYIMLJYCNYGBH-UHFFFAOYSA-N 0.000 description 1
- NUXLDNTZFXDNBA-UHFFFAOYSA-N 6-bromo-2-methyl-4h-1,4-benzoxazin-3-one Chemical compound C1=C(Br)C=C2NC(=O)C(C)OC2=C1 NUXLDNTZFXDNBA-UHFFFAOYSA-N 0.000 description 1
- YBUSAOXTVKRWBM-UHFFFAOYSA-N 6-hydroxy-5-(2-methylprop-2-enoyloxy)bicyclo[2.2.1]hept-2-ene-2-carboxylic acid Chemical compound C(C(=C)C)(=O)OC1C2C=C(C(C1O)C2)C(=O)O YBUSAOXTVKRWBM-UHFFFAOYSA-N 0.000 description 1
- HENOIELGCBDCOI-UHFFFAOYSA-N 6-hydroxy-5-prop-2-enoyloxybicyclo[2.2.1]hept-2-ene-2-carboxylic acid Chemical compound C(C=C)(=O)OC1C2C=C(C(C1O)C2)C(=O)O HENOIELGCBDCOI-UHFFFAOYSA-N 0.000 description 1
- JRLTTZUODKEYDH-UHFFFAOYSA-N 8-methylquinoline Chemical group C1=CN=C2C(C)=CC=CC2=C1 JRLTTZUODKEYDH-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical group NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- UJCDHVHLRYVDIJ-UHFFFAOYSA-N B(OC1=CC=CC=C1)(OC1=CC=CC=C1)OC1=CC=CC=C1.[B] Chemical class B(OC1=CC=CC=C1)(OC1=CC=CC=C1)OC1=CC=CC=C1.[B] UJCDHVHLRYVDIJ-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- UPIYXCQZCKSJJX-UHFFFAOYSA-N CCCCOCC=C(C)C(N)=O Chemical compound CCCCOCC=C(C)C(N)=O UPIYXCQZCKSJJX-UHFFFAOYSA-N 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 102100024342 Contactin-2 Human genes 0.000 description 1
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- XXRCUYVCPSWGCC-UHFFFAOYSA-N Ethyl pyruvate Chemical compound CCOC(=O)C(C)=O XXRCUYVCPSWGCC-UHFFFAOYSA-N 0.000 description 1
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 description 1
- 101000909516 Homo sapiens Contactin-2 Proteins 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M Methanesulfonate Chemical compound CS([O-])(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SVYKKECYCPFKGB-UHFFFAOYSA-N N,N-dimethylcyclohexylamine Chemical compound CN(C)C1CCCCC1 SVYKKECYCPFKGB-UHFFFAOYSA-N 0.000 description 1
- QAPCGCUXFUVGLZ-UHFFFAOYSA-N NC(=O)N.C(CCC)OCC#C Chemical group NC(=O)N.C(CCC)OCC#C QAPCGCUXFUVGLZ-UHFFFAOYSA-N 0.000 description 1
- CYMUWKHIPQGGNU-UHFFFAOYSA-N NC(=O)N.COCC#C Chemical group NC(=O)N.COCC#C CYMUWKHIPQGGNU-UHFFFAOYSA-N 0.000 description 1
- 241000047703 Nonion Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 229910052581 Si3N4 Inorganic materials 0.000 description 1
- 239000006087 Silane Coupling Agent Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- YMOONIIMQBGTDU-VOTSOKGWSA-N [(e)-2-bromoethenyl]benzene Chemical compound Br\C=C\C1=CC=CC=C1 YMOONIIMQBGTDU-VOTSOKGWSA-N 0.000 description 1
- UUQQGGWZVKUCBD-UHFFFAOYSA-N [4-(hydroxymethyl)-2-phenyl-1h-imidazol-5-yl]methanol Chemical compound N1C(CO)=C(CO)N=C1C1=CC=CC=C1 UUQQGGWZVKUCBD-UHFFFAOYSA-N 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229920013820 alkyl cellulose Polymers 0.000 description 1
- FTWHFXMUJQRNBK-UHFFFAOYSA-N alpha-Methylen-gamma-aminobuttersaeure Natural products NCCC(=C)C(O)=O FTWHFXMUJQRNBK-UHFFFAOYSA-N 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 125000005577 anthracene group Chemical group 0.000 description 1
- JOTMSPQTVYMNNI-UHFFFAOYSA-N anthracene;2-methylprop-2-enoic acid Chemical compound CC(=C)C(O)=O.C1=CC=CC2=CC3=CC=CC=C3C=C21 JOTMSPQTVYMNNI-UHFFFAOYSA-N 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- GCTPMLUUWLLESL-UHFFFAOYSA-N benzyl prop-2-enoate Chemical compound C=CC(=O)OCC1=CC=CC=C1 GCTPMLUUWLLESL-UHFFFAOYSA-N 0.000 description 1
- USFRYJRPHFMVBZ-UHFFFAOYSA-M benzyl(triphenyl)phosphanium;chloride Chemical compound [Cl-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)CC1=CC=CC=C1 USFRYJRPHFMVBZ-UHFFFAOYSA-M 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- XCEUHXVTRJQJSR-UHFFFAOYSA-N bromo(phenyl)phosphane Chemical compound BrPC1=CC=CC=C1 XCEUHXVTRJQJSR-UHFFFAOYSA-N 0.000 description 1
- QDHFHIQKOVNCNC-UHFFFAOYSA-N butane-1-sulfonic acid Chemical compound CCCCS(O)(=O)=O QDHFHIQKOVNCNC-UHFFFAOYSA-N 0.000 description 1
- IKWKJIWDLVYZIY-UHFFFAOYSA-M butyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(CCCC)C1=CC=CC=C1 IKWKJIWDLVYZIY-UHFFFAOYSA-M 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 238000010538 cationic polymerization reaction Methods 0.000 description 1
- 239000007809 chemical reaction catalyst Substances 0.000 description 1
- 230000003098 cholesteric effect Effects 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 101150005988 cin2 gene Proteins 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229920005565 cyclic polymer Polymers 0.000 description 1
- OIWOHHBRDFKZNC-UHFFFAOYSA-N cyclohexyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC1CCCCC1 OIWOHHBRDFKZNC-UHFFFAOYSA-N 0.000 description 1
- KBLWLMPSVYBVDK-UHFFFAOYSA-N cyclohexyl prop-2-enoate Chemical compound C=CC(=O)OC1CCCCC1 KBLWLMPSVYBVDK-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- SIGZQNJITOWQEF-VICXVTCVSA-M dicloxacillin sodium monohydrate Chemical compound O.[Na+].N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C([O-])=O)=O)C(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1Cl SIGZQNJITOWQEF-VICXVTCVSA-M 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 description 1
- ROORDVPLFPIABK-UHFFFAOYSA-N diphenyl carbonate Chemical compound C=1C=CC=CC=1OC(=O)OC1=CC=CC=C1 ROORDVPLFPIABK-UHFFFAOYSA-N 0.000 description 1
- UKXCWLFBHULELL-UHFFFAOYSA-N diphenylmethanone;n-ethylethanamine Chemical compound CCNCC.C=1C=CC=CC=1C(=O)C1=CC=CC=C1 UKXCWLFBHULELL-UHFFFAOYSA-N 0.000 description 1
- GPAYUJZHTULNBE-UHFFFAOYSA-N diphenylphosphine Chemical compound C=1C=CC=CC=1PC1=CC=CC=C1 GPAYUJZHTULNBE-UHFFFAOYSA-N 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 229940060296 dodecylbenzenesulfonic acid Drugs 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- AZDCYKCDXXPQIK-UHFFFAOYSA-N ethenoxymethylbenzene Chemical compound C=COCC1=CC=CC=C1 AZDCYKCDXXPQIK-UHFFFAOYSA-N 0.000 description 1
- MMVJBWFKSYKXIA-UHFFFAOYSA-N ethoxyethane;2-methylprop-2-enoic acid Chemical compound CCOCC.CC(=C)C(O)=O MMVJBWFKSYKXIA-UHFFFAOYSA-N 0.000 description 1
- LVMRFLWAXIZLNG-UHFFFAOYSA-N ethoxyethane;prop-2-enoic acid Chemical compound CCOCC.OC(=O)C=C LVMRFLWAXIZLNG-UHFFFAOYSA-N 0.000 description 1
- GFUIDHWFLMPAGY-UHFFFAOYSA-N ethyl 2-hydroxy-2-methylpropanoate Chemical compound CCOC(=O)C(C)(C)O GFUIDHWFLMPAGY-UHFFFAOYSA-N 0.000 description 1
- ZANNOFHADGWOLI-UHFFFAOYSA-N ethyl 2-hydroxyacetate Chemical compound CCOC(=O)CO ZANNOFHADGWOLI-UHFFFAOYSA-N 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- IIQWTZQWBGDRQG-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate;isocyanic acid Chemical compound N=C=O.CCOC(=O)C(C)=C IIQWTZQWBGDRQG-UHFFFAOYSA-N 0.000 description 1
- BHXIWUJLHYHGSJ-UHFFFAOYSA-N ethyl 3-ethoxypropanoate Chemical compound CCOCCC(=O)OCC BHXIWUJLHYHGSJ-UHFFFAOYSA-N 0.000 description 1
- 229940117360 ethyl pyruvate Drugs 0.000 description 1
- HZZUMXSLPJFMCB-UHFFFAOYSA-M ethyl(triphenyl)phosphanium;acetate Chemical compound CC([O-])=O.C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(CC)C1=CC=CC=C1 HZZUMXSLPJFMCB-UHFFFAOYSA-M 0.000 description 1
- SLAFUPJSGFVWPP-UHFFFAOYSA-M ethyl(triphenyl)phosphanium;iodide Chemical compound [I-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(CC)C1=CC=CC=C1 SLAFUPJSGFVWPP-UHFFFAOYSA-M 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- SLGWESQGEUXWJQ-UHFFFAOYSA-N formaldehyde;phenol Chemical compound O=C.OC1=CC=CC=C1 SLGWESQGEUXWJQ-UHFFFAOYSA-N 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- VPVSTMAPERLKKM-UHFFFAOYSA-N glycoluril Chemical compound N1C(=O)NC2NC(=O)NC21 VPVSTMAPERLKKM-UHFFFAOYSA-N 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 229920013819 hydroxyethyl ethylcellulose Polymers 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M isovalerate Chemical compound CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- SKTCDJAMAYNROS-UHFFFAOYSA-N methoxycyclopentane Chemical compound COC1CCCC1 SKTCDJAMAYNROS-UHFFFAOYSA-N 0.000 description 1
- YSGBMDFJWFIEDF-UHFFFAOYSA-N methyl 2-hydroxy-3-methylbutanoate Chemical compound COC(=O)C(O)C(C)C YSGBMDFJWFIEDF-UHFFFAOYSA-N 0.000 description 1
- RIOOIQBUNJDFON-UHFFFAOYSA-N methyl 2-methylprop-2-enoate oxolane Chemical compound O1CCCC1.COC(C(=C)C)=O RIOOIQBUNJDFON-UHFFFAOYSA-N 0.000 description 1
- BDJSOPWXYLFTNW-UHFFFAOYSA-N methyl 3-methoxypropanoate Chemical compound COCCC(=O)OC BDJSOPWXYLFTNW-UHFFFAOYSA-N 0.000 description 1
- FNVQPLCHYJQMHP-UHFFFAOYSA-N methyl prop-2-enoate oxolane Chemical compound C(C=C)(=O)OC.O1CCCC1 FNVQPLCHYJQMHP-UHFFFAOYSA-N 0.000 description 1
- CWKLZLBVOJRSOM-UHFFFAOYSA-N methyl pyruvate Chemical compound COC(=O)C(C)=O CWKLZLBVOJRSOM-UHFFFAOYSA-N 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- LSEFCHWGJNHZNT-UHFFFAOYSA-M methyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C)C1=CC=CC=C1 LSEFCHWGJNHZNT-UHFFFAOYSA-M 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- JESXATFQYMPTNL-UHFFFAOYSA-N mono-hydroxyphenyl-ethylene Natural products OC1=CC=CC=C1C=C JESXATFQYMPTNL-UHFFFAOYSA-N 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- ICWPRFNZEBFLPT-UHFFFAOYSA-N n-(2-hydroxyphenyl)-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NC1=CC=CC=C1O ICWPRFNZEBFLPT-UHFFFAOYSA-N 0.000 description 1
- KIQBVKPQYARZTK-UHFFFAOYSA-N n-(2-hydroxyphenyl)prop-2-enamide Chemical compound OC1=CC=CC=C1NC(=O)C=C KIQBVKPQYARZTK-UHFFFAOYSA-N 0.000 description 1
- YGRMNBNGHHDGCX-UHFFFAOYSA-N n-(ethoxymethyl)-2-methylprop-2-enamide Chemical compound CCOCNC(=O)C(C)=C YGRMNBNGHHDGCX-UHFFFAOYSA-N 0.000 description 1
- DNTMQTKDNSEIFO-UHFFFAOYSA-N n-(hydroxymethyl)-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NCO DNTMQTKDNSEIFO-UHFFFAOYSA-N 0.000 description 1
- YOZHLACIXDCHPV-UHFFFAOYSA-N n-(methoxymethyl)-2-methylprop-2-enamide Chemical compound COCNC(=O)C(C)=C YOZHLACIXDCHPV-UHFFFAOYSA-N 0.000 description 1
- DYLMGWPMAXPGEB-UHFFFAOYSA-N n-ethoxy-2-methylprop-2-enamide Chemical compound CCONC(=O)C(C)=C DYLMGWPMAXPGEB-UHFFFAOYSA-N 0.000 description 1
- OHPZPBNDOVQJMH-UHFFFAOYSA-N n-ethyl-4-methylbenzenesulfonamide Chemical compound CCNS(=O)(=O)C1=CC=C(C)C=C1 OHPZPBNDOVQJMH-UHFFFAOYSA-N 0.000 description 1
- IIXYEVUNJFXWEB-UHFFFAOYSA-N n-hydroxy-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NO IIXYEVUNJFXWEB-UHFFFAOYSA-N 0.000 description 1
- SEEYREPSKCQBBF-UHFFFAOYSA-N n-methylmaleimide Chemical compound CN1C(=O)C=CC1=O SEEYREPSKCQBBF-UHFFFAOYSA-N 0.000 description 1
- KKFHAJHLJHVUDM-UHFFFAOYSA-N n-vinylcarbazole Chemical compound C1=CC=C2N(C=C)C3=CC=CC=C3C2=C1 KKFHAJHLJHVUDM-UHFFFAOYSA-N 0.000 description 1
- HVYCQBKSRWZZGX-UHFFFAOYSA-N naphthalen-1-yl 2-methylprop-2-enoate Chemical compound C1=CC=C2C(OC(=O)C(=C)C)=CC=CC2=C1 HVYCQBKSRWZZGX-UHFFFAOYSA-N 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 1
- WLGDAKIJYPIYLR-UHFFFAOYSA-N octane-1-sulfonic acid Chemical compound CCCCCCCCS(O)(=O)=O WLGDAKIJYPIYLR-UHFFFAOYSA-N 0.000 description 1
- 150000002903 organophosphorus compounds Chemical class 0.000 description 1
- QUBQYFYWUJJAAK-UHFFFAOYSA-N oxymethurea Chemical compound OCNC(=O)NCO QUBQYFYWUJJAAK-UHFFFAOYSA-N 0.000 description 1
- RJQRCOMHVBLQIH-UHFFFAOYSA-N pentane-1-sulfonic acid Chemical compound CCCCCS(O)(=O)=O RJQRCOMHVBLQIH-UHFFFAOYSA-N 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- JGTNAGYHADQMCM-UHFFFAOYSA-N perfluorobutanesulfonic acid Chemical compound OS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F JGTNAGYHADQMCM-UHFFFAOYSA-N 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- QIWKUEJZZCOPFV-UHFFFAOYSA-N phenyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC1=CC=CC=C1 QIWKUEJZZCOPFV-UHFFFAOYSA-N 0.000 description 1
- WRAQQYDMVSCOTE-UHFFFAOYSA-N phenyl prop-2-enoate Chemical compound C=CC(=O)OC1=CC=CC=C1 WRAQQYDMVSCOTE-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920000083 poly(allylamine) Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 239000009719 polyimide resin Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- BOQSSGDQNWEFSX-UHFFFAOYSA-N propan-2-yl 2-methylprop-2-enoate Chemical compound CC(C)OC(=O)C(C)=C BOQSSGDQNWEFSX-UHFFFAOYSA-N 0.000 description 1
- LYBIZMNPXTXVMV-UHFFFAOYSA-N propan-2-yl prop-2-enoate Chemical compound CC(C)OC(=O)C=C LYBIZMNPXTXVMV-UHFFFAOYSA-N 0.000 description 1
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 150000003440 styrenes Chemical class 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- SJMYWORNLPSJQO-UHFFFAOYSA-N tert-butyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(C)(C)C SJMYWORNLPSJQO-UHFFFAOYSA-N 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- BJQWBACJIAKDTJ-UHFFFAOYSA-N tetrabutylphosphanium Chemical compound CCCC[P+](CCCC)(CCCC)CCCC BJQWBACJIAKDTJ-UHFFFAOYSA-N 0.000 description 1
- RKHXQBLJXBGEKF-UHFFFAOYSA-M tetrabutylphosphanium;bromide Chemical compound [Br-].CCCC[P+](CCCC)(CCCC)CCCC RKHXQBLJXBGEKF-UHFFFAOYSA-M 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- YRHRIQCWCFGUEQ-UHFFFAOYSA-N thioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3SC2=C1 YRHRIQCWCFGUEQ-UHFFFAOYSA-N 0.000 description 1
- KSBAEPSJVUENNK-UHFFFAOYSA-L tin(ii) 2-ethylhexanoate Chemical compound [Sn+2].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O KSBAEPSJVUENNK-UHFFFAOYSA-L 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- HVLLSGMXQDNUAL-UHFFFAOYSA-N triphenyl phosphite Natural products C=1C=CC=CC=1OP(OC=1C=CC=CC=1)OC1=CC=CC=C1 HVLLSGMXQDNUAL-UHFFFAOYSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- CHJMFFKHPHCQIJ-UHFFFAOYSA-L zinc;octanoate Chemical compound [Zn+2].CCCCCCCC([O-])=O.CCCCCCCC([O-])=O CHJMFFKHPHCQIJ-UHFFFAOYSA-L 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/04—Acids; Metal salts or ammonium salts thereof
- C08F220/06—Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
- C08F220/32—Esters containing oxygen in addition to the carboxy oxygen containing epoxy radicals
- C08F220/325—Esters containing oxygen in addition to the carboxy oxygen containing epoxy radicals containing glycidyl radical, e.g. glycidyl (meth)acrylate
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
- C08J5/18—Manufacture of films or sheets
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B5/00—Optical elements other than lenses
- G02B5/30—Polarising elements
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1335—Structural association of cells with optical devices, e.g. polarisers or reflectors
- G02F1/13363—Birefringent elements, e.g. for optical compensation
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
- G02F1/133711—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
Landscapes
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Nonlinear Science (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Mathematical Physics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Liquid Crystal (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Polarising Elements (AREA)
Abstract
本發明的課題為提供形成具備優良液晶配向性與密合性之硬化膜的硬化膜形成組成物、其硬化膜、使用該硬化膜所形成之光學薄膜、配向材料及相位差材料。 其解決手段為含有(A)具有光配向性基、羥基,與含有C=C雙鍵之聚合性基的聚合物、(B)交聯劑,及(C)交聯觸媒之硬化膜形成組成物、由該硬化膜形成組成物所形成之硬化膜、使用該硬化膜所形成之光學薄膜、配向材料、相位差材料。An object of the present invention is to provide a cured film-forming composition that forms a cured film having excellent liquid crystal alignment and adhesion, its cured film, an optical film, an alignment material, and a retardation material formed using the cured film. The solution is to form a cured film containing (A) a polymer with photoalignment groups, hydroxyl groups, and polymerizable groups containing C=C double bonds, (B) cross-linking agents, and (C) cross-linking catalysts. Composition, cured film formed from the cured film forming composition, optical film formed using the cured film, alignment material, and retardation material.
Description
本發明係關於形成使液晶分子配向之硬化膜的硬化膜形成組成物、硬化膜、光學薄膜、配向材料及相位差材料。本發明特別關於使用於圓偏光眼鏡方式之3D顯示器的經圖型化之相位差材料,使用於作為及有機EL顯示器之抗反射膜使用的圓偏光板之相位差材料,以及有用於製作該相位差材料的硬化膜形成組成物、硬化膜、光學薄膜及配向材料。The present invention relates to a cured film-forming composition, a cured film, an optical film, an alignment material, and a retardation material that form a cured film that aligns liquid crystal molecules. The present invention particularly relates to patterned phase difference materials used in 3D displays using circularly polarized glasses, phase difference materials used in circularly polarizing plates used as anti-reflective films in organic EL displays, and useful in making the phase difference materials. Cured film forming compositions, cured films, optical films and alignment materials of poor materials.
圓偏光眼鏡方式之3D顯示器的情況,通常係於液晶面板等之形成影像的顯示元件上配置相位差材料。該相位差材料,係分別複數、規則地配置有相位差特性相異之2種相位差區域,構成經圖型化之相位差材料。再者,以下,本說明書中,係將以配置如此的相位差特性相異之複數個相位差區域的方式經圖型化之相位差材料稱為圖型化相位差材料。In the case of 3D displays using circularly polarized glasses, phase difference materials are usually placed on display elements that form images, such as liquid crystal panels. This phase difference material has two types of phase difference regions with different phase difference characteristics arranged in a plural and regular manner, forming a patterned phase difference material. In the following, in this specification, a retardation material patterned in such a manner that a plurality of retardation regions with different retardation characteristics are arranged is called a patterned retardation material.
圖型化相位差材料,例如如專利文獻1所揭示,可藉由將由聚合性液晶所構成之相位差材料予以光學圖型化來製作。由聚合性液晶所構成之相位差材料之光學圖型化,係利用於液晶面板之配向材料形成中已知的光配向技術。亦即,於基板上設置由光配向性之材料所構成之塗膜,對其照射偏光方向相異之2種之偏光。然後,得到光配向膜,作為形成有液晶之配向控制方向相異之2種液晶配向區域的配向材料。對該光配向膜之上塗佈含有聚合性液晶之溶液狀之相位差材料,而實現聚合性液晶之配向。之後,使經配向之聚合性液晶硬化,而形成圖型化相位差材料。A patterned retardation material can be produced by optically patterning a retardation material composed of polymerizable liquid crystal, as disclosed in Patent Document 1, for example. Optical patterning of phase difference materials composed of polymeric liquid crystals utilizes photo-alignment technology known in the formation of alignment materials for liquid crystal panels. That is, a coating film composed of a photo-alignment material is provided on a substrate, and two types of polarized light with different polarization directions are irradiated onto the coating film. Then, a photo-alignment film is obtained as an alignment material in which two types of liquid crystal alignment regions having different alignment control directions of liquid crystal are formed. A solution phase difference material containing polymerizable liquid crystal is coated on the photo-alignment film to realize alignment of the polymerizable liquid crystal. Afterwards, the aligned polymeric liquid crystal is hardened to form a patterned retardation material.
有機EL顯示器之抗反射膜,係以直線偏光板、1/4波長相位差板所構成,將朝向影像顯示面板之面板面的外來光藉由直線偏光板轉換為直線偏光,接著藉由1/4波長相位差板轉換為圓偏光。此處該圓偏光之外來光,係於影像顯示面板之表面等反射,但該反射時偏光面之旋轉方向會逆轉。其結果,該反射光係與到來時相反,由1/4波長相位差板,藉由直線偏光板轉換為被遮光之方向的直線偏光後,接著藉由直線偏光板而被遮光,其結果,對外部的出射顯著被抑制。The anti-reflective film of the organic EL display is composed of a linear polarizing plate and a 1/4 wavelength phase difference plate. The external light directed towards the panel surface of the image display panel is converted into linearly polarized light by the linear polarizing plate, and then 1/4 wave retardation plate is used. The 4-wavelength phase difference plate converts circularly polarized light. Here, the circularly polarized external light is reflected from the surface of the image display panel, but the rotation direction of the polarizing surface is reversed during this reflection. As a result, the reflected light is reversed when it arrives, and is converted by the 1/4 wavelength phase difference plate into linearly polarized light in the direction of being blocked by the linear polarizing plate, and then is blocked by the linear polarizing plate. As a result, Emission to the outside is significantly suppressed.
關於該1/4波長相位差板,專利文獻2中,提出藉由組合1/2波長板、1/4波長板來構成1/4波長相位差板,而藉由逆分散特性來構成該光學薄膜的方法。該方法的情況時,於進行彩色影像顯示之寬的波長帶,可使用正的分散特性之液晶材料,藉由逆分散特性構成光學薄膜。Regarding this 1/4-wavelength retardation plate, Patent Document 2 proposes that a 1/4-wavelength retardation plate is constituted by combining a 1/2-wavelength plate and a 1/4-wavelength plate, and the optical structure is configured with reverse dispersion characteristics. thin film method. In the case of this method, a liquid crystal material with positive dispersion characteristics can be used in a wide wavelength band for color image display, and an optical film can be formed by using reverse dispersion characteristics.
又,近年來,作為可應用於該相位差層之液晶材料,提出有具備逆分散特性者(專利文獻3、4)。依照如此的逆分散特性之液晶材料,藉由單層來構成相位差層,以取代組合1/2波長板、1/4波長板藉由2層相位差層來構成1/4波長相位差板,可確保逆分散特性,藉此,可藉由簡易的構成,來實現可於寬的波長帶確保所期望之相位差的光學薄膜。Furthermore, in recent years, liquid crystal materials having reverse dispersion characteristics that can be applied to the retardation layer have been proposed (Patent Documents 3 and 4). According to the liquid crystal material with such reverse dispersion characteristics, the retardation layer is composed of a single layer, instead of combining the 1/2-wavelength plate and the 1/4-wavelength plate, the 1/4-wavelength retardation plate is composed of two retardation layers. , can ensure reverse dispersion characteristics, thereby realizing an optical film that can ensure a desired phase difference in a wide wavelength band with a simple structure.
為了使液晶配向,係使用配向層。配向層之形成方法,已知有例如摩擦法或光配向法,光配向法於不產生摩擦法之問題點的靜電或灰塵,可控制定量的配向處理方面係有用的。In order to align the liquid crystal, an alignment layer is used. Known methods for forming the alignment layer include the rubbing method and the photo-alignment method. The photo-alignment method is useful in a quantitative alignment process that does not cause static electricity or dust, which is a problem with the rubbing method.
使用光配向法形成配向材料時,作為可利用之光配向性的材料,已知有於側鏈具有桂皮醯基及查耳酮基等之光二聚化部位的丙烯酸樹脂或聚醯亞胺樹脂等。有報告此等之樹脂,藉由照射偏光UV,會顯示控制液晶之配向的性能(以下亦稱為液晶配向性)(參照專利文獻5~專利文獻7)。When forming an alignment material using a photo-alignment method, known materials with photo-alignment properties that can be used include acrylic resins and polyimide resins that have photodimerization sites such as cinnamyl groups and chalcone groups in their side chains. . It has been reported that these resins can exhibit the ability to control the alignment of liquid crystals (hereinafter also referred to as liquid crystal alignment properties) by irradiating polarized UV (refer to Patent Documents 5 to 7).
又,對於配向層不只要求液晶配向能力,且要求耐溶劑性。例如,配向層在相位差材料之製造過程中有暴露於熱或溶劑的情況。配向層暴露於溶劑時,有液晶配向能顯著降低之虞。In addition, the alignment layer requires not only liquid crystal alignment ability but also solvent resistance. For example, the alignment layer may be exposed to heat or solvent during the manufacturing process of the retardation material. When the alignment layer is exposed to solvent, there is a risk that the liquid crystal alignment energy will be significantly reduced.
因而,例如專利文獻8中,為了得到安定之液晶配向能力,提出含有具有可藉由光進行交聯反應之結構與可藉由熱進行交聯之結構的聚合物成分之液晶配向劑,及含有可具有藉由光進行交聯反應之結構的聚合物成分與具有可藉由熱進行交聯之結構的化合物之液晶配向劑。Therefore, for example, in Patent Document 8, in order to obtain stable liquid crystal alignment ability, a liquid crystal alignment agent containing a polymer component having a structure capable of cross-linking reaction by light and a structure capable of cross-linking by heat is proposed, and a liquid crystal alignment agent containing A liquid crystal alignment agent having a polymer component having a structure that can be cross-linked by light and a compound having a structure that can be cross-linked with heat.
此外,對於配向層,係要求與液晶層之密合性。配向層與形成於其上之液晶層的密合力不充分時,例如於相位差薄膜製造時之捲繞步驟等中,上述液晶層可能剝離。 [先前技術文獻] [專利文獻]In addition, the alignment layer is required to have good adhesion with the liquid crystal layer. When the adhesion between the alignment layer and the liquid crystal layer formed thereon is insufficient, for example, during the winding step in manufacturing the retardation film, the liquid crystal layer may peel off. [Prior technical literature] [Patent Document]
[專利文獻1]日本特開2005-49865號公報 [專利文獻2]日本特開平10-68816號公報 [專利文獻3]美國專利第8119026號說明書 [專利文獻4]日本特開2009-179563號公報 [專利文獻5]日本專利第3611342號公報 [專利文獻6]日本特開2009-058584號公報 [專利文獻7]日本特表2001-517719號公報 [專利文獻8]日本專利第4207430號公報[Patent Document 1] Japanese Patent Application Publication No. 2005-49865 [Patent Document 2] Japanese Patent Application Publication No. 10-68816 [Patent Document 3] U.S. Patent No. 8119026 Specification [Patent Document 4] Japanese Patent Application Publication No. 2009-179563 [Patent Document 5] Japanese Patent No. 3611342 [Patent Document 6] Japanese Patent Application Publication No. 2009-058584 [Patent Document 7] Japanese Patent Publication No. 2001-517719 [Patent Document 8] Japanese Patent No. 4207430
[發明所欲解決之課題][Problem to be solved by the invention]
本發明係基於以上見解或探討結果而為者。亦即,本發明之目的,為提供用以形成使用於形成具有優良之耐溶劑性,能夠以高感度使聚合性液晶配向,與液晶層之密合性優良的配向材料之硬化膜的硬化膜形成組成物。 又,本發明之目的,為提供具有上述硬化膜之光學薄膜、使用該硬化膜或光學薄膜所形成之配向材料及相位差材料。The present invention is based on the above insights or research results. That is, an object of the present invention is to provide a cured film for use in forming a cured film of an alignment material that has excellent solvent resistance, can align polymerizable liquid crystal with high sensitivity, and has excellent adhesion to the liquid crystal layer. form composition. Furthermore, an object of the present invention is to provide an optical film having the above-mentioned cured film, and an alignment material and a retardation material formed using the cured film or optical film.
本發明之其他目的及優點,由以下記載即明顯可知。 [用以解決課題之手段]Other objects and advantages of the present invention will become apparent from the following description. [Means used to solve problems]
本發明之第1態樣,係關於一種硬化膜形成組成物,其含有 (A)具有光配向性基、羥基,與含有C=C雙鍵之聚合性基的聚合物、 (B)交聯劑,及 (C)交聯觸媒。 本發明之第1態樣中,(A)成分之光配向性基較佳為具有光二聚化或光異構化之結構的官能基。 本發明之第1態樣中,(A)成分之光配向性基較佳為具有桂皮醯基或偶氮苯結構之基。 本發明之第1態樣中,較佳為進一步含有(D)具有選自由羥基、羧基、醯胺基、胺基及烷氧基矽烷基所成之群的至少一種基之聚合物。 本發明之第1態樣中,(A)成分之聚合物,較佳包含具有羥基之結構單位與具有含有C=C雙鍵之聚合性基的結構單位,該具有羥基之結構單位之存在比例,相對於該聚合物之全部結構單位100莫耳%而言,為20莫耳%以上,且該具有含有C=C雙鍵之聚合性基的結構單位之存在比例,相對於該聚合物之全部結構單位100莫耳%而言,為5莫耳%以上。 本發明之第1態樣中,前述硬化膜形成組成物,以(A)成分之100質量份為基準,較佳含有5質量份至500質量份之(B)成分。 本發明之第1態樣中,前述硬化膜形成組成物,以(A)成分之100質量份為基準,較佳含有0.01質量份至20質量份之(C)成分。A first aspect of the present invention relates to a cured film forming composition containing (A) A polymer having a photoalignment group, a hydroxyl group, and a polymerizable group containing a C=C double bond, (B) cross-linking agent, and (C) Cross-linking catalyst. In the first aspect of the present invention, the photo-alignment group of component (A) is preferably a functional group having a structure of photodimerization or photoisomerization. In the first aspect of the present invention, the photo-alignment group of component (A) is preferably a group having a cinnamonyl group or an azobenzene structure. In the first aspect of the present invention, it is preferred that the polymer further contains (D) a polymer having at least one group selected from the group consisting of a hydroxyl group, a carboxyl group, a amide group, an amine group, and an alkoxysilyl group. In the first aspect of the present invention, the polymer of component (A) preferably contains a structural unit having a hydroxyl group and a structural unit having a polymerizable group containing a C=C double bond, and the ratio of the structural unit having a hydroxyl group is , relative to 100 mol% of all structural units of the polymer, is 20 mol% or more, and the proportion of the structural units having polymerizable groups containing C=C double bonds is relative to the polymer. In terms of 100 mol% of all structural units, it is more than 5 mol%. In the first aspect of the present invention, the cured film forming composition preferably contains 5 to 500 parts by mass of component (B) based on 100 parts by mass of component (A). In the first aspect of the present invention, the cured film forming composition preferably contains 0.01 to 20 parts by mass of component (C) based on 100 parts by mass of component (A).
本發明之第2態樣,係關於由本發明之第1態樣之硬化膜形成組成物所得到的硬化膜。A second aspect of the present invention relates to a cured film obtained from the cured film forming composition of the first aspect of the present invention.
本發明之第3態樣,係關於具有由本發明之第1態樣之硬化膜形成組成物所得到的硬化膜之光學薄膜。A third aspect of the present invention relates to an optical film having a cured film obtained from the cured film-forming composition of the first aspect of the present invention.
本發明之第4態樣,係關於一種配向材料,其特徵為使用本發明之第2態樣之硬化膜所形成。A fourth aspect of the present invention relates to an alignment material, characterized by being formed using the cured film of the second aspect of the present invention.
本發明之第5態樣,係關於一種相位差材料,其特徵為使用本發明之第2態樣之硬化膜所形成。 [發明之效果]A fifth aspect of the present invention relates to a retardation material, characterized by being formed using the cured film of the second aspect of the present invention. [Effects of the invention]
依照本發明,可提供具有優良之耐溶劑性,能夠以高感度使聚合性液晶配向,與液晶層之密合性優良的硬化膜,與適於其形成的硬化膜形成組成物。 又,依照本發明,可提供具有上述硬化膜之光學薄膜,及使用硬化膜或光學薄膜所形成之配向材料及相位差材料。According to the present invention, it is possible to provide a cured film having excellent solvent resistance, capable of aligning polymerizable liquid crystal with high sensitivity, excellent adhesion to the liquid crystal layer, and a cured film-forming composition suitable for its formation. Furthermore, according to the present invention, it is possible to provide an optical film having the above-mentioned cured film, and an alignment material and a retardation material formed using the cured film or the optical film.
如上所述,具有優良之耐溶劑性,能夠以高感度使聚合性液晶配向,與液晶層之密合性優良的硬化膜(配向材料)係受到需求。此外,適於形成如此性能之硬化膜(配向材料)的硬化膜形成組成物係受到需求。As described above, there is a demand for a cured film (alignment material) that has excellent solvent resistance, can align polymerizable liquid crystal with high sensitivity, and has excellent adhesion to the liquid crystal layer. In addition, a cured film forming composition suitable for forming a cured film (alignment material) with such properties is in demand.
本發明者為了回應上述要求,進行深入探討的結果,發現由具有特定組成之硬化膜形成組成物所得到的硬化膜,可利用作為具有優良之耐溶劑性,能夠以高感度使聚合性液晶配向,與液晶層之密合性優良的配向材料。In order to respond to the above request, the present inventors conducted in-depth research and found that a cured film obtained from a cured film-forming composition having a specific composition can be used as a cured film that has excellent solvent resistance and can align polymeric liquid crystals with high sensitivity. , an alignment material with excellent adhesion to the liquid crystal layer.
以下,一邊列舉成分等之具體例一邊詳細說明本發明之硬化膜形成組成物。此外,說明使用本發明之硬化膜形成組成物的本發明之硬化膜及配向材料,以及使用該配向材料所形成之相位差材料及液晶顯示元件等。Hereinafter, the cured film forming composition of the present invention will be described in detail while listing specific examples of components and the like. In addition, the cured film and alignment material of the present invention using the cured film forming composition of the present invention, as well as the retardation material and liquid crystal display element formed using the alignment material will be described.
<硬化膜形成組成物> 本發明之硬化膜形成組成物,含有(A)成分的具有光配向性基、羥基,與含有C=C雙鍵之聚合性基的聚合物、(B)成分的交聯劑,及(C)成分的交聯觸媒。又,可含有(D)成分的具有選自由羥基、羧基、醯胺基、胺基及烷氧基矽烷基所成之群的至少一種基之聚合物。進一步地,只要不損及本發明之效果,則可含有其他添加劑。進一步地,可含有溶劑。 以下說明各成分之詳情。<Cure film forming composition> The cured film forming composition of the present invention contains a polymer having a photoalignment group, a hydroxyl group, and a polymerizable group containing a C=C double bond as the component (A), a cross-linking agent as the component (B), and (C). ) component of the cross-linking catalyst. Moreover, the polymer which has at least one group selected from the group consisting of a hydroxyl group, a carboxyl group, a amide group, an amino group, and an alkoxysilyl group may contain (D) component. Furthermore, other additives may be included as long as the effects of the present invention are not impaired. Furthermore, a solvent may be included. Details of each ingredient are explained below.
[(A)成分] 本發明之硬化膜形成組成物中之(A)成分,為具有光配向性基、羥基,與含有C=C雙鍵之聚合性基的聚合物。亦即(A)成分為對由本發明之硬化膜形成組成物所得到的硬化膜賦予光配向性之成分,本說明書中,亦將(A)成分稱為光配向成分。[(A) ingredient] Component (A) in the cured film forming composition of the present invention is a polymer having a photo-alignment group, a hydroxyl group, and a polymerizable group containing a C=C double bond. That is, component (A) is a component that imparts photo-alignment properties to the cured film obtained from the cured film-forming composition of the present invention. In this specification, component (A) is also referred to as a photo-alignment component.
本發明之硬化膜形成組成物中所含有的(A)成分,較佳為具有光配向性基、羥基,與含有C=C雙鍵之聚合性基的丙烯酸共聚物。The component (A) contained in the cured film forming composition of the present invention is preferably an acrylic copolymer having a photo-alignment group, a hydroxyl group, and a polymerizable group containing a C=C double bond.
本發明中,丙烯酸共聚物,係指使丙烯酸酯、甲基丙烯酸酯、苯乙烯等之具有不飽和雙鍵之單體聚合而得到的共聚物。In the present invention, an acrylic copolymer refers to a copolymer obtained by polymerizing monomers having unsaturated double bonds such as acrylate, methacrylate, and styrene.
(A)成分之具有光配向性基、羥基,與含有C=C雙鍵之聚合性基的丙烯酸共聚物(以下,亦稱為特定共聚物),只要係具有如此結構之丙烯酸共聚物即可,構成丙烯酸共聚物之高分子的主鏈之骨架及側鏈之種類等並無特殊限定。The component (A) is an acrylic copolymer having a photoalignment group, a hydroxyl group, and a polymerizable group containing a C=C double bond (hereinafter also referred to as a specific copolymer), as long as it is an acrylic copolymer having such a structure , the skeleton of the main chain of the polymer constituting the acrylic copolymer and the types of side chains are not particularly limited.
光配向性基,可列舉桂皮醯基、查耳酮基、香豆素基、蒽基等。此等之中,由於在可見光區域之透明性高,及光二聚化反應性高,故較佳為桂皮醯基。更佳的桂皮醯基及包含桂皮醯基結構之取代基,可列舉下述式[1]或式[2]表示之結構。再者本說明書中,桂皮醯基中之苯環為萘環之基,亦包含在「桂皮醯基」及「包含桂皮醯基結構之取代基」中。Examples of the photoalignment group include cinnamyl group, chalcone group, coumarin group, and anthracenyl group. Among these, cinnamyl group is preferred because of its high transparency in the visible light region and high photodimerization reactivity. More preferred cinnamyl groups and substituents containing a cinnamyl group structure include structures represented by the following formula [1] or formula [2]. Furthermore, in this specification, the benzene ring in the cinnamonyl group is the base of the naphthalene ring, and is also included in the "cinnamonyl group" and "substituents containing the cinnamonyl group structure".
上述式[1]中,X1 表示氫原子、碳原子數1至18之烷基、苯基或聯苯基。此時,苯基及聯苯基亦可經鹵素原子及氰基的任一者取代。In the above formula [1], X 1 represents a hydrogen atom, an alkyl group having 1 to 18 carbon atoms, a phenyl group or a biphenyl group. In this case, the phenyl group and the biphenyl group may be substituted by either a halogen atom or a cyano group.
上述式[2]中,X2 表示氫原子、氰基、碳原子數1至18之烷基、苯基、聯苯基、環己基。此時,碳原子數1至18之烷基、苯基、聯苯基、環己基,亦可透過由共價鍵、醚鍵、酯鍵、醯胺鍵、脲鍵、胺基甲酸酯鍵、胺基鍵、羰基或該等之組合中選出的1種或2種以上之鍵結,而鍵結有複數種。In the above formula [2], X 2 represents a hydrogen atom, a cyano group, an alkyl group having 1 to 18 carbon atoms, a phenyl group, a biphenyl group, or a cyclohexyl group. At this time, alkyl groups, phenyl groups, biphenyl groups, and cyclohexyl groups with carbon atoms of 1 to 18 can also be formed through covalent bonds, ether bonds, ester bonds, amide bonds, urea bonds, and urethane bonds. , amine bond, carbonyl group, or one or more types of bonds selected from a combination thereof, and there are multiple types of bonds.
上述式[1]及式[2]中,A表示式[A1]、式[A2]、式[A3]、式[A4]、式[A5]及式[A6]之任一者。In the above formula [1] and formula [2], A represents any one of formula [A1], formula [A2], formula [A3], formula [A4], formula [A5], and formula [A6].
上述式[A1]、式[A2]、式[A3]、式[A4]、式[A5]及式[A6]中,R31 、R32 、R33 、R34 、R35 、R36 、R37 及R38 ,係分別獨立地表示氫原子、碳原子數1至4之烷基、碳原子數1至4之烷氧基、鹵素原子、三氟甲基或氰基。In the above formula [A1], formula [A2], formula [A3], formula [A4], formula [A5] and formula [A6], R 31 , R 32 , R 33 , R 34 , R 35 , R 36 , R 37 and R 38 each independently represent a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a halogen atom, a trifluoromethyl group or a cyano group.
羥基為藉由加熱而與(B)成分的交聯劑鍵結之部位。又,本發明之聚合物,亦可具有羥基以外之熱交聯性部位,具體例子為羧基、醯胺基、胺基、烷氧基矽烷基等。 (A)成分之聚合物中,具有羥基之結構單位之存在比例,相對於該聚合物之全部結構單位100莫耳%而言,較佳為20莫耳%以上。藉由成為20莫耳%以上,由本發明之硬化膜形成組成物所得到的硬化膜,可提高用於光配向之光反應的效率,可具有優良的配向感度。 此處,(A)成分之聚合物中包含2個以上的具有羥基之結構單位時,具有羥基之結構單位之存在比例,係表示聚合物之全部結構單位每100莫耳之(具有羥基之結構單位之莫耳數)×(該結構單位中所包含的羥基數)。The hydroxyl group is a site bonded to the cross-linking agent of component (B) by heating. Furthermore, the polymer of the present invention may have thermally cross-linkable moieties other than hydroxyl groups. Specific examples include carboxyl groups, amide groups, amine groups, alkoxysilyl groups, and the like. In the polymer of component (A), the proportion of the structural unit having a hydroxyl group is preferably 20 mol% or more relative to 100 mol% of all structural units of the polymer. By making the content 20 mol% or more, the cured film obtained from the cured film-forming composition of the present invention can improve the efficiency of the photoreaction for photoalignment and can have excellent alignment sensitivity. Here, when the polymer of component (A) contains two or more structural units having a hydroxyl group, the ratio of the structural units having a hydroxyl group is expressed as the ratio of the structural units having a hydroxyl group per 100 moles of all structural units of the polymer. The number of moles in the unit) × (the number of hydroxyl groups contained in the structural unit).
(A)成分之丙烯酸共聚物,重量平均分子量較佳為3,000至200,000。重量平均分子量超過200,000而過大時,有對溶劑之溶解性降低,操作性降低的情況,另一方面,重量平均分子量未達3,000而過小時,係有熱硬化時硬化不足,溶劑耐受性降低或耐熱性降低的情況。The acrylic copolymer of component (A) preferably has a weight average molecular weight of 3,000 to 200,000. If the weight average molecular weight exceeds 200,000 and is too large, the solubility in solvents may be reduced and the operability may be reduced. On the other hand, if the weight average molecular weight is less than 3,000 and is too small, the hardening may be insufficient during thermal hardening and the solvent tolerance may be reduced. Or the heat resistance is reduced.
(A)具有成分之光配向性基、羥基,與含有C=C雙鍵之聚合性基的丙烯酸共聚物之製造方法,可列舉下述方法。(A) A method for producing an acrylic copolymer having a photo-alignment group, a hydroxyl group, and a polymerizable group containing a C=C double bond as components can be exemplified by the following method.
(A)成分之製造方法1,為使具有光二聚化部位之單體,與具有環氧基之單體共聚合後,使所得之共聚物的環氧基,再與具有羧基與含有C=C雙鍵之聚合性基之化合物反應的方法。Method 1 for producing component (A): after copolymerizing a monomer having a photodimerization site and a monomer having an epoxy group, the epoxy group of the resulting copolymer is then copolymerized with a monomer having a carboxyl group and containing C= A method for reacting compounds with polymerizable groups of C double bonds.
(A)成分之製造方法2,為使具有光二聚化部位之單體,與具有羧基之單體共聚合後,使所得之共聚物的羧基,再與具有環氧基與含有C=C雙鍵之聚合性基之化合物反應的方法。Method 2 for producing component (A) is to copolymerize a monomer with a photodimerization site and a monomer with a carboxyl group, and then combine the carboxyl group of the resulting copolymer with an epoxy group and a C=C double A method for reacting compounds with polymeric groups bonded to them.
具有光二聚化部位之單體,例如可列舉具有桂皮醯基、查耳酮基、香豆素基、蒽基等之單體。此等之中,由於在可見光區域之透明性高及光二聚化反應性高,故特佳為具有桂皮醯基之單體。Examples of the monomer having a photodimerization site include monomers having a cinnamyl group, a chalcone group, a coumarin group, an anthracene group, and the like. Among these, a monomer having a cinnamonyl group is particularly preferred because of its high transparency in the visible light region and high photodimerization reactivity.
其中尤以具有上述式[1]或式[2]表示之結構的桂皮醯基及包含桂皮醯基結構之取代基的單體更佳。如此的單體之具體例子,列舉有下述式[3]或式[4]表示之單體。Among them, monomers containing a cinnamyl group having a structure represented by the above formula [1] or formula [2] and a substituent of the cinnamyl group structure are particularly preferred. Specific examples of such monomers include monomers represented by the following formula [3] or formula [4].
上述式[3]中,X1 表示氫原子、碳原子數1至18之烷基、苯基或聯苯基。此時,苯基及聯苯基亦可經鹵素原子及氰基的任一者取代。 L1 及L2 ,係分別獨立地表示共價鍵、醚鍵、酯鍵、醯胺鍵、脲鍵或胺基甲酸酯鍵。In the above formula [3], X 1 represents a hydrogen atom, an alkyl group having 1 to 18 carbon atoms, a phenyl group or a biphenyl group. In this case, the phenyl group and the biphenyl group may be substituted by either a halogen atom or a cyano group. L 1 and L 2 independently represent a covalent bond, an ether bond, an ester bond, an amide bond, a urea bond or a urethane bond.
上述式[4]中,X2 表示氫原子、氰基、碳原子數1至18之烷基、苯基、聯苯基、環己基。此時,碳原子數1至18之烷基、苯基、聯苯基、環己基,亦可透過共價鍵、醚鍵、酯鍵、醯胺鍵、脲鍵而鍵結。In the above formula [4], X 2 represents a hydrogen atom, a cyano group, an alkyl group having 1 to 18 carbon atoms, a phenyl group, a biphenyl group, or a cyclohexyl group. At this time, alkyl groups, phenyl groups, biphenyl groups, and cyclohexyl groups with 1 to 18 carbon atoms can also be bonded through covalent bonds, ether bonds, ester bonds, amide bonds, and urea bonds.
上述式[3]及式[4]中,X3 及X5 係分別獨立地表示單鍵、碳原子數1至20之伸烷基、2價之芳香族環、2價之脂肪族環。此處,碳原子數1至20之伸烷基可為分支狀亦可為直鏈狀。In the above formulas [3] and [4], X 3 and X 5 independently represent a single bond, an alkylene group having 1 to 20 carbon atoms, a divalent aromatic ring, and a divalent aliphatic ring. Here, the alkylene group having 1 to 20 carbon atoms may be branched or linear.
上述式[3]及式[4]中,X4 表示聚合性基。該聚合性基之具體例子,例如可列舉丙烯醯基、甲基丙烯醯基、苯乙烯基、馬來醯亞胺基、丙烯醯胺基、甲基丙烯醯胺基等。In the above formula [3] and formula [4], X 4 represents a polymerizable group. Specific examples of the polymerizable group include an acrylyl group, a methacrylamide group, a styryl group, a maleimide group, an acrylamide group, and a methacrylamide group.
上述式[3]及式[4]中,A係與前述相同地,表示式[A1]、式[A2]、式[A3]、式[A4]、式[A5]及式[A6]之任一者。In the above-mentioned formula [3] and formula [4], A represents formula [A1], formula [A2], formula [A3], formula [A4], formula [A5] and formula [A6] in the same manner as above. Either.
具有含有C=C雙鍵之聚合性基與羧基之單體,例如可列舉丙烯酸、甲基丙烯酸、巴豆酸、單-(2-(丙烯醯基氧基)乙基)鄰苯二甲酸酯、單-(2-(甲基丙烯醯基氧基)乙基)鄰苯二甲酸酯、單-(2-(丙烯醯基氧基)乙基)六氫鄰苯二甲酸酯、單-(2-(甲基丙烯醯基氧基)乙基)六氫鄰苯二甲酸酯、單-(2-(丙烯醯基氧基)乙基)琥珀酸酯、單-(2-(甲基丙烯醯基氧基)乙基)琥珀酸酯、N-(羧基苯基)馬來醯亞胺、N-(羧基苯基)甲基丙烯醯胺、N-(羧基苯基)丙烯醯胺及ω-羧基-聚己內酯單(甲基)丙烯酸酯。此等之單體,例如可使用作為「LIGHT ESTER HO-MS」、「LIGHT ACRYLATE HOA-MS(N)」、「LIGHT ACRYLATE HOA-HH(N)」及「LIGHT ACRYLATE HOA-MPL(N)」(以上,共榮社化學股份有限公司製,商品名)、Aronix M-5300、Aronix M-5400(以上,東亞合成(股)製,商品名)、A-SA、SA(以上,新中村化學工業(股)製,商品名)而市售者。Monomers having a polymerizable group and a carboxyl group containing a C=C double bond, such as acrylic acid, methacrylic acid, crotonic acid, and mono-(2-(acryloxy)ethyl) phthalate , mono-(2-(methacryloxy)ethyl) phthalate, mono-(2-(acryloxy)ethyl) hexahydrophthalate, mono -(2-(methacryloxy)ethyl)hexahydrophthalate, mono-(2-(acryloxy)ethyl)succinate, mono-(2-( Methacryloxy)ethyl)succinate, N-(carboxyphenyl)maleimide, N-(carboxyphenyl)methacrylamide, N-(carboxyphenyl)acrylamide Amine and omega-carboxy-polycaprolactone mono(meth)acrylate. These monomers can be used, for example, as "LIGHT ESTER HO-MS", "LIGHT ACRYLATE HOA-MS(N)", "LIGHT ACRYLATE HOA-HH(N)" and "LIGHT ACRYLATE HOA-MPL(N)" (above, trade name manufactured by Kyoeisha Chemical Co., Ltd.), Aronix M-5300, Aronix M-5400 (above, manufactured by Toa Gosei Co., Ltd., trade name), A-SA, SA (above, Shin Nakamura Chemical Industrial (stock) system, trade name) and commercially available.
具有含有C=C雙鍵之聚合性基與環氧基之單體,例如可列舉甲基丙烯酸縮水甘油酯、丙烯酸縮水甘油酯、甲基丙烯酸4-羥基丁酯縮水甘油醚、烯丙基縮水甘油醚、o-乙烯基苄基縮水甘油醚、m-乙烯基苄基縮水甘油醚、p-乙烯基苄基縮水甘油醚、3-乙烯基-7-氧雜雙環[4.1.0]庚烷、1,2-環氧基-5-己烯及1,7-辛二烯單環氧化物等。Monomers having a polymerizable group and an epoxy group containing a C=C double bond include, for example, glycidyl methacrylate, glycidyl acrylate, 4-hydroxybutyl methacrylate glycidyl ether, and allyl glycidyl ether. Glyceryl ether, o-vinylbenzyl glycidyl ether, m-vinylbenzyl glycidyl ether, p-vinylbenzyl glycidyl ether, 3-vinyl-7-oxabicyclo[4.1.0]heptane , 1,2-epoxy-5-hexene and 1,7-octadiene monoepoxide, etc.
此處,(A)成分的聚合物之製造中,作為原料之具有環氧基之單體及具有羧基之單體的至少一方,較佳選擇於聚合性基與由環氧基及羧基中選出之基之間具有間隔基(spacer)者。藉由選擇如此的原料,所得到的本發明之硬化膜其與液晶層之密合性成為更良好。Here, in the production of the polymer of component (A), at least one of the monomer having an epoxy group and the monomer having a carboxyl group as the raw material is preferably selected from the group consisting of a polymerizable group and an epoxy group and a carboxyl group. There is a spacer between the bases. By selecting such raw materials, the adhesiveness of the cured film of the present invention obtained to the liquid crystal layer becomes better.
具有間隔基及羧基之單體的較佳結構,為下述(SC-1)及(SC-2)之任一者。 式中,X4 表示聚合性基,該聚合性基之具體例子,例如可列舉丙烯醯基、甲基丙烯醯基、苯乙烯基、馬來醯亞胺基、丙烯醯胺基、甲基丙烯醯胺基等。L1 表示共價鍵、醚鍵、酯鍵、醯胺鍵、脲鍵或胺基甲酸酯鍵。Q1 及Q3 係分別獨立地表示碳原子數2至10之伸烷基,Q2 表示具有源自二羧酸酐之結構的二價基。n表示1~10之自然數。The preferred structure of the monomer having a spacer group and a carboxyl group is either of the following (SC-1) and (SC-2). In the formula , amide group, etc. L 1 represents a covalent bond, ether bond, ester bond, amide bond, urea bond or urethane bond. Q 1 and Q 3 each independently represent an alkylene group having 2 to 10 carbon atoms, and Q 2 represents a divalent group having a structure derived from a dicarboxylic anhydride. n represents a natural number from 1 to 10.
如此的具有間隔基及羧基之單體,較佳為單-(2-(丙烯醯基氧基)乙基)鄰苯二甲酸酯、單-(2-(甲基丙烯醯基氧基)乙基)鄰苯二甲酸酯、單-(2-(丙烯醯基氧基)乙基)六氫鄰苯二甲酸酯、單-(2-(甲基丙烯醯基氧基)乙基)六氫鄰苯二甲酸酯、單-(2-(丙烯醯基氧基)乙基)琥珀酸酯、單-(2-(甲基丙烯醯基氧基)乙基)琥珀酸酯及ω-羧基-聚己內酯單(甲基)丙烯酸酯。又,亦佳為具有羧基之多官能丙烯酸酯。市售者例如可使用作為「LIGHT ESTER HO-MS」、「LIGHT ACRYLATE HOA-MS(N)」、「LIGHT ACRYLATE HOA-HH (N)」及「LIGHT ACRYLATE HOA-MPL(N)」(以上,共榮社化學股份有限公司製,商品名)、Aronix M-5300、Aronix M-5400(以上,東亞合成(股)製,商品名)而市售者。Such a monomer having a spacer group and a carboxyl group is preferably mono-(2-(acryloxy)ethyl) phthalate or mono-(2-(methacryloxy)) Ethyl) phthalate, mono-(2-(acryloxy)ethyl) hexahydrophthalate, mono-(2-(methacryloxy)ethyl ) Hexahydrophthalate, mono-(2-(acryloxy)ethyl)succinate, mono-(2-(methacryloxy)ethyl)succinate and Omega-carboxy-polycaprolactone mono(meth)acrylate. Furthermore, a polyfunctional acrylate having a carboxyl group is also preferred. Commercially available products include "LIGHT ESTER HO-MS", "LIGHT ACRYLATE HOA-MS(N)", "LIGHT ACRYLATE HOA-HH (N)" and "LIGHT ACRYLATE HOA-MPL(N)" (the above, Commercially available are Aronix M-5300, Aronix M-5400 (above, manufactured by Kyoeisha Chemical Co., Ltd., trade name), Aronix M-5300, and Aronix M-5400 (above, manufactured by Toa Gosei Co., Ltd., trade name).
具有間隔基及環氧基之單體的較佳結構係以下述(SE-1)表示。 式中,X4 表示聚合性基,該聚合性基之具體例子,例如可列舉丙烯醯基、甲基丙烯醯基、苯乙烯基、馬來醯亞胺基、丙烯醯胺基、甲基丙烯醯胺基等。L1 表示共價鍵、醚鍵、酯鍵、醯胺鍵、脲鍵或胺基甲酸酯鍵。Q1 表示碳原子數2至10之伸烷基。The preferred structure of the monomer having a spacer group and an epoxy group is represented by the following (SE-1). In the formula , amide group, etc. L 1 represents a covalent bond, ether bond, ester bond, amide bond, urea bond or urethane bond. Q 1 represents an alkylene group having 2 to 10 carbon atoms.
如此的具有間隔基及環氧基之單體,例如可列舉甲基丙烯酸4-羥基丁酯縮水甘油醚、o-乙烯基苄基縮水甘油醚、m-乙烯基苄基縮水甘油醚、p-乙烯基苄基縮水甘油醚等。Examples of such monomers having a spacer group and an epoxy group include 4-hydroxybutyl methacrylate glycidyl ether, o-vinylbenzyl glycidyl ether, m-vinylbenzyl glycidyl ether, p- Vinyl benzyl glycidyl ether, etc.
用以對聚合物所具有之環氧基接枝的具有含有C=C雙鍵之聚合性基與羧基之單體,亦佳為下述(SC-3)表示之具有羧基之多官能丙烯酸酯。 式中,X4 表示聚合性基,該聚合性基之具體例子,例如可列舉丙烯醯基、甲基丙烯醯基、苯乙烯基、馬來醯亞胺基、丙烯醯胺基、甲基丙烯醯胺基等。L1 表示共價鍵、醚鍵、酯鍵、醯胺鍵、脲鍵或胺基甲酸酯鍵。Q4 表示(m+1)價有機基,m表示2~10之自然數。The monomer having a polymerizable group containing a C=C double bond and a carboxyl group used to graft the epoxy group of the polymer is also preferably a polyfunctional acrylate having a carboxyl group represented by the following (SC-3) . In the formula , amide group, etc. L 1 represents a covalent bond, ether bond, ester bond, amide bond, urea bond or urethane bond. Q 4 represents (m+1)-valent organic radical, and m represents a natural number from 2 to 10.
如此的化合物,可使用作為Aronix M-510、M-520(以上,東亞合成(股)製,商品名)所市售者。Such compounds can be used as those commercially available as Aronix M-510 and M-520 (above, trade names manufactured by Toagosei Co., Ltd.).
為了遵照製造方法1而得到特定共聚物所使用的具有光二聚化部位之單體及具有環氧基之單體之使用量,基於為了得到特定共聚物所使用之全部單體的合計量,較佳為具有光二聚化部位之單體為40質量%~95質量%、具有環氧基之單體為5質量%~60質量%。藉由使具有光二聚化部位之單體含量成為40質量%以上,可賦予高感度且良好之液晶配向性。另一方面,藉由為95質量%以下,可賦予充分的熱硬化性,且可維持高感度且良好的液晶配向性。The usage amount of the monomer having a photodimerization site and the monomer having an epoxy group used to obtain the specific copolymer according to Production Method 1 is based on the total amount of all monomers used to obtain the specific copolymer, which is less than Preferably, the monomer having a photodimerization site is 40% to 95% by mass, and the monomer having an epoxy group is 5% to 60% by mass. By setting the content of the monomer having a photodimerization site to 40% by mass or more, high sensitivity and good liquid crystal alignment can be provided. On the other hand, by being 95 mass % or less, sufficient thermosetting properties can be provided, and high sensitivity and good liquid crystal alignment can be maintained.
為了遵照製造方法2而得到特定共聚物所使用的具有光二聚化部位之單體及具有羧基之單體之使用量,係準用上述具有光二聚化部位之單體及具有環氧基之單體之使用量中的具有環氧基之單體之使用量。In order to obtain a specific copolymer in accordance with Production Method 2, the usage amounts of the monomer having a photodimerization site and the monomer having a carboxyl group used are the above-mentioned monomers having a photodimerization site and the monomer having an epoxy group. The usage amount of the monomer with epoxy group.
又,本發明之硬化膜形成組成物中,得到作為特定共聚物之前驅物的聚合物時,可合併使用可與具有光二聚化部位、環氧基及羧基(以下將此等亦稱為特定官能基)之任一者的單體共聚合之單體(以下亦稱為具有非反應性官能基之單體)。In addition, in the cured film forming composition of the present invention, when obtaining a polymer as a precursor of a specific copolymer, it may be used in combination with a polymer having a photodimerization site, an epoxy group and a carboxyl group (hereinafter also referred to as a specific copolymer). A monomer copolymerized with any monomer having a non-reactive functional group (hereinafter also referred to as a monomer having a non-reactive functional group).
如此的單體之具體例子,可列舉丙烯酸酯化合物、甲基丙烯酸酯化合物、馬來醯亞胺化合物、丙烯醯胺化合物、丙烯腈、馬來酸酐、苯乙烯化合物及乙烯基化合物等。 以下,列舉上述單體之具體例子,但本發明不限定於此等。Specific examples of such monomers include acrylate compounds, methacrylate compounds, maleimide compounds, acrylamide compounds, acrylonitrile, maleic anhydride, styrene compounds, vinyl compounds, and the like. Specific examples of the above monomers are listed below, but the present invention is not limited to these.
上述丙烯酸酯化合物,例如可列舉丙烯酸甲酯、丙烯酸乙酯、丙烯酸異丙酯、丙烯酸苄酯、丙烯酸萘酯、丙烯酸蒽酯、丙烯酸蒽基甲酯、丙烯酸苯酯、丙烯酸縮水甘油酯、丙烯酸2,2,2-三氟乙酯、丙烯酸tert-丁酯、丙烯酸環己酯、丙烯酸異莰酯、丙烯酸2-甲氧基乙酯、甲氧基三乙二醇丙烯酸酯、丙烯酸2-乙氧基乙酯、丙烯酸四氫呋喃甲酯、丙烯酸3-甲氧基丁酯、丙烯酸2-甲基-2-金剛烷酯、丙烯酸2-丙基-2-金剛烷酯、丙烯酸8-甲基-8-三環癸酯,及丙烯酸8-乙基-8-三環癸酯等。Examples of the acrylate compound include methyl acrylate, ethyl acrylate, isopropyl acrylate, benzyl acrylate, naphthyl acrylate, anthryl acrylate, anthracenyl methyl acrylate, phenyl acrylate, glycidyl acrylate, and 2 acrylate. ,2,2-trifluoroethyl, tert-butyl acrylate, cyclohexyl acrylate, isocamphenyl acrylate, 2-methoxyethyl acrylate, methoxytriethylene glycol acrylate, 2-ethoxy acrylate Ethyl acrylate, tetrahydrofuran methyl acrylate, 3-methoxybutyl acrylate, 2-methyl-2-adamantyl acrylate, 2-propyl-2-adamantyl acrylate, 8-methyl-8-acrylate Tricyclodecyl ester, and 8-ethyl-8-tricyclodecyl acrylate, etc.
上述甲基丙烯酸酯化合物,例如可列舉甲基丙烯酸甲酯、甲基丙烯酸乙酯、甲基丙烯酸異丙酯、甲基丙烯酸苄酯、甲基丙烯酸萘酯、甲基丙烯酸蒽酯、甲基丙烯酸蒽基甲酯、甲基丙烯酸苯酯、甲基丙烯酸縮水甘油酯、甲基丙烯酸2,2,2-三氟乙酯、甲基丙烯酸tert-丁酯、甲基丙烯酸環己酯、甲基丙烯酸異莰酯、甲基丙烯酸2-甲氧基乙酯、甲氧基三乙二醇甲基丙烯酸酯、甲基丙烯酸2-乙氧基乙酯、甲基丙烯酸四氫呋喃甲酯、甲基丙烯酸3-甲氧基丁酯、甲基丙烯酸2-甲基-2-金剛烷酯、γ-丁內酯甲基丙烯酸酯、甲基丙烯酸2-丙基-2-金剛烷酯、甲基丙烯酸8-甲基-8-三環癸酯,及甲基丙烯酸8-乙基-8-三環癸酯等。Examples of the methacrylate compound include methyl methacrylate, ethyl methacrylate, isopropyl methacrylate, benzyl methacrylate, naphthyl methacrylate, anthracene methacrylate, and methacrylic acid. Anthryl methyl ester, phenyl methacrylate, glycidyl methacrylate, 2,2,2-trifluoroethyl methacrylate, tert-butyl methacrylate, cyclohexyl methacrylate, methacrylic acid Isocamphenyl, 2-methoxyethyl methacrylate, methoxytriethylene glycol methacrylate, 2-ethoxyethyl methacrylate, tetrahydrofuran methyl methacrylate, 3-methacrylate Methoxybutyl ester, 2-methyl-2-adamantyl methacrylate, γ-butyrolactone methacrylate, 2-propyl-2-adamantyl methacrylate, 8-methyl methacrylate methyl-8-tricyclodecyl ester, and 8-ethyl-8-tricyclodecyl methacrylate, etc.
上述乙烯基化合物,例如可列舉甲基乙烯基醚、苄基乙烯基醚、乙烯基萘、乙烯基咔唑、烯丙基縮水甘油醚、3-乙烯基-7-氧雜雙環[4.1.0]庚烷、1,2-環氧基-5-己烯,及1,7-辛二烯單環氧化物等。Examples of the vinyl compound include methyl vinyl ether, benzyl vinyl ether, vinyl naphthalene, vinyl carbazole, allyl glycidyl ether, and 3-vinyl-7-oxabicyclo [4.1.0 ]Heptane, 1,2-epoxy-5-hexene, and 1,7-octadiene monoepoxide, etc.
上述苯乙烯化合物,例如可列舉苯乙烯、甲基苯乙烯、氯苯乙烯,及溴苯乙烯等。Examples of the above-mentioned styrene compound include styrene, methylstyrene, chlorostyrene, bromostyrene, and the like.
上述馬來醯亞胺化合物,例如可列舉馬來醯亞胺、N-甲基馬來醯亞胺、N-苯基馬來醯亞胺,及N-環己基馬來醯亞胺等。Examples of the maleimide compound include maleimide, N-methylmaleimide, N-phenylmaleimide, and N-cyclohexylmaleimide.
得到作為用於本發明之硬化膜形成組成物的特定共聚物之前驅物的聚合物之方法並無特殊限定,例如係於共存有具有由光二聚化部位、環氧基及羧基中選出的特定官能基之單體、依期望之具有非反應性官能基之單體及聚合起始劑等的溶劑中,於50℃~110℃之溫度下進行聚合反應而得到。此時,所用的溶劑,只要會溶解具有特定官能基之單體、依期望所用的具有非反應性官能基之單體及聚合起始劑等者則無特殊限定。具體例子可列舉後述溶劑所記載之溶劑。The method of obtaining a polymer as a precursor of a specific copolymer used in the cured film forming composition of the present invention is not particularly limited. For example, a specific copolymer having a photodimerization site, an epoxy group, and a carboxyl group coexists. It is obtained by polymerizing a monomer with a functional group, a monomer with a non-reactive functional group as desired, and a polymerization initiator in a solvent at a temperature of 50°C to 110°C. At this time, the solvent used is not particularly limited as long as it can dissolve a monomer having a specific functional group, a monomer having a non-reactive functional group as desired, a polymerization initiator, etc. Specific examples include solvents described below as solvents.
側鏈具有環氧基之聚合物,與具有特定羧基與含有C=C雙鍵之聚合性基之化合物的反應生成物,如上所述,可藉由使具有環氧基之聚合物,與具有特定羧基與含有C=C雙鍵之聚合性基的化合物,較佳為於觸媒存在下、較佳為於適當有機溶劑中反應來合成。 反應時所使用之具有羧基與含有C=C雙鍵之聚合性基的化合物之使用比例,相對於具有環氧基之聚合物中所含有的環氧基1莫耳而言,較佳為0.01~0.9莫耳、更佳為0.05~0.8莫耳、又更佳為0.1~0.7莫耳。The reaction product of a polymer having an epoxy group in the side chain and a compound having a specific carboxyl group and a polymerizable group containing a C=C double bond can be obtained by mixing a polymer having an epoxy group with The compound of a specific carboxyl group and a polymerizable group containing a C=C double bond is preferably synthesized by reacting in the presence of a catalyst, preferably in an appropriate organic solvent. The ratio of the compound having a carboxyl group and a polymerizable group containing a C=C double bond used in the reaction is preferably 0.01 per mole of epoxy group contained in the polymer having an epoxy group. ~0.9 mole, more preferably 0.05~0.8 mole, and more preferably 0.1~0.7 mole.
側鏈具有羧基之聚合物,與具有特定環氧基與含有C=C雙鍵之聚合性基的化合物之反應生成物,如上所述,可藉由使具有羧基之聚合物,與具有特定環氧基與含有C=C雙鍵之聚合性基的化合物,較佳為於觸媒存在下、較佳為於適當有機溶劑中反應來合成。 反應時所使用之具有環氧基與含有C=C雙鍵之聚合性基的化合物之使用比例,相對於具有羧基之聚合物中所含有的羧基1莫耳而言,較佳為0.01~0.9莫耳、更佳為0.05~0.8莫耳、又更佳為0.1~0.7莫耳。The reaction product of a polymer having a carboxyl group in the side chain and a compound having a specific epoxy group and a polymerizable group containing a C=C double bond can be obtained by reacting a polymer having a carboxyl group with a specific ring The compound of an oxygen group and a polymerizable group containing a C=C double bond is preferably synthesized by reacting in the presence of a catalyst, preferably in an appropriate organic solvent. The ratio of the compound having an epoxy group and a polymerizable group containing a C=C double bond used in the reaction is preferably 0.01 to 0.9 per mole of carboxyl groups contained in the polymer having a carboxyl group. mole, more preferably 0.05~0.8 mole, more preferably 0.1~0.7 mole.
此處可使用之有機觸媒,可使用作為促進有機鹼或環氧化合物與羧基之反應的所謂硬化促進劑而公知之化合物。As the organic catalyst that can be used here, a compound known as a so-called hardening accelerator that accelerates the reaction between an organic base or an epoxy compound and a carboxyl group can be used.
上述有機鹼,例如可列舉如乙胺、二乙胺、哌嗪、哌啶、吡咯啶、吡咯之1~2級有機胺;如三乙胺、三-n-丙胺、三-n-丁胺、吡啶、4-二甲基胺基吡啶、二氮雜雙環十一烯之3級有機胺;如氫氧化四甲基銨之4級有機胺等。此等有機鹼當中,較佳為如三乙胺、三-n-丙胺、三-n-丁胺、吡啶、4-二甲基胺基吡啶之3級有機胺;如氫氧化四甲基銨之4級有機胺。Examples of the above-mentioned organic base include 1st and 2nd-level organic amines such as ethylamine, diethylamine, piperazine, piperidine, pyrrolidine, and pyrrole; such as triethylamine, tri-n-propylamine, and tri-n-butylamine. , pyridine, 4-dimethylaminopyridine, 3-level organic amines of diazabicycloundecene; such as 4-level organic amines of tetramethylammonium hydroxide, etc. Among these organic bases, preferred are tertiary organic amines such as triethylamine, tri-n-propylamine, tri-n-butylamine, pyridine, and 4-dimethylaminopyridine; such as tetramethylammonium hydroxide Class 4 organic amines.
上述硬化促進劑,例如可列舉如苄基二甲胺、2,4,6-參(二甲基胺基甲基)酚、環己基二甲胺、三乙醇胺之3級胺;如2-甲基咪唑、2-n-庚基咪唑、2-n-十一烷基咪唑、2-苯基咪唑、2-苯基-4-甲基咪唑、1-苄基-2-甲基咪唑、1-苄基-2-苯基咪唑、1,2-二甲基咪唑、2-乙基-4-甲基咪唑、1-(2-氰基乙基)-2-甲基咪唑、1-(2-氰基乙基)-2-n-十一烷基咪唑、1-(2-氰基乙基)-2-苯基咪唑、1-(2-氰基乙基)-2-乙基-4-甲基咪唑、2-苯基-4-甲基-5-羥基甲基咪唑、2-苯基-4,5-二(羥基甲基)咪唑、1-(2-氰基乙基)-2-苯基-4,5-二〔(2’-氰基乙氧基)甲基〕咪唑、1-(2-氰基乙基)-2-n-十一烷基咪唑鎓偏苯三甲酸鹽、1-(2-氰基乙基)-2-苯基咪唑鎓偏苯三甲酸鹽、1-(2-氰基乙基)-2-乙基-4-甲基咪唑鎓偏苯三甲酸鹽、2,4-二胺基-6-〔2’-甲基咪唑基-(1’)〕乙基-s-三嗪、2,4-二胺基-6-(2’-n-十一烷基咪唑基)乙基-s-三嗪、2,4-二胺基-6-〔2’-乙基-4’-甲基咪唑基-(1’)〕乙基-s-三嗪、2-甲基咪唑之異三聚氰酸加成物、2-苯基咪唑之異三聚氰酸加成物、2,4-二胺基-6-〔2’-甲基咪唑基-(1’)〕乙基-s-三嗪之異三聚氰酸加成物之咪唑化合物;如二苯基膦、三苯基膦、亞磷酸三苯酯之有機磷化合物;Examples of the above-mentioned hardening accelerator include tertiary amines such as benzyldimethylamine, 2,4,6-shen(dimethylaminomethyl)phenol, cyclohexyldimethylamine, and triethanolamine; such as 2-methane 2-n-heptyl imidazole, 2-n-undecyl imidazole, 2-phenyl imidazole, 2-phenyl-4-methylimidazole, 1-benzyl-2-methylimidazole, 1 -Benzyl-2-phenylimidazole, 1,2-dimethylimidazole, 2-ethyl-4-methylimidazole, 1-(2-cyanoethyl)-2-methylimidazole, 1-( 2-cyanoethyl)-2-n-undecylimidazole, 1-(2-cyanoethyl)-2-phenylimidazole, 1-(2-cyanoethyl)-2-ethyl -4-Methylimidazole, 2-phenyl-4-methyl-5-hydroxymethylimidazole, 2-phenyl-4,5-di(hydroxymethyl)imidazole, 1-(2-cyanoethyl) )-2-phenyl-4,5-bis[(2'-cyanoethoxy)methyl]imidazole, 1-(2-cyanoethyl)-2-n-undecylimidazolium Trimellitic acid salt, 1-(2-cyanoethyl)-2-phenylimidazolium trimellitate, 1-(2-cyanoethyl)-2-ethyl-4-methylimidazolium Trimellitic acid salt, 2,4-diamino-6-[2'-methylimidazolyl-(1')]ethyl-s-triazine, 2,4-diamino-6-(2 '-n-Undecyl imidazolyl)ethyl-s-triazine, 2,4-diamino-6-[2'-ethyl-4'-methylimidazolyl-(1')]ethyl -s-triazine, 2-methylimidazole isocyanuric acid adduct, 2-phenylimidazole isocyanuric acid adduct, 2,4-diamino-6-[2' -Imidazole compound of isocyanuric acid adduct of -methylimidazolyl-(1')]ethyl-s-triazine; such as diphenylphosphine, triphenylphosphine, organophosphorus of triphenyl phosphite compound;
如苄基三苯基鏻氯化物、四-n-丁基鏻溴化物、甲基三苯基鏻溴化物、乙基三苯基鏻溴化物、n-丁基三苯基鏻溴化物、四苯基鏻溴化物、乙基三苯基鏻碘化物、乙基三苯基鏻乙酸鹽、四-n-丁基鏻o,o-二乙基偶磷基二硫磺酸鹽、四-n-丁基鏻苯并三唑鹽、四-n-丁基鏻四氟硼酸鹽、四-n-丁基鏻四苯基硼酸鹽、四苯基鏻四苯基硼酸鹽之4級鏻鹽;如1,8-二氮雜雙環[5.4.0]十一烯-7或其有機酸鹽之二氮雜雙環烯;如辛酸鋅、辛酸錫、鋁乙醯丙酮錯合物之有機金屬化合物;如四乙基銨溴化物、四-n-丁基銨溴化物、四乙基銨氯化物、四-n-丁基銨氯化物之4級銨鹽;如三氟化硼、硼酸三苯酯之硼化合物;如氯化鋅、氯化錫(IV)之金屬鹵化合物;二氰二胺或胺與環氧樹脂之加成物等之胺加成型促進劑等之高熔點分散型潛在性硬化促進劑;將前述咪唑化合物、有機磷化合物或4級鏻鹽等之硬化促進劑的表面以聚合物被覆而得之微膠囊型潛在性硬化促進劑;胺鹽型潛在性硬化劑促進劑;路易士酸鹽、布忍斯特酸鹽等之高溫解離型之熱陽離子聚合型潛在性硬化促進劑等之潛在性硬化促進劑等。 此等之中,較佳為如四乙基銨溴化物、四-n-丁基銨溴化物、四乙基銨氯化物、四-n-丁基銨氯化物之4級銨鹽。Such as benzyl triphenyl phosphonium chloride, tetrakis-n-butyl phosphonium bromide, methyl triphenyl phosphonium bromide, ethyl triphenyl phosphonium bromide, n-butyl triphenyl phosphonium bromide, tetrakis Phenylphosphonium bromide, ethyltriphenylphosphonium iodide, ethyltriphenylphosphonium acetate, tetrakis-n-butylphosphonium o,o-diethylphosphodisulfonate, tetrakis-n- Butylphosphonium benzotriazole salt, tetrakis-n-butylphosphonium tetrafluoroborate, tetrakis-n-butylphosphonium tetraphenylborate, tetraphenylphosphonium tetraphenylborate and the 4th grade phosphonium salt; such as Diazabicyclones of 1,8-diazabicyclo[5.4.0]undecene-7 or its organic acid salts; such as zinc octoate, tin octoate, and organic metal compounds of aluminum acetyl acetone complexes; such as Tetraethylammonium bromide, tetraethylammonium bromide, tetraethylammonium chloride, tetraethylammonium chloride, tetraethylammonium chloride, 4th grade ammonium salt; such as boron trifluoride, triphenyl borate Boron compounds; metal halide compounds such as zinc chloride and tin (IV) chloride; amine addition accelerators such as dicyandiamine or adducts of amines and epoxy resins, etc. High melting point dispersion type latent hardening accelerators Agent; microcapsule type latent hardening accelerator obtained by coating the surface of the aforementioned imidazole compound, organophosphorus compound or fourth-grade phosphonium salt hardening accelerator with a polymer; amine salt type latent hardening accelerator; Lewis Potential hardening accelerators such as high-temperature dissociation type thermal cationic polymerization type latent hardening accelerators such as acid salts and bronzite salts. Among these, quaternary ammonium salts such as tetraethylammonium bromide, tetraethylammonium bromide, tetraethylammonium chloride, and tetraethylammonium chloride are preferred.
觸媒之使用比例,相對於具有環氧基之聚合物或具有羧基之聚合物100質量份而言,較佳為100質量份以下、更佳為0.01~100質量份、又更佳為0.1~20質量份。The usage ratio of the catalyst is preferably 100 parts by mass or less, more preferably 0.01 to 100 parts by mass, and still more preferably 0.1 to 100 parts by mass relative to 100 parts by mass of the polymer having an epoxy group or the polymer having a carboxyl group. 20 parts by mass.
上述有機溶劑,例如可列舉烴化合物、醚化合物、酯化合物、酮化合物、醯胺化合物、醇化合物等。此等之中,就原料及生成物之溶解性以及生成物之純化容易性的觀點,較佳為醚化合物、酯化合物、酮化合物、醇化合物。溶劑係以固體成分濃度(反應溶液中之溶劑以外的成分之質量佔溶液全部質量之比例)較佳成為0.1質量%以上,更佳成為5~50質量%之量來使用。Examples of the organic solvent include hydrocarbon compounds, ether compounds, ester compounds, ketone compounds, amide compounds, alcohol compounds, and the like. Among these, ether compounds, ester compounds, ketone compounds, and alcohol compounds are preferred from the viewpoint of the solubility of the raw materials and products and the ease of purification of the products. The solvent is used in an amount such that the solid content concentration (the ratio of the mass of components other than the solvent in the reaction solution to the total mass of the solution) is preferably 0.1 mass % or more, more preferably 5 to 50 mass %.
反應溫度較佳為0~200℃、更佳為50~150℃。反應時間較佳為0.1~50小時、更佳為0.5~20小時。The reaction temperature is preferably 0 to 200°C, more preferably 50 to 150°C. The reaction time is preferably 0.1 to 50 hours, more preferably 0.5 to 20 hours.
<(A)成分之製造方法3> (A)成分之製造方法3,為使桂皮酸衍生物,及前述之具有羧基與含有C=C雙鍵之聚合性基的化合物,與側鏈具有環氧基之聚合物反應之方法。<Production method of (A) component 3> Method 3 for producing component (A) is a method of reacting a cinnamic acid derivative and the aforementioned compound having a carboxyl group and a polymerizable group containing a C=C double bond with a polymer having an epoxy group in the side chain.
側鏈具有環氧基之聚合物,例如可為前述之具有環氧基之單體的聚合物,亦可為前述之具有環氧基之單體,與前述之具有非反應性官能基之單體的共聚物。The polymer with an epoxy group in the side chain can be, for example, the polymer of the aforementioned monomer with an epoxy group, or the aforementioned monomer with an epoxy group, and the aforementioned monomer with a non-reactive functional group. body copolymer.
具有環氧基之聚合物中的具有環氧基之聚合性不飽和化合物之共聚合比例,較佳為30質量%以上、更佳為50質量%以上。The copolymerization ratio of the polymerizable unsaturated compound having an epoxy group in the polymer having an epoxy group is preferably 30 mass% or more, more preferably 50 mass% or more.
具有環氧基之聚合物之合成,較佳可於溶劑中、適當的聚合起始劑之存在下,藉由公知之自由基聚合法來進行。The synthesis of the polymer having an epoxy group can preferably be carried out by a known free radical polymerization method in a solvent and in the presence of an appropriate polymerization initiator.
側鏈具有環氧基之聚合物,亦可使用市售品。該市售品例如可列舉EHPE3150、EHPE3150CE(以上,(股)Daicel製)、UG-4010、UG-4035、UG-4040、UG-4070(以上,東亞合成(股)製ARUFON系列)、ECN-1299(旭化成(股)製)、DEN431、DEN438(以上,陶氏化學公司製)、jER-152(三菱化學(股)製)、EPICLON N-660、N-665、N-670、N-673、N-695、N-740、N-770、N-775(以上,DIC(股)製)、EOCN-1020、EOCN-102S、EOCN-104S(以上,日本化藥(股)製)等。Commercially available polymers having epoxy groups in their side chains can also be used. Examples of such commercially available products include EHPE3150, EHPE3150CE (above, manufactured by Daicel Co., Ltd.), UG-4010, UG-4035, UG-4040, UG-4070 (above, ARUFON series manufactured by Toa Gosei Co., Ltd.), ECN- 1299 (manufactured by Asahi Kasei Co., Ltd.), DEN431, DEN438 (above, manufactured by Dow Chemical Co., Ltd.), jER-152 (manufactured by Mitsubishi Chemical Co., Ltd.), EPICLON N-660, N-665, N-670, N-673 , N-695, N-740, N-770, N-775 (above, manufactured by DIC Co., Ltd.), EOCN-1020, EOCN-102S, EOCN-104S (above, manufactured by Nippon Kayaku Co., Ltd.), etc.
具有羧基之桂皮酸衍生物,例如可列舉下述式(1-1)~(1-5) (式中,R1 表示氫原子、鹵素原子、碳原子數1至6之烷基、碳原子數1至6之烷氧基等)的任一者表示之化合物等。 又,具有羧基之桂皮酸衍生物,亦適合使用上述式[3]表示之單體中,X1 為氫原子之化合物。Examples of cinnamic acid derivatives having a carboxyl group include the following formulas (1-1) to (1-5) (In the formula, R 1 represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, etc.). Furthermore, as the cinnamic acid derivative having a carboxyl group, a compound in which X 1 is a hydrogen atom in the monomer represented by the above formula [3] is also suitably used.
上述桂皮酸衍生物,可適當組合有機化學之規定方法來合成。The above-mentioned cinnamic acid derivatives can be synthesized by appropriately combining prescribed methods of organic chemistry.
此處,具有羧基與含有C=C雙鍵之聚合性基的化合物(單體),如前所述,較佳選擇於具有C=C雙鍵之基與羧基之間具有間隔基者。Here, the compound (monomer) having a carboxyl group and a polymerizable group containing a C=C double bond is preferably one having a spacer group between the group having a C=C double bond and the carboxyl group, as mentioned above.
使桂皮酸衍生物,及前述之具有羧基與含有C=C雙鍵之聚合性基的化合物,與側鏈具有環氧基之聚合物反應之方法係如前述。此時,可使桂皮酸衍生物,及前述之具有羧基與含有C=C雙鍵之聚合性基的化合物一起與側鏈具有環氧基之聚合物反應,亦可分別地反應。The method of reacting a cinnamic acid derivative and the aforementioned compound having a carboxyl group and a polymerizable group containing a C=C double bond with a polymer having an epoxy group in the side chain is as described above. At this time, the cinnamic acid derivative and the aforementioned compound having a carboxyl group and a polymerizable group containing a C=C double bond may be reacted together with the polymer having an epoxy group in the side chain, or they may be reacted separately.
(A)成分之聚合物中,具有含有C=C雙鍵之聚合性基的結構單位之存在比例,相對於該聚合物之全部結構單位100莫耳%而言,較佳為5莫耳%以上、更佳為10莫耳%以上。合計未達5莫耳%時,有與液晶層之密合性變得不充分的情況。 此處,(A)成分之聚合物中含有2個以上之具有含有C=C雙鍵之聚合性基的結構單位時,具有含有C=C雙鍵之聚合性基的結構單位之存在比例,係表示聚合物之全部結構單位每100莫耳之(具有含有C=C雙鍵之聚合性基的結構單位之莫耳數)×(該結構單位中所含有的含有C=C雙鍵之聚合性基之數)。In the polymer of component (A), the proportion of structural units having a polymerizable group containing a C=C double bond is preferably 5 mol% relative to 100 mol% of all structural units of the polymer. More than 10 mol%, preferably more than 10 mol%. When the total amount is less than 5 mol%, the adhesiveness with the liquid crystal layer may become insufficient. Here, when the polymer of component (A) contains two or more structural units having a polymerizable group containing a C=C double bond, the proportion of the structural units having a polymerizable group containing a C=C double bond is, It means the number of moles of the total structural units of the polymer per 100 moles (the number of moles of the structural unit having a polymerizable group containing a C=C double bond) × (the number of polymers containing a C=C double bond contained in the structural unit number of sexual bases).
如此地,可得到含有(A)成分的具有光配向性基、羥基,與含有C=C雙鍵之聚合性基的聚合物之溶液。該溶液可直接供液晶配向劑之配製,可將溶液中所含的聚合物單離後供液晶配向劑之配製,或亦可將單離之聚合物純化後供液晶配向劑之配製。In this way, a solution containing a polymer having a photoalignment group, a hydroxyl group, and a polymerizable group containing a C=C double bond as the component (A) can be obtained. The solution can be directly used for the preparation of a liquid crystal alignment agent, the polymer contained in the solution can be isolated and used for the preparation of a liquid crystal alignment agent, or the isolated polymer can be purified and used for the preparation of a liquid crystal alignment agent.
又,藉由將如上述般所得到的特定共聚物之溶液,投入二乙基醚或水等之攪拌下進行再沈澱,且將所生成之沈澱物予以過濾/洗淨後,在常壓或減壓下,常溫或加熱乾燥,可成為特定共聚物之粉體。藉由如此的操作,可去除與特定共聚物共存之聚合起始劑或未反應單體,其結果,可得到經純化之特定共聚物之粉體。以一次的操作無法充分純化時,只要將所得之粉體再溶解於溶劑中,重複進行上述操作即可。In addition, the solution of the specific copolymer obtained as above is put into diethyl ether or water and stirred to perform redrecipitation, and the generated precipitate is filtered/washed, and then subjected to normal pressure or It can be dried under reduced pressure at room temperature or heated to become the powder of a specific copolymer. By such an operation, the polymerization initiator or unreacted monomer coexisting with the specific copolymer can be removed, and as a result, a purified powder of the specific copolymer can be obtained. If it is not possible to purify sufficiently with one operation, the obtained powder can be redissolved in a solvent and the above operation can be repeated.
本發明之硬化膜形成組成物中,可將上述特定共聚物之粉體直接使用作為(A)成分,或亦可將該粉體例如再溶解於後述之溶劑中,作為溶液的狀態使用。In the cured film-forming composition of the present invention, the powder of the above-mentioned specific copolymer can be used directly as the component (A), or the powder can be redissolved in a solvent described below and used as a solution.
又,本實施形態中,(A)成分之丙烯酸共聚物,亦可為複數種特定共聚物之混合物。Furthermore, in this embodiment, the acrylic copolymer of component (A) may be a mixture of a plurality of specific copolymers.
如以上所述,本發明中,可使用高分子量之特定共聚物,作為(A)成分。又,(A)成分亦可為1種以上之特定共聚物之混合物。As described above, in the present invention, a specific copolymer of high molecular weight can be used as the component (A). In addition, component (A) may be a mixture of one or more specific copolymers.
[(B)成分] 本發明之硬化膜形成組成物,含有交聯劑作為(B)成分。更詳細而言,(B)成分為與上述(A)成分及(C)成分反應之交聯劑。(B)成分係與(A)成分的聚合物之熱交聯性基(特別是羥基),及(C)成分中所含的羥基鍵結。此外,本實施形態之硬化膜形成組成物,可形成光反應效率高的配向材料,作為硬化膜。[(B)Component] The cured film forming composition of the present invention contains a cross-linking agent as component (B). More specifically, the component (B) is a cross-linking agent that reacts with the component (A) and (C) mentioned above. The component (B) is bonded to the thermally crosslinkable group (especially hydroxyl group) of the polymer of the component (A) and the hydroxyl group contained in the component (C). In addition, the cured film forming composition of this embodiment can form an alignment material with high photoreaction efficiency as a cured film.
(B)成分的交聯劑,可列舉環氧化合物、羥甲基化合物及異氰酸酯化合物等之化合物,較佳為羥甲基化合物。其中,(B)成分的交聯劑,尤以具有2個以上之與前述(A)成分的可熱交聯之官能基形成交聯之基的化合物為佳,例如較佳為具有2個以上之羥甲基或烷氧基甲基的交聯劑。具有此等基之化合物,例如可列舉烷氧基甲基化乙炔脲、烷氧基甲基化苯并胍胺及烷氧基甲基化三聚氰胺等之羥甲基化合物。Examples of the crosslinking agent of the component (B) include epoxy compounds, methylol compounds, isocyanate compounds, and the like, and a methylol compound is preferred. Among them, the cross-linking agent of component (B) is particularly preferably a compound having two or more groups that form cross-links with the thermally cross-linkable functional group of component (A). For example, a compound having two or more groups is preferred. hydroxymethyl or alkoxymethyl cross-linking agent. Examples of compounds having such groups include methylol compounds such as alkoxymethylated acetylene urea, alkoxymethylated benzoguanamine, and alkoxymethylated melamine.
上述羥甲基化合物之具體例子,例如可列舉烷氧基甲基化乙炔脲、烷氧基甲基化苯并胍胺、烷氧基甲基化三聚氰胺、四(烷氧基甲基)雙酚及四(羥基甲基)雙酚等之化合物。Specific examples of the hydroxymethyl compound include alkoxymethylated acetylene urea, alkoxymethylated benzoguanamine, alkoxymethylated melamine, and tetrakis(alkoxymethyl)bisphenol. And compounds such as tetra(hydroxymethyl)bisphenol.
烷氧基甲基化乙炔脲之具體例子,例如可列舉1,3,4,6-肆(甲氧基甲基)乙炔脲、1,3,4,6-肆(丁氧基甲基)乙炔脲、1,3,4,6-肆(羥基甲基)乙炔脲、1,3-雙(羥基甲基)脲、1,1,3,3-肆(丁氧基甲基)脲、1,1,3,3-肆(甲氧基甲基)脲、1,3-雙(羥基甲基)-4,5-二羥基-2-咪唑啉酮,及1,3-雙(甲氧基甲基)-4,5-二甲氧基-2-咪唑啉酮等。市售品可列舉三井Cytec(股)製乙炔脲化合物(商品名:Cymel(註冊商標)1170、Powderlink(註冊商標)1174)等之化合物、甲基化脲樹脂(商品名:UFR(註冊商標)65)、丁基化脲樹脂(商品名:UFR(註冊商標)300、U-VAN10S60、U-VAN10R、U-VAN11HV)、DIC(股)製脲/甲醛系樹脂(高縮合型,商品名:BECKAMINE(註冊商標)J-300S、同P-955、同N)等。Specific examples of alkoxymethylated acetylene urea include 1,3,4,6-quaternary (methoxymethyl) acetylene urea and 1,3,4,6-quaternary (butoxymethyl) Acetylene urea, 1,3,4,6-(hydroxymethyl)acetylene urea, 1,3-bis(hydroxymethyl)urea, 1,1,3,3-(butoxymethyl)urea, 1,1,3,3-Methoxymethylurea, 1,3-bis(hydroxymethyl)-4,5-dihydroxy-2-imidazolinone, and 1,3-bis(methyl) Oxymethyl)-4,5-dimethoxy-2-imidazolinone, etc. Examples of commercially available products include compounds such as acetylene urea compounds (trade names: Cymel (registered trademark) 1170, Powderlink (registered trademark) 1174) manufactured by Mitsui Cytec Co., Ltd., and methylated urea resin (trade name: UFR (registered trademark) 65), butylated urea resin (trade name: UFR (registered trademark) 300, U-VAN10S60, U-VAN10R, U-VAN11HV), DIC Co., Ltd. urea/formaldehyde resin (high condensation type, trade name: BECKAMINE (registered trademark) J-300S, same as P-955, same as N), etc.
烷氧基甲基化苯并胍胺之具體例子,例如可列舉四甲氧基甲基苯并胍胺等。市售品可列舉三井Cytec(股)製(商品名:Cymel(註冊商標)1123)、(股)三和化學製(商品名:NIKALAC(註冊商標)BX-4000、同BX-37、同BL-60、同BX-55H)等。Specific examples of the alkoxymethylated benzoguanamine include tetramethoxymethylbenzoguanamine. Examples of commercially available products include Mitsui Cytec Co., Ltd. (trade name: Cymel (registered trademark) 1123), Sanwa Chemical Co., Ltd. (trade name: NIKALAC (registered trademark)) BX-4000, BX-37, and BL -60, same as BX-55H), etc.
烷氧基甲基化三聚氰胺之具體例子,例如可列舉六甲氧基甲基三聚氰胺等。市售品可列舉三井Cytec(股)製甲氧基甲基型三聚氰胺化合物(商品名:Cymel(註冊商標)300、同301、同303、同350)、丁氧基甲基型三聚氰胺化合物(商品名:Mycoat(註冊商標)506、同508)、(股)三和化學製甲氧基甲基型三聚氰胺化合物(商品名:NIKALAC(註冊商標)MW-30、同MW-22、同MW-11、同MW-100LM、同MS-001、同MX-002、同MX-730、同MX-750、同MX-035)、丁氧基甲基型三聚氰胺化合物(商品名:NIKALAC(註冊商標)MX-45、同MX-410、同MX-302)等。Specific examples of alkoxymethylated melamine include hexamethoxymethylmelamine. Examples of commercially available products include methoxymethyl melamine compounds (trade names: Cymel (registered trademark) 300, Cymel (registered trademark) 300, Cymel 303, Cymel 350) manufactured by Mitsui Cytec Co., Ltd., and butoxymethyl melamine compounds (trade names). Name: Mycoat (registered trademark) 506, same as 508), methoxymethyl melamine compound manufactured by Sanwa Chemical Co., Ltd. (trade name: NIKALAC (registered trademark) MW-30, same as MW-22, same as MW-11 , same as MW-100LM, same as MS-001, same as MX-002, same as MX-730, same as MX-750, same as MX-035), butoxymethyl melamine compound (trade name: NIKALAC (registered trademark) MX -45, same as MX-410, same as MX-302), etc.
四(烷氧基甲基)雙酚及四(羥基甲基)雙酚之例子,可列舉四(烷氧基甲基)雙酚A、四(羥基甲基)雙酚A等。Examples of tetrakis(alkoxymethyl)bisphenol and tetrakis(hydroxymethyl)bisphenol include tetrakis(alkoxymethyl)bisphenol A, tetrakis(hydroxymethyl)bisphenol A, and the like.
又,(B)成分的交聯劑,亦可為使如此的胺基之氫原子被羥甲基或烷氧基甲基取代之三聚氰胺化合物、脲化合物、乙炔脲化合物及苯并胍胺化合物縮合而得的化合物。例如,可列舉美國專利第6323310號說明書所記載之由三聚氰胺化合物及苯并胍胺化合物所製造之高分子量之化合物。前述三聚氰胺化合物之市售品,可列舉商品名:Cymel(註冊商標)303(三井Cytec(股)製)等,前述苯并胍胺化合物之市售品,可列舉商品名:Cymel(註冊商標)1123(三井Cytec(股)製)等。In addition, the cross-linking agent of component (B) may be a melamine compound, a urea compound, an acetylene urea compound and a benzoguanamine compound in which the hydrogen atom of the amine group is substituted by a hydroxymethyl group or an alkoxymethyl group. The compound obtained. For example, a high molecular weight compound produced from a melamine compound and a benzoguanamine compound described in US Patent No. 6323310 can be cited. Examples of commercially available products of the aforementioned melamine compound include trade name: Cymel (registered trademark) 303 (manufactured by Mitsui Cytec Co., Ltd.), and examples of commercially available products of the aforementioned benzoguanamine compound include trade name: Cymel (registered trademark) 1123 (controlled by Mitsui Cytec Co., Ltd.), etc.
進一步地,(B)成分之交聯劑,亦可利用使用N-羥基甲基丙烯醯胺、N-甲氧基甲基甲基丙烯醯胺、N-乙氧基甲基丙烯醯胺、N-丁氧基甲基甲基丙烯醯胺等之經羥基甲基(亦即羥甲基)或烷氧基甲基取代的丙烯醯胺化合物或甲基丙烯醯胺化合物所製造之聚合物。Furthermore, as the cross-linking agent of component (B), N-hydroxymethacrylamide, N-methoxymethylmethacrylamide, N-ethoxymethacrylamide, N -Polymers made from acrylamide compounds or methacrylamide compounds substituted with hydroxymethyl (i.e., hydroxymethyl) or alkoxymethyl groups, such as butoxymethylmethacrylamide.
如此的聚合物,例如可列舉聚(N-丁氧基甲基丙烯醯胺)、N-丁氧基甲基丙烯醯胺與苯乙烯之共聚物、N-羥基甲基甲基丙烯醯胺與甲基丙烯酸甲酯之共聚物、N-乙氧基甲基甲基丙烯醯胺與甲基丙烯酸苄酯之共聚物,及N-丁氧基甲基丙烯醯胺與甲基丙烯酸苄酯與甲基丙烯酸2-羥基丙酯之共聚物等。Examples of such polymers include poly(N-butoxymethacrylamide), copolymers of N-butoxymethacrylamide and styrene, and N-hydroxymethylmethacrylamide and Copolymers of methyl methacrylate, copolymers of N-ethoxymethylmethacrylamide and benzyl methacrylate, and copolymers of N-butoxymethacrylamide and benzyl methacrylate and methacrylate Copolymer of 2-hydroxypropyl acrylate, etc.
又,如此的聚合物,亦可使用具有N-烷氧基甲基與含有C=C雙鍵之聚合性基的聚合物。Furthermore, as such a polymer, a polymer having an N-alkoxymethyl group and a polymerizable group containing a C=C double bond can also be used.
含有C=C雙鍵之聚合性基,可列舉丙烯醯基、甲基丙烯醯基、乙烯基、烯丙基、馬來醯亞胺基等。Examples of the polymerizable group containing a C=C double bond include an acryl group, a methacryloyl group, a vinyl group, an allyl group, a maleimide group, and the like.
得到具有含有C=C雙鍵之聚合性基的聚合物之方法,並無特殊限定。若舉一例,係預先藉由自由基聚合等之聚合方法,生成具有特定官能基之丙烯酸聚合物。接著,藉由使該特定官能基,與末端具有不飽和鍵之化合物(以下稱為特定化合物)反應,可對(B)成分的聚合物導入含有C=C雙鍵之聚合性基。The method for obtaining a polymer having a polymerizable group containing a C=C double bond is not particularly limited. For example, an acrylic polymer having a specific functional group is produced in advance by a polymerization method such as radical polymerization. Next, by reacting the specific functional group with a compound having an unsaturated bond at the terminal (hereinafter referred to as a specific compound), a polymerizable group containing a C=C double bond can be introduced into the polymer of component (B).
此處,特定官能基,係指羧基、縮水甘油基、羥基、具有活性氫之胺基、酚性羥基或異氰酸酯基等之官能基,或由此等中選出的複數種官能基。藉由使具有此等基之單體聚合,可得到具有特定官能基之丙烯酸聚合物。Here, the specific functional group refers to a functional group such as a carboxyl group, a glycidyl group, a hydroxyl group, an amine group having an active hydrogen, a phenolic hydroxyl group, an isocyanate group, or a plurality of functional groups selected from these groups. By polymerizing monomers having these groups, acrylic polymers having specific functional groups can be obtained.
具有羧基之單體,例如可列舉丙烯酸、甲基丙烯酸、巴豆酸、單-(2-(丙烯醯基氧基)乙基)鄰苯二甲酸酯、單-(2-(甲基丙烯醯基氧基)乙基)鄰苯二甲酸酯、N-(羧基苯基)馬來醯亞胺、N-(羧基苯基)甲基丙烯醯胺及N-(羧基苯基)丙烯醯胺等。Examples of monomers having carboxyl groups include acrylic acid, methacrylic acid, crotonic acid, mono-(2-(acryloxy)ethyl) phthalate, and mono-(2-(methacryloxy)ethyl). Oxy)ethyl) phthalate, N-(carboxyphenyl)maleimide, N-(carboxyphenyl)methacrylamide and N-(carboxyphenyl)acrylamide wait.
具有縮水甘油基之單體,例如可列舉甲基丙烯酸縮水甘油酯、丙烯酸縮水甘油酯、烯丙基縮水甘油醚、3-乙烯基-7-氧雜雙環[4.1.0]庚烷、1,2-環氧基-5-己烯及1,7-辛二烯單環氧化物等。Examples of monomers having a glycidyl group include glycidyl methacrylate, glycidyl acrylate, allyl glycidyl ether, 3-vinyl-7-oxabicyclo[4.1.0]heptane, 1, 2-epoxy-5-hexene and 1,7-octadiene monoepoxide, etc.
具有羥基之單體,例如可列舉丙烯酸2-羥基乙酯、甲基丙烯酸2-羥基乙酯、丙烯酸2-羥基丙酯、甲基丙烯酸2-羥基丙酯、丙烯酸4-羥基丁酯、甲基丙烯酸4-羥基丁酯、丙烯酸2,3-二羥基丙酯、甲基丙烯酸2,3-二羥基丙酯、二乙二醇單丙烯酸酯、二乙二醇單甲基丙烯酸酯、己內酯2-(丙烯醯基氧基)乙酯、己內酯2-(甲基丙烯醯基氧基)乙酯、聚(乙二醇)乙基醚丙烯酸酯、聚(乙二醇)乙基醚甲基丙烯酸酯、5-丙烯醯基氧基-6-羥基降莰烯-2-羧酸-6-內酯及5-甲基丙烯醯基氧基-6-羥基降莰烯-2-羧酸-6-內酯等。Examples of the monomer having a hydroxyl group include 2-hydroxyethyl acrylate, 2-hydroxyethyl methacrylate, 2-hydroxypropyl acrylate, 2-hydroxypropyl methacrylate, 4-hydroxybutyl acrylate, and methyl 4-hydroxybutyl acrylate, 2,3-dihydroxypropyl acrylate, 2,3-dihydroxypropyl methacrylate, diethylene glycol monoacrylate, diethylene glycol monomethacrylate, caprolactone 2-(acryloxy)ethyl ester, caprolactone 2-(methacryloxy)ethyl ester, poly(ethylene glycol) ethyl ether acrylate, poly(ethylene glycol) ethyl ether Methacrylate, 5-acryloxy-6-hydroxynorbornene-2-carboxylic acid-6-lactone and 5-methacryloxy-6-hydroxynorbornene-2-carboxylic acid Acid-6-lactone, etc.
具有胺基之單體,例如可列舉丙烯酸2-胺基乙酯及甲基丙烯酸2-胺基甲酯等。Examples of the monomer having an amino group include 2-aminoethyl acrylate and 2-aminomethyl methacrylate.
具有酚性羥基之單體,例如可列舉羥基苯乙烯、N-(羥基苯基)丙烯醯胺、N-(羥基苯基)甲基丙烯醯胺及N-(羥基苯基)馬來醯亞胺等。Monomers with phenolic hydroxyl groups include, for example, hydroxystyrene, N-(hydroxyphenyl)acrylamide, N-(hydroxyphenyl)methacrylamide, and N-(hydroxyphenyl)maleamide. Amines etc.
具有異氰酸酯基之單體,例如可列舉異氰酸丙烯醯基乙酯、異氰酸甲基丙烯醯基乙酯及m-四甲基二甲苯異氰酸酯等。Examples of the monomer having an isocyanate group include acryloyl ethyl isocyanate, methacryloyl ethyl isocyanate, m-tetramethylxylene isocyanate, and the like.
上述反應中,特定官能基,與特定化合物所具有之與反應相關的官能基之較佳組合,係羧基與環氧基、羥基與異氰酸酯基、酚性羥基與環氧基、羧基與異氰酸酯基、胺基與異氰酸酯基,或羥基與酸氯化物等。進一步地,更佳之組合,係羧基與甲基丙烯酸縮水甘油酯,或羥基與異氰酸酯甲基丙烯酸乙酯。In the above reaction, the preferred combinations of specific functional groups and functional groups related to the reaction possessed by the specific compound are carboxyl and epoxy groups, hydroxyl and isocyanate groups, phenolic hydroxyl and epoxy groups, carboxyl and isocyanate groups, Amino group and isocyanate group, or hydroxyl group and acid chloride, etc. Furthermore, a more preferred combination is carboxyl and glycidyl methacrylate, or hydroxyl and isocyanate ethyl methacrylate.
如此的聚合物之重量平均分子量(聚苯乙烯換算值),係1,000~500,000,較佳為2,000~200,000、更佳為3,000~150,000、又更佳為3,000~50,000。The weight average molecular weight (polystyrene equivalent) of such a polymer is 1,000 to 500,000, preferably 2,000 to 200,000, more preferably 3,000 to 150,000, still more preferably 3,000 to 50,000.
此等交聯劑,可單獨或組合2種以上使用。These cross-linking agents can be used alone or in combination of two or more.
本發明之硬化膜形成組成物中之(B)成分之交聯劑之含量,基於(A)成分之聚合物及(C)成分之交聯觸媒的合計量100質量份而言,較佳為5質量份至500質量份、更佳為10質量份~400質量份。交聯劑之含量過小時,有由硬化膜形成組成物所得之硬化膜的溶劑耐受性降低,液晶配向性降低之虞。另一方面,含量過大時,有液晶配向性及保存安定性降低之虞。The content of the cross-linking agent of component (B) in the cured film forming composition of the present invention is preferably based on 100 parts by mass of the total amount of the polymer of component (A) and the cross-linking catalyst of component (C). The amount is 5 parts by mass to 500 parts by mass, and more preferably 10 parts by mass to 400 parts by mass. If the content of the cross-linking agent is too small, the solvent resistance of the cured film obtained from the cured film-forming composition may decrease, and the liquid crystal alignment may decrease. On the other hand, when the content is too large, liquid crystal alignment and storage stability may be reduced.
[(C)成分] 形成本發明之光學薄膜中之表面的硬化膜之硬化膜形成組成物,除了上述(A)成分及(B)成分以外,可進一步含有(C)成分的交聯觸媒。 (C)成分的交聯觸媒,例如可列舉酸或熱酸產生劑。該(C)成分,係於使用形成本發明之光學薄膜中之表面的硬化膜之硬化膜形成組成物來形成硬化膜時,有效於促進熱硬化反應。[(C)Component] The cured film-forming composition that forms the cured film on the surface of the optical film of the present invention may further contain a crosslinking catalyst of the component (C) in addition to the above-mentioned components (A) and (B). Examples of the cross-linking catalyst of component (C) include acid or thermal acid generator. This component (C) is effective in promoting a thermosetting reaction when a cured film is formed using a cured film-forming composition that forms a cured film on the surface of the optical film of the present invention.
使用酸或熱酸產生劑作為(C)成分時,(C)成分只要係含有磺酸基之化合物、鹽酸或其鹽、預烘烤或後烘烤時熱分解而產生酸之化合物,亦即於溫度80℃~250℃熱分解而產生酸之化合物,則無特殊限定。When an acid or thermal acid generator is used as component (C), component (C) only needs to be a compound containing a sulfonic acid group, hydrochloric acid or its salt, or a compound that generates acid by thermal decomposition during pre-baking or post-baking, that is, There are no special restrictions on compounds that thermally decompose at temperatures between 80°C and 250°C to produce acids.
如此的化合物例如可列舉鹽酸、甲磺酸、乙磺酸、丙磺酸、丁磺酸、戊磺酸、辛磺酸、苯磺酸、p-甲苯磺酸、樟腦磺酸、三氟甲磺酸、p-酚磺酸、2-萘磺酸、均三甲苯磺酸、p-二甲苯-2-磺酸、m-二甲苯-2-磺酸、4-乙基苯磺酸、1H,1H,2H,2H-全氟辛磺酸、全氟(2-乙氧基乙烷)磺酸、五氟乙磺酸、九氟丁烷-1-磺酸、十二烷基苯磺酸等之磺酸或其水合物或鹽等。Examples of such compounds include hydrochloric acid, methanesulfonic acid, ethanesulfonic acid, propanesulfonic acid, butanesulfonic acid, pentansulfonic acid, octanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, camphorsulfonic acid, and trifluoromethanesulfonate. Acid, p-phenol sulfonic acid, 2-naphthalene sulfonic acid, mesitylenesulfonic acid, p-xylene-2-sulfonic acid, m-xylene-2-sulfonic acid, 4-ethylbenzenesulfonic acid, 1H, 1H,2H,2H-Perfluorooctane sulfonic acid, perfluoro(2-ethoxyethane)sulfonic acid, pentafluoroethanesulfonic acid, nonafluorobutane-1-sulfonic acid, dodecylbenzenesulfonic acid, etc. Sulfonic acid or its hydrate or salt, etc.
又,因熱而產生酸之化合物,例如可列舉雙(甲苯磺醯氧基)乙烷、雙(甲苯磺醯氧基)丙烷、雙(甲苯磺醯氧基)丁烷、甲苯磺酸p-硝基苄酯、甲苯磺酸o-硝基苄酯、1,2,3-伸苯基參(甲基磺酸酯)、p-甲苯磺酸吡啶鎓鹽、p-甲苯磺酸嗎啉鎓鹽、p-甲苯磺酸乙酯、p-甲苯磺酸丙酯、p-甲苯磺酸丁酯、p-甲苯磺酸異丁酯、p-甲苯磺酸甲酯、p-甲苯磺酸苯乙酯、p-甲苯磺酸氰基甲酯、p-甲苯磺酸2,2,2-三氟乙酯、p-甲苯磺酸2-羥基丁酯、N-乙基-4-甲苯磺醯胺,及下述式[TAG-1]至式[TAG-41]表示之化合物等。Examples of compounds that generate acids due to heat include bis(toluenesulfonyloxy)ethane, bis(toluenesulfonyloxy)propane, bis(toluenesulfonyloxy)butane, and p-toluenesulfonate. Nitrobenzyl ester, o-nitrobenzyl tosylate, 1,2,3-phenylenesulfonate (methylsulfonate), p-pyridinium tosylate, p-morpholinium tosylate Salt, p-ethyl toluenesulfonate, p-propyl toluenesulfonate, p-butyl toluenesulfonate, p-isobutyl toluenesulfonate, p-methyl toluenesulfonate, p-phenyl toluenesulfonate Ester, p-cyanomethyl toluenesulfonate, p-2,2,2-trifluoroethyl toluenesulfonate, p-hydroxybutyl toluenesulfonate, N-ethyl-4-toluenesulfonamide , and compounds represented by the following formulas [TAG-1] to formulas [TAG-41], etc.
本發明之實施形態之硬化膜形成組成物中的(C)成分之含量,相對於(A)成分的聚合物100質量份而言,係0.01質量份~20質量份、較佳為0.01質量份~10質量份、更佳為0.05質量份~8質量份、又更佳為0.1質量份~6質量份。藉由使(C)成分之含量為0.01質量份以上,可賦予充分的熱硬化性與溶劑耐受性,亦可賦予對曝光的高感度。又,藉由為20質量份以下,可使硬化膜形成組成物之保存安定性成為良好。The content of component (C) in the cured film forming composition according to the embodiment of the present invention is 0.01 to 20 parts by mass, preferably 0.01 part by mass relative to 100 parts by mass of the polymer of component (A). ~10 parts by mass, more preferably 0.05 parts by mass ~ 8 parts by mass, and more preferably 0.1 parts by mass ~ 6 parts by mass. By setting the content of component (C) to 0.01 parts by mass or more, sufficient thermal curability and solvent resistance can be imparted, and high sensitivity to exposure can also be imparted. Moreover, by being 20 parts by mass or less, the storage stability of the cured film forming composition can be made good.
[(D)成分] 本發明之組成物,可進一步含有具有選自由羥基、羧基、醯胺基、胺基及烷氧基矽烷基所成之群的至少一種基之聚合物,作為(D)成分。[(D)Component] The composition of the present invention may further contain a polymer having at least one group selected from the group consisting of a hydroxyl group, a carboxyl group, a amide group, an amine group, and an alkoxysilyl group as the component (D).
(D)成分的聚合物,例如可列舉丙烯酸聚合物、胺基甲酸酯改質丙烯酸聚合物、聚醯胺酸、聚醯亞胺、聚乙烯醇、聚酯、聚酯聚羧酸、聚醚多元醇、聚酯多元醇、聚碳酸酯多元醇、聚己內酯多元醇、聚烷亞胺(polyalkylenimine)、聚烯丙胺、纖維素類(纖維素或其衍生物)、酚酚醛清漆樹脂等之具有直鏈結構或分支結構之聚合物、環糊精類等之環狀聚合物等。Examples of the polymer of component (D) include acrylic polymer, urethane-modified acrylic polymer, polyamide, polyimide, polyvinyl alcohol, polyester, polyester-polycarboxylic acid, polyamide Ether polyol, polyester polyol, polycarbonate polyol, polycaprolactone polyol, polyalkylenimine, polyallylamine, cellulose (cellulose or its derivatives), phenolic novolac resin Polymers with linear or branched structures, cyclic polymers such as cyclodextrins, etc.
其中,丙烯酸聚合物可應用使丙烯酸酯、甲基丙烯酸酯、苯乙烯等之具有不飽和雙鍵之單體聚合而得的聚合物。作為其合成方法,係以使具有選自由上述(A)成分及(B)成分之章所例示之具有羥基之單體、具有羧基之單體、具有醯胺基之單體、具有胺基之單體及具有烷氧基矽烷基之單體所成之群的至少一種基之單體,與依期望之其以外的單體,以上述(A)成分及(B)成分之章所記載的方法(共)聚合之方法為簡便。Among them, a polymer obtained by polymerizing a monomer having an unsaturated double bond such as acrylate, methacrylate, styrene, etc. can be used as the acrylic polymer. As the synthesis method, a monomer having a hydroxyl group, a monomer having a carboxyl group, a monomer having a amide group, and a monomer having an amine group selected from the group consisting of the above-mentioned components (A) and (B) are exemplified. At least one monomer of the group consisting of a monomer and a monomer having an alkoxysilyl group, and other monomers as desired, as described in the chapters of the above-mentioned (A) component and (B) component. Methods The method of (co)polymerization is simple.
(D)成分之例子的丙烯酸聚合物,重量平均分子量較佳為3000至200000、更佳為4000至150000、又更佳為5000至100000。The weight average molecular weight of the acrylic polymer as an example of component (D) is preferably 3,000 to 200,000, more preferably 4,000 to 150,000, still more preferably 5,000 to 100,000.
(D)成分之較佳一例的聚醚多元醇,可列舉對聚乙二醇、聚丙二醇、丙二醇或雙酚A、三乙二醇、山梨醇等之多元醇加成環氧丙烷或聚乙二醇、聚丙二醇等者。聚醚多元醇之具體例子可列舉(股)ADEKA製Adeka Polyether P系列、G系列、EDP系列、BPX系列、FC系列、CM系列、日油(股)製Uniox(註冊商標)HC-40、HC-60、ST-30E、ST-40E、G-450、G-750、Uniol(註冊商標)TG-330、TG-1000、TG-3000、TG-4000、HS-1600D、DA-400、DA-700、DB-400、Nonion(註冊商標)LT-221、ST-221、OT-221等。Preferable examples of polyether polyols as component (D) include propylene oxide or polyethylene added to polyethylene glycol, polypropylene glycol, propylene glycol, bisphenol A, triethylene glycol, sorbitol, and other polyols. Glycol, polypropylene glycol, etc. Specific examples of polyether polyols include Adeka Polyether P series, G series, EDP series, BPX series, FC series, CM series manufactured by ADEKA Co., Ltd., Uniox (registered trademark) HC-40, HC manufactured by NOF Co., Ltd. -60, ST-30E, ST-40E, G-450, G-750, Uniol (registered trademark) TG-330, TG-1000, TG-3000, TG-4000, HS-1600D, DA-400, DA- 700, DB-400, Nonion (registered trademark) LT-221, ST-221, OT-221, etc.
(D)成分之較佳一例的聚酯多元醇,可列舉使乙二醇、丙二醇、丁二醇、聚乙二醇、聚丙二醇等之二醇與己二酸、癸二酸、間苯二甲酸等之多元羧酸反應者。聚酯多元醇之具體例子,可列舉DIC(股)製Polylite(註冊商標)OD-X-286、OD-X-102、OD-X-355、OD-X-2330、OD-X-240、OD-X-668、OD-X-2108、OD-X-2376、OD-X-2044、OD-X-688、OD-X-2068、OD-X-2547、OD-X-2420、OD-X-2523、OD-X-2555、OD-X-2560、(股)Kuraray製Polyol P-510、P-1010、P-2010、P-3010、P-4010、P-5010、P-6010、F-510、F-1010、F-2010、F-3010、P-1011、P-2011、P-2013、P-2030、N-2010、PNNA-2016等。Preferable examples of the polyester polyol of component (D) include glycols such as ethylene glycol, propylene glycol, butylene glycol, polyethylene glycol, and polypropylene glycol, and adipic acid, sebacic acid, isophthalic acid, etc. Formic acid and other polycarboxylic acid reactants. Specific examples of the polyester polyol include Polylite (registered trademark) OD-X-286, OD-X-102, OD-X-355, OD-X-2330, OD-X-240, manufactured by DIC Co., Ltd. OD-X-668, OD-X-2108, OD-X-2376, OD-X-2044, OD-X-688, OD-X-2068, OD-X-2547, OD-X-2420, OD- X-2523, OD-X-2555, OD-X-2560, Polyol P-510, P-1010, P-2010, P-3010, P-4010, P-5010, P-6010, manufactured by Kuraray Co., Ltd. F-510, F-1010, F-2010, F-3010, P-1011, P-2011, P-2013, P-2030, N-2010, PNNA-2016, etc.
(D)成分之較佳一例的聚己內酯多元醇,可列舉以三羥甲基丙烷或乙二醇等之多元醇為起始劑,使ε-己內酯開環聚合者。聚己內酯多元醇之具體例子,可列舉DIC(股)製Polylite(註冊商標)OD-X-2155、OD-X-640、OD-X-2568、Daicel化學製Placcel(註冊商標)205、L205AL、205U、208、210、212、L212AL、220、230、240、303、305、308、312、320等。A preferred example of polycaprolactone polyol as component (D) is one in which ε-caprolactone is ring-opening polymerized using a polyol such as trimethylolpropane or ethylene glycol as a initiator. Specific examples of polycaprolactone polyol include Polylite (registered trademark) OD-X-2155, OD-X-640, OD-X-2568 manufactured by DIC Co., Ltd., Placcel (registered trademark) 205 manufactured by Daicel Chemical Co., Ltd. L205AL, 205U, 208, 210, 212, L212AL, 220, 230, 240, 303, 305, 308, 312, 320, etc.
(D)成分之較佳一例的聚碳酸酯多元醇,可列舉使三羥甲基丙烷或乙二醇等之多元醇與碳酸二乙酯、碳酸二苯酯、碳酸伸乙酯等反應者。聚碳酸酯多元醇之具體例子可列舉(股)Daicel製Placcel(註冊商標)CD205、CD205PL、CD210、CD220、(股)Kuraray製之C-590、C-1050、C-2050、C-2090、C-3090等。A preferred example of the polycarbonate polyol of the component (D) is one made by reacting a polyol such as trimethylolpropane or ethylene glycol with diethyl carbonate, diphenyl carbonate, ethylene carbonate, or the like. Specific examples of polycarbonate polyols include Placcel (registered trademark) CD205, CD205PL, CD210, CD220 manufactured by Daicel Co., Ltd., C-590, C-1050, C-2050, C-2090 manufactured by Kuraray Co., Ltd. C-3090 etc.
(D)成分之較佳一例的纖維素,可列舉羥基乙基纖維素、羥基丙基纖維素等之羥基烷基纖維素類、羥基乙基甲基纖維素、羥基丙基甲基纖維素、羥基乙基乙基纖維素等之羥基烷基烷基纖維素類及纖維素等,較佳為例如羥基乙基纖維素、羥基丙基纖維素等之羥基烷基纖維素類。Preferable examples of cellulose as the component (D) include hydroxyalkyl celluloses such as hydroxyethyl cellulose and hydroxypropyl cellulose, hydroxyethyl methyl cellulose, and hydroxypropyl methyl cellulose. Hydroxyalkyl alkyl celluloses such as hydroxyethyl ethyl cellulose and cellulose, etc. are preferably hydroxyalkyl celluloses such as hydroxyethyl cellulose and hydroxypropyl cellulose.
(D)成分之較佳一例的環糊精,可列舉α-環糊精、β-環糊精及γ環糊精等之環糊精;甲基-α-環糊精、甲基-β-環糊精以及甲基-γ-環糊精等之甲基化環糊精;羥基甲基-α-環糊精、羥基甲基-β-環糊精、羥基甲基-γ-環糊精、2-羥基乙基-α-環糊精、2-羥基乙基-β-環糊精、2-羥基乙基-γ-環糊精、2-羥基丙基-α-環糊精、2-羥基丙基-β-環糊精、2-羥基丙基-γ-環糊精、3-羥基丙基-α-環糊精、3-羥基丙基-β-環糊精、3-羥基丙基-γ-環糊精、2,3-二羥基丙基-α-環糊精、2,3-二羥基丙基-β-環糊精、2,3-二羥基丙基-γ-環糊精等之羥基烷基環糊精等。Preferable examples of cyclodextrins as the component (D) include cyclodextrins such as α-cyclodextrin, β-cyclodextrin, and γ-cyclodextrin; methyl-α-cyclodextrin, methyl-β - Methylated cyclodextrins such as cyclodextrin and methyl-γ-cyclodextrin; hydroxymethyl-α-cyclodextrin, hydroxymethyl-β-cyclodextrin, hydroxymethyl-γ-cyclodextrin Essence, 2-hydroxyethyl-α-cyclodextrin, 2-hydroxyethyl-β-cyclodextrin, 2-hydroxyethyl-γ-cyclodextrin, 2-hydroxypropyl-α-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin, 2-hydroxypropyl-γ-cyclodextrin, 3-hydroxypropyl-α-cyclodextrin, 3-hydroxypropyl-β-cyclodextrin, 3- Hydroxypropyl-γ-cyclodextrin, 2,3-dihydroxypropyl-α-cyclodextrin, 2,3-dihydroxypropyl-β-cyclodextrin, 2,3-dihydroxypropyl-γ -Hydroxyalkyl cyclodextrin, etc. of cyclodextrin, etc.
(D)成分之較佳一例的胺基甲酸酯改質丙烯酸聚合物,作為市售品可列舉大成FINE CHEMICAL(股)製Acrit(註冊商標)8UA-017、8UA-239、8UA-239H、8UA-140、8UA-146、8UA-585H、8UA-301、8UA-318、8UA-347A、8UA-347H、8UA-366等。(D) A preferred example of the urethane-modified acrylic polymer of the component, commercially available products include Acrit (registered trademark) 8UA-017, 8UA-239, 8UA-239H manufactured by Daesung Fine Chemical Co., Ltd. 8UA-140, 8UA-146, 8UA-585H, 8UA-301, 8UA-318, 8UA-347A, 8UA-347H, 8UA-366, etc.
(D)成分之較佳一例的酚酚醛清漆樹脂,例如可列舉酚-甲醛聚縮合物等。A preferred example of the phenol novolac resin as the component (D) includes, for example, a phenol-formaldehyde polycondensate.
本發明之組成物中,(D)成分之聚合物,能夠以粉體形態,或將經純化之粉末再溶解於後述溶劑的溶液形態來使用。In the composition of the present invention, the polymer of component (D) can be used in the form of powder or in the form of a solution obtained by redissolving the purified powder in a solvent described below.
又,本發明之組成物中,(D)成分亦可為作為(D)成分所例示的聚合物之複數種之混合物。Furthermore, in the composition of the present invention, component (D) may be a mixture of plural types of polymers exemplified as component (D).
本發明之硬化膜形成組成物中之(D)成分之含量,以(A)成分之100質量份為基準,係5質量份至500質量份。The content of component (D) in the cured film forming composition of the present invention is 5 to 500 parts by mass based on 100 parts by mass of component (A).
[(E)成分] 本發明之組成物,可進一步含有低分子光配向成分,作為(E)成分。藉由含有低分子光配向成分,發揮配向膜表層之光配向性基的存在量增加,提高配向感度的效果。如此的低分子光配向成分,可列舉於本說明書之(A)成分之項所例示的式[3]表示之單體、式[4]表示之單體、式[3]表示之單體之基X4 取代為氫原子之化合物、式[4]表示之單體之基X4 取代為氫原子之化合物、上述式(1-1)~(1-5)的任一者表示之具有羧基之桂皮酸衍生物。[(E) Component] The composition of the present invention may further contain a low molecular weight photo-alignment component as the (E) component. By containing low-molecular photo-alignment components, the amount of photo-alignment groups on the surface of the alignment film is increased, thereby improving the alignment sensitivity. Such low molecular weight photoalignment components can be listed among the monomer represented by formula [3], the monomer represented by formula [4], and the monomer represented by formula [3] exemplified in the section (A) component of this specification. Compounds in which the base Cinnamic acid derivatives.
又,本發明之組成物中,(E)成分亦可為作為(E)成分所例示的化合物之複數種之混合物。Furthermore, in the composition of the present invention, component (E) may be a mixture of a plurality of compounds exemplified as component (E).
本發明之硬化膜形成組成物中含有(E)成分時之含量,基於(A)成分之聚合物100質量份,為5質量份至500質量份。When the cured film forming composition of the present invention contains component (E), the content is 5 to 500 parts by mass based on 100 parts by mass of the polymer of component (A).
[其他添加劑] 本發明之實施形態之硬化膜形成組成物,只要不損及本發明之效果,則可含有其他添加劑。 作為其他添加劑,例如可含有增感劑。增感劑係於形成本發明之光學薄膜中之表面的硬化膜時,有效於促進其光反應。[Other additives] The cured film forming composition according to the embodiment of the present invention may contain other additives as long as the effects of the present invention are not impaired. As other additives, a sensitizer may be included, for example. The sensitizer is effective in promoting the photoreaction when forming a cured film on the surface of the optical film of the present invention.
增感劑可列舉二苯甲酮、蒽、蒽醌及噻噸酮等之衍生物以及硝基苯基化合物等。此等之中特佳為二苯甲酮之衍生物的N,N-二乙基胺基二苯甲酮,及硝基苯基化合物的2-硝基茀、2-硝基茀酮、5-硝基苊萘、4-硝基聯苯、4-硝基桂皮酸、4-硝基二苯乙烯、4-硝基二苯甲酮、5-硝基吲哚。Examples of the sensitizer include derivatives of benzophenone, anthracene, anthraquinone, thioxanthone, and nitrophenyl compounds. Particularly preferred among these are N,N-diethylamine benzophenone, which is a derivative of benzophenone, and 2-nitrobenzene, 2-nitrobenzone, 5-nitrophenyl compounds, which are nitrophenyl compounds. -Nitroacenaphthylene, 4-nitrobephenyl, 4-nitrocinnamic acid, 4-nitrostilbene, 4-nitrobenzophenone, 5-nitroindole.
此等增感劑不特別限定為上述者。此等可單獨或合併使用2種以上之化合物。These sensitizers are not particularly limited to those mentioned above. These compounds may be used alone or in combination of two or more.
本發明之實施形態中,增感劑之使用比例,相對於(A)成分之100質量份而言,較佳為0.1質量份~20質量份、更佳為0.2質量份~10質量份。該比例過小時,有無法充分得到作為增感劑之效果的情況,過大時可能所形成之硬化膜的透過率降低,或塗膜粗糙。In the embodiment of the present invention, the usage ratio of the sensitizer is preferably 0.1 to 20 parts by mass, and more preferably 0.2 to 10 parts by mass relative to 100 parts by mass of component (A). If the ratio is too small, the effect as a sensitizer may not be fully obtained. If the ratio is too large, the transmittance of the cured film formed may be reduced or the coating film may be rough.
又,本發明之實施形態之硬化膜形成組成物,只要不損及本發明之效果,則可含有作為其他添加劑之矽烷偶合劑、界面活性劑、流變性調整劑、顏料、染料、保存安定劑、消泡劑、抗氧化劑等。In addition, the cured film-forming composition according to the embodiment of the present invention may contain silane coupling agents, surfactants, rheology regulators, pigments, dyes, and storage stabilizers as other additives as long as the effects of the present invention are not impaired. , defoaming agents, antioxidants, etc.
[溶劑] 本發明之實施形態之硬化膜形成組成物,多以溶解於溶劑的溶液狀態來使用。此時所用之溶劑,為會溶解(A)成分、(B)成分及(C)成分、依期望之(D)成分、(E)成分及/或其他添加劑者,只要係具有如此的溶解能力之溶劑,則其種類及結構等並無特殊限定。[Solvent] The cured film-forming composition according to the embodiment of the present invention is often used in a solution state dissolved in a solvent. The solvent used at this time is one that can dissolve component (A), (B) and (C), as well as component (D), (E) and/or other additives as desired, as long as it has such dissolving ability. The type and structure of the solvent are not particularly limited.
列舉溶劑之具體例子時,例如可列舉乙二醇單甲基醚、乙二醇單乙基醚、甲基賽珞蘇乙酸酯、乙基賽珞蘇乙酸酯、二乙二醇單甲基醚、二乙二醇單乙基醚、丙二醇、丙二醇單甲基醚、丙二醇單甲基醚乙酸酯、丙二醇丙基醚、丙二醇丙基醚乙酸酯、環戊基甲基醚、甲苯、二甲苯、甲基乙基酮、環戊酮、環己酮、2-丁酮、3-甲基-2-戊酮、2-戊酮、2-庚酮、γ-丁內酯、2-羥基丙酸乙酯、2-羥基-2-甲基丙酸乙酯、乙氧基乙酸乙酯、羥基乙酸乙酯、2-羥基-3-甲基丁酸甲酯、3-甲氧基丙酸甲酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸甲酯、3-乙氧基丙酸乙酯、丙酮酸甲酯、丙酮酸乙酯、乙酸乙酯、乙酸丁酯、乳酸乙酯、乳酸丁酯、乙酸n-丙酯、乙酸異丙酯、異丙醇、N,N-二甲基甲醯胺、N,N-二甲基乙醯胺,及N-甲基-2-吡咯啶酮等。Specific examples of the solvent include ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, methylcellulosulfonate acetate, ethylcellulosulfonate acetate, and diethylene glycol monomethyl ether. ether, diethylene glycol monoethyl ether, propylene glycol, propylene glycol monomethyl ether, propylene glycol monomethyl ether acetate, propylene glycol propyl ether, propylene glycol propyl ether acetate, cyclopentyl methyl ether, toluene , xylene, methyl ethyl ketone, cyclopentanone, cyclohexanone, 2-butanone, 3-methyl-2-pentanone, 2-pentanone, 2-heptanone, γ-butyrolactone, 2 -Ethyl hydroxypropionate, ethyl 2-hydroxy-2-methylpropionate, ethoxyethyl acetate, ethyl glycolate, methyl 2-hydroxy-3-methylbutyrate, 3-methoxy Methyl propionate, ethyl 3-methoxypropionate, methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, methyl pyruvate, ethyl pyruvate, ethyl acetate, acetic acid Butyl ester, ethyl lactate, butyl lactate, n-propyl acetate, isopropyl acetate, isopropyl alcohol, N,N-dimethylformamide, N,N-dimethylacetamide, and N -Methyl-2-pyrrolidone, etc.
此等溶劑,可一種單獨,或組合二種以上使用。此等溶劑當中,由於成膜性良好,安全性高,故更佳為丙二醇單甲基醚、丙二醇單甲基醚乙酸酯、甲基乙基酮、環己酮、2-庚酮、丙二醇丙基醚、丙二醇丙基醚乙酸酯、乙酸乙酯、乳酸乙酯、乳酸丁酯、3-甲氧基丙酸甲酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸乙酯及3-乙氧基丙酸甲酯。These solvents can be used alone or in combination of two or more. Among these solvents, due to their good film-forming properties and high safety, propylene glycol monomethyl ether, propylene glycol monomethyl ether acetate, methyl ethyl ketone, cyclohexanone, 2-heptanone, and propylene glycol are more preferred. Propyl ether, propylene glycol propyl ether acetate, ethyl acetate, ethyl lactate, butyl lactate, methyl 3-methoxypropionate, ethyl 3-methoxypropionate, 3-ethoxypropane Ethyl acid ester and methyl 3-ethoxypropionate.
<硬化膜形成組成物之配製> 本發明之硬化膜形成組成物,為具有光配向性之熱硬化性之硬化膜形成組成物。本發明之硬化膜形成組成物,如上所述,含有(A)成分的具有光配向性基、羥基,與含有C=C雙鍵之聚合性基的聚合物、(B)成分的交聯劑及(C)成分的交聯觸媒。依需要,含有(D)成分的具有選自由羥基、羧基、醯胺基、胺基及烷氧基矽烷基所成之群的至少一種基之聚合物。而只要不損及本發明之效果,可含有其他添加劑,進一步地,可含有溶劑。<Preparation of cured film forming composition> The cured film-forming composition of the present invention is a thermosetting cured film-forming composition having photoalignment properties. The cured film forming composition of the present invention contains, as mentioned above, a polymer having a photo-alignment group and a hydroxyl group as the component (A), a polymerizable group containing a C=C double bond, and a cross-linking agent as the component (B). and the cross-linking catalyst of component (C). If necessary, the polymer containing (D) component has at least one group selected from the group consisting of a hydroxyl group, a carboxyl group, a amide group, an amino group, and an alkoxysilyl group. As long as the effect of the present invention is not impaired, other additives may be included, and further, a solvent may be included.
本實施形態之硬化膜形成組成物的較佳例子,係如以下所述。 [1]:含有(A)成分的具有光配向性基、羥基,與含有C=C雙鍵之聚合性基的聚合物、基於(A)成分的聚合物100質量份而言為1質量份~500質量份、較佳為5質量份~500質量份之(B)成分的交聯劑,及相對於(A)成分的聚合物100質量份而言,為0.01質量份~20質量份之(C)成分的交聯觸媒之硬化膜形成組成物。Preferable examples of the cured film forming composition of this embodiment are as follows. [1]: A polymer containing a photoalignable group, a hydroxyl group, and a polymerizable group containing a C=C double bond as the component (A), 1 part by mass based on 100 parts by mass of the polymer as the component (A) ~500 parts by mass, preferably 5 parts by mass to 500 parts by mass of the cross-linking agent of component (B), and 0.01 parts by mass to 20 parts by mass relative to 100 parts by mass of the polymer of component (A) (C) A cured film-forming composition of a cross-linking catalyst of the component.
[2]:含有(A)成分的具有光配向性基、羥基,與含有C=C雙鍵之聚合性基的聚合物、基於(A)成分的聚合物100質量份而言為1質量份~500質量份、較佳為5質量份~500質量份之(B)成分的交聯劑,及相對於(A)成分的聚合物100質量份而言,為0.01質量份~20質量份之(C)成分的交聯觸媒、溶劑,且進一步地,含有基於(A)成分的聚合物100質量份而言為5質量份~500質量份之(D)成分的具有選自由羥基、羧基、醯胺基、胺基及烷氧基矽烷基所成之群的至少一種基之聚合物、溶劑之硬化膜形成組成物。[2]: A polymer containing a photoalignable group, a hydroxyl group, and a polymerizable group containing a C=C double bond as the component (A), 1 part by mass based on 100 parts by mass of the polymer as the component (A) ~500 parts by mass, preferably 5 parts by mass to 500 parts by mass of the cross-linking agent of component (B), and 0.01 parts by mass to 20 parts by mass relative to 100 parts by mass of the polymer of component (A) The cross-linking catalyst and solvent of the component (C), and further, 5 to 500 parts by mass of the component (D) having a hydroxyl group and a carboxyl group selected from 100 parts by mass of the polymer of the component (A). , a cured film-forming composition of a polymer and a solvent containing at least one type of group consisting of a amide group, an amine group and an alkoxysilane group.
使用本實施形態之硬化膜形成組成物作為溶液時之摻合比例、配製方法等詳述如下。The blending ratio, preparation method, etc. when using the cured film forming composition of this embodiment as a solution are described in detail below.
本發明之硬化膜形成組成物中之固體成分的比例,只要各成分均勻溶解於溶劑則無特殊限定,其係1質量%~80質量%、較佳為2質量%~60質量%、更佳為3質量%~40質量%。此處,固體成分係指由硬化膜形成組成物之全部成分中去除溶劑之後者。The proportion of solid components in the cured film forming composition of the present invention is not particularly limited as long as each component is uniformly dissolved in the solvent. It is 1 mass% to 80 mass%, preferably 2 mass% to 60 mass%, and more preferably It is 3 mass%~40 mass%. Here, the solid content refers to all the components of the cured film-forming composition excluding the solvent.
本發明之硬化膜形成組成物之配製方法並無特殊限定。配製法例如可列舉於溶解於溶劑之(A)成分之溶液中將(B)成分、(C)成分、進而(D)成分、(E)成分及/或其他添加劑以特定比例混合,成為均勻溶液之方法,或於該配製法之適當階段,依需要進一步添加其他添加劑並予以混合之方法。The preparation method of the cured film forming composition of the present invention is not particularly limited. Preparation methods include, for example, mixing component (B), component (C), component (D), component (E) and/or other additives in a specific ratio into a solution of component (A) dissolved in a solvent to form a uniform mixture. solution method, or a method in which other additives are further added and mixed as needed at appropriate stages of the preparation method.
本發明之硬化膜形成組成物之配製中,可直接使用藉由溶劑中之聚合反應所得的特定共聚物之溶液。此時,例如於經配製(A)成分之聚合物(丙烯酸聚合物)的溶液中,添加(B)成分、(C)成分、進而(D)成分、(E)成分及/或其他添加劑,成為均勻溶液。此時,亦可以調整濃度為目的,進一步追加投入溶劑。此時,(A)成分之配製過程所用之溶劑,與硬化膜形成組成物之濃度調整所用之溶劑,可為相同亦可相異。In the preparation of the cured film-forming composition of the present invention, a solution of a specific copolymer obtained by polymerization in a solvent can be directly used. At this time, for example, in the solution of the polymer (acrylic polymer) prepared with component (A), component (B), component (C), and further component (D), component (E) and/or other additives are added, become a homogeneous solution. At this time, additional solvent may be added for the purpose of adjusting the concentration. At this time, the solvent used in the preparation process of component (A) and the solvent used in adjusting the concentration of the cured film forming composition may be the same or different.
又,所配製之硬化膜形成組成物之溶液,較佳使用孔徑0.2μm左右的濾器等過濾後使用。In addition, the prepared solution of the cured film-forming composition is preferably filtered using a filter with a pore size of about 0.2 μm before use.
如以上所述,本發明之硬化膜形成組成物,係含有選自由(A)成分的具有光配向性基、羥基,與含有C=C雙鍵之聚合性基的聚合物所成之群的至少一種、(B)成分的交聯劑,及(C)成分的交聯觸媒而構成。As described above, the cured film-forming composition of the present invention contains a polymer selected from the group consisting of (A) component having a photoalignment group, a hydroxyl group, and a polymerizable group containing a C=C double bond. It consists of at least one cross-linking agent of component (B) and a cross-linking catalyst of component (C).
因此,由本發明之硬化膜形成組成物所形成之硬化膜,起因於(A)成分之性質,其內部形成為親水性,以使膜結構安定化。而硬化膜中之(A)成分之光配向性基及含有C=C雙鍵之聚合性基,係較多存在於硬化膜之表面附近。更具體而言,(A)成分之聚合物,係採取親水性之羥基朝向硬化膜之內部側、疏水性之光反應部及含有C=C雙鍵之聚合性基朝向表面側之結構,同時較多存在於硬化膜之表面附近。其結果,本發明之硬化膜,實現於表面附近所存在之(A)成分之光反應性基及含有C=C雙鍵之聚合性基的比例增加之結構。此外,本發明之硬化膜,當使用作為配向材料時,可提高用於光配向之光反應的效率,可具有優良之配向感度。進一步地,係成為適於形成圖型化相位差材料的配向材料,使用其所製造的圖型化相位差材料,可具有優良的圖型形成性。Therefore, the inside of the cured film formed from the cured film-forming composition of the present invention becomes hydrophilic due to the properties of component (A) to stabilize the film structure. The photo-alignment group of component (A) in the cured film and the polymerizable group containing C=C double bonds are mostly present near the surface of the cured film. More specifically, the polymer of component (A) has a structure in which the hydrophilic hydroxyl group faces the inner side of the cured film, the hydrophobic photoreactive portion and the polymerizable group containing the C=C double bond face the surface side. Most of them are found near the surface of the hardened film. As a result, the cured film of the present invention has a structure in which the proportion of the photoreactive group and the polymerizable group containing the C=C double bond of component (A) present near the surface is increased. In addition, when used as an alignment material, the cured film of the present invention can improve the efficiency of photoreaction for photoalignment and can have excellent alignment sensitivity. Furthermore, the alignment material is suitable for forming patterned retardation materials, and the patterned retardation materials produced using the alignment material can have excellent pattern formability.
又,本發明之硬化膜形成組成物,如上所述,含有(B)成分的交聯劑。因此,於由本發明之硬化膜形成組成物所得到的硬化膜之內部,於(A)成分之聚合物之光配向性基所致之光反應之前,能夠以與(B)成分之熱反應來進行交聯反應。其結果,當使用作為配向材料時,可提高對塗佈於其上之聚合性液晶或其溶劑的耐受性。Moreover, the cured film forming composition of this invention contains the crosslinking agent of (B) component as mentioned above. Therefore, inside the cured film obtained from the cured film-forming composition of the present invention, before the photoreaction caused by the photoalignment group of the polymer of the component (A), it is possible to react with the heat of the component (B). Carry out cross-linking reaction. As a result, when used as an alignment material, the resistance to the polymerizable liquid crystal or its solvent coated thereon can be improved.
又,(A)成分的聚合物之含有C=C雙鍵之聚合性基,當使用由本發明之硬化膜形成組成物所得到的硬化膜作為配向材料時,係以強化與其上所形成之經硬化的聚合性液晶之層之間的密合性的方式來發揮功能。Furthermore, when the cured film obtained from the cured film-forming composition of the present invention is used as an alignment material, the polymerizable group containing a C=C double bond in the polymer of component (A) strengthens the structure formed thereon. It functions through the adhesion between layers of hardened polymeric liquid crystal.
<硬化膜、配向材料及相位差材料> 將本實施形態之硬化膜形成組成物之溶液於基板(例如矽/二氧化矽被覆基板、氮化矽基板、被覆有金屬例如鋁、鉬、鉻等之基板、玻璃基板、石英基板、ITO基板等)或薄膜(例如三乙醯纖維素(TAC)薄膜、環烯烴聚合物薄膜、聚對苯二甲酸乙二酯薄膜、丙烯酸薄膜等之樹脂薄膜)等之上,藉由棒塗佈、旋轉塗佈、流動塗佈、輥塗佈、狹縫塗佈、狹縫之後旋轉塗佈、噴墨塗佈、印刷等進行塗佈而形成塗膜,之後,可藉由以加熱板或烘箱等加熱乾燥,形成硬化膜。<Cure film, alignment material and phase difference material> The solution of the cured film forming composition of this embodiment is applied to a substrate (such as a silicon/silica-coated substrate, a silicon nitride substrate, a substrate coated with metal such as aluminum, molybdenum, chromium, etc., a glass substrate, a quartz substrate, an ITO substrate) etc.) or films (such as triacetyl cellulose (TAC) films, cyclic olefin polymer films, polyethylene terephthalate films, acrylic films, resin films, etc.), etc., by rod coating, rotating Coating, flow coating, roll coating, slit coating, slit spin coating, inkjet coating, printing, etc. can be applied to form a coating film. After that, it can be heated with a hot plate or oven. Dry to form a hardened film.
加熱乾燥之條件,只要硬化反應進行到由硬化膜所形成之配向材料之成分,不會溶出於其上所塗佈的聚合性液晶溶液之程度即可,例如係採用由溫度60℃~200℃、時間0.4分鐘~60分鐘之範圍中所適當選擇的加熱溫度及加熱時間。加熱溫度及加熱時間,較佳為70℃~160℃、0.5分鐘~10分鐘。The conditions for heating and drying are as long as the hardening reaction proceeds to the extent that the components of the alignment material formed by the cured film will not dissolve in the polymerizable liquid crystal solution coated on it. For example, the temperature range is from 60°C to 200°C. , the heating temperature and heating time should be appropriately selected within the range of 0.4 minutes to 60 minutes. The heating temperature and heating time are preferably 70°C to 160°C and 0.5 minutes to 10 minutes.
使用本實施形態之硬化性組成物所形成的硬化膜之膜厚,例如為0.05μm~5μm,可考慮所使用之基板的階差或光學、電氣性質來適當選擇。The film thickness of the cured film formed using the curable composition of this embodiment is, for example, 0.05 μm to 5 μm, and can be appropriately selected in consideration of the step difference or optical and electrical properties of the substrate used.
如此方式所形成之硬化膜,藉由進行偏光UV照射,可作為配向材料,亦即使含有聚合性液晶等之具有液晶性的化合物配向之構件來發揮功能。The cured film formed in this way can function as an alignment material, that is, a member containing a liquid crystalline compound such as polymerizable liquid crystal, by irradiating it with polarized UV light.
偏光UV之照射方法,通常使用150nm~450nm波長之紫外光~可見光,藉由在室溫或加熱狀態下,由垂直或斜方向照射直線偏光來進行。The polarized UV irradiation method usually uses ultraviolet light to visible light with a wavelength of 150nm to 450nm, and is carried out by irradiating linearly polarized light from a vertical or oblique direction at room temperature or under heating.
使用由本發明之硬化膜形成組成物所形成之硬化膜所形成的配向材料具有耐溶劑性及耐熱性,因此於該配向材料上塗佈由聚合性液晶溶液所構成之相位差材料後,藉由加熱至該液晶之相轉移溫度,使相位差材料成為液晶狀態,於配向材料上使其配向。然後可使成為所期望之配向狀態的相位差材料直接硬化,形成具備具有光學各向異性之層的相位差材料。An alignment material formed using a cured film formed of the cured film-forming composition of the present invention has solvent resistance and heat resistance. Therefore, after coating a retardation material composed of a polymerizable liquid crystal solution on the alignment material, it is Heating to the phase transition temperature of the liquid crystal causes the phase difference material to become a liquid crystal state and aligns the material on the alignment material. Then, the retardation material in the desired alignment state can be directly hardened to form a retardation material having a layer having optical anisotropy.
相位差材料例如使用具有聚合性基之液晶單體及含有其之組成物等。而形成配向材料之基板為薄膜時,具有本實施形態之相位差材料的薄膜,係有用於作為相位差薄膜。形成如此的相位差材料之相位差材料,係成為液晶狀態,有於配向材料上採取水平配向、膽固醇狀配向、垂直配向、混合配向等之配向狀態者,可各自依所必要之相位差特性來分別使用。As the retardation material, for example, a liquid crystal monomer having a polymerizable group and a composition containing the liquid crystal monomer are used. When the substrate on which the alignment material is formed is a thin film, the thin film containing the retardation material of this embodiment is useful as a retardation film. The retardation material that forms such a retardation material becomes a liquid crystal state. If the alignment material adopts an alignment state such as horizontal alignment, cholesteric alignment, vertical alignment, mixed alignment, etc., each can be configured according to the necessary phase difference characteristics. used separately.
又,製造3D顯示器所用之圖型化相位差材料時,係對以上述方法由本發明之硬化膜形成組成物所形成之硬化膜,由特定基準,透過線與間隙(line and space)圖型之遮罩,例如以+45度之方向進行偏光UV曝光,接著,移去遮罩後以-45度之方向進行偏光UV曝光,來形成形成有液晶之配向控制方向不同的2種液晶配向區域之配向材料。之後,塗佈由聚合性液晶溶液所構成之相位差材料後,藉由加熱至液晶之相轉移溫度,而使相位差材料成為液晶狀態。成為液晶狀態之聚合性液晶,係於形成有2種液晶配向區域的配向材料上配向,形成分別對應於各液晶配向區域之配向狀態。然後,可將實現如此的配向狀態之相位差材料直接硬化,使上述配向狀態固定化,得到分別規則地配置有複數個相位差特性不同的2種相位差區域之圖型化相位差材料。In addition, when manufacturing a patterned retardation material used in a 3D display, the cured film formed from the cured film-forming composition of the present invention by the above-mentioned method is used to pass a line and space pattern based on a specific reference. Mask, for example, perform polarized UV exposure in the direction of +45 degrees. Then, remove the mask and perform polarized UV exposure in the direction of -45 degrees to form one of two types of liquid crystal alignment areas with different alignment control directions of liquid crystals. Alignment materials. Thereafter, a retardation material composed of a polymerizable liquid crystal solution is applied, and then the retardation material is brought into a liquid crystal state by heating to the phase transition temperature of the liquid crystal. The polymerizable liquid crystal that becomes a liquid crystal state is aligned on an alignment material in which two types of liquid crystal alignment areas are formed, forming an alignment state corresponding to each liquid crystal alignment area. Then, the retardation material that achieves such an alignment state can be directly hardened to fix the above-mentioned alignment state, thereby obtaining a patterned retardation material in which a plurality of two types of retardation regions with different retardation characteristics are regularly arranged.
又,使用由本發明之硬化膜形成組成物所形成之硬化膜所形成的配向材料,亦可利用作為液晶顯示元件之液晶配向膜。例如,可使用如上述般所形成的具有本發明之配向材料的2枚基板,隔著間隔件使兩基板上之配向材料互相對向的方式貼合後,於該等基板之間注入液晶,製造液晶經配向之液晶顯示元件。 因此,本實施形態之硬化膜形成組成物,可適合地使用於製造各種相位差材料(相位差薄膜)或液晶顯示元件等。 [實施例]Furthermore, an alignment material formed using a cured film formed of the cured film-forming composition of the present invention can also be utilized as a liquid crystal alignment film for a liquid crystal display element. For example, two substrates having the alignment material of the present invention formed as described above can be used. After the alignment materials on the two substrates face each other through a spacer, liquid crystal can be injected between the substrates. Manufacture of liquid crystal display elements with aligned liquid crystals. Therefore, the cured film-forming composition of this embodiment can be suitably used for manufacturing various retardation materials (retardation films), liquid crystal display elements, and the like. [Example]
以下,列舉本發明之實施例,以具體說明本發明,但本發明並非限定解釋為此等。Hereinafter, examples of the present invention are enumerated to illustrate the present invention in detail, but the present invention is not limited to these examples.
[實施例所用之縮寫] 以下實施例所用之縮寫的意義係如下所述。 <原料> GMA:甲基丙烯酸縮水甘油酯 AIBN:α,α’-偶氮二異丁腈 BMAA:N-丁氧基甲基丙烯醯胺 CIN1: CIN2: [Abbreviations used in the examples] The meanings of the abbreviations used in the following examples are as follows. <Raw materials> GMA: Glycidyl methacrylate AIBN: α,α'-azobisisobutyronitrile BMAA: N-butoxymethacrylamide CIN1: CIN2:
P-2:EHPE3150((股)Daicel製、環氧當量180g/eq) P-2: EHPE3150 (manufactured by Daicel Co., Ltd., epoxy equivalent 180g/eq)
A-1:Aronix M-5300(東亞合成(股)製) A-1: Aronix M-5300 (manufactured by Toa Gosei Co., Ltd.)
A-2:Aronix M-5400(東亞合成(股)製) A-2: Aronix M-5400 (manufactured by Toa Gosei Co., Ltd.)
A-3:琥珀酸2-丙烯醯基氧基乙酯 A-3: 2-propenyloxyethyl succinate
<B成分> HMM:下述結構式表示之三聚氰胺交聯劑[Cymel(註冊商標)303(三井Cytec(股)製)] <Component B> HMM: Melamine cross-linking agent represented by the following structural formula [Cymel (registered trademark) 303 (manufactured by Mitsui Cytec Co., Ltd.)]
<C成分> PTSA:p-甲苯磺酸・一水合物<C component> PTSA: p-toluenesulfonic acid・monohydrate
<D成分> PEPO:聚酯多元醇聚合物(具有下述結構單位之己二酸/二乙二醇共聚物。分子量4,800) (上述式中,R表示伸烷基)<D component> PEPO: Polyester polyol polymer (adipic acid/diethylene glycol copolymer having the following structural units. Molecular weight 4,800) (In the above formula, R represents an alkylene group)
<溶劑> PM:丙二醇單甲基醚 EA:乙酸乙酯<Solvent> PM: propylene glycol monomethyl ether EA: Ethyl acetate
<聚合物之分子量之測定> 聚合例中之丙烯酸(共)聚合物之分子量,係使用(股)Shodex公司製常溫凝膠滲透層析(GPC)裝置(GPC-101)、(股)Shodex公司製管柱(KD-803、KD-805)如以下般測定。 再者,下述數平均分子量(以下稱為Mn)及重量平均分子量(以下稱為Mw),係以聚苯乙烯換算值表示。 管柱溫度:40℃ 溶離液:四氫呋喃 流速:1.0mL/分鐘 檢量線製成用標準樣品:昭和電工(股)製 標準聚苯乙烯(分子量 約197,000、55,100、12,800、3,950、1,260、580)。<Measurement of molecular weight of polymer> The molecular weight of the acrylic (co)polymer in the polymerization examples was determined using a normal temperature gel permeation chromatography (GPC) device (GPC-101) manufactured by Shodex Corporation, a column (KD-803, manufactured by Shodex Corporation). KD-805) was measured as follows. In addition, the following number average molecular weight (hereinafter referred to as Mn) and weight average molecular weight (hereinafter referred to as Mw) are expressed in terms of polystyrene conversion values. Tube string temperature: 40℃ Eluate: Tetrahydrofuran Flow rate: 1.0mL/min Standard sample for calibration line preparation: Standard polystyrene manufactured by Showa Denko Co., Ltd. (molecular weight: approximately 197,000, 55,100, 12,800, 3,950, 1,260, 580).
<A成分之合成> <合成例1> 將GMA 15.0g、作為聚合觸媒之AIBN 0.8g溶解於四氫呋喃 63.0g中,於加熱回流下反應20小時藉以得到丙烯酸聚合物溶液。將丙烯酸聚合物溶液慢慢滴下至二乙基醚 500.0g中,使固體析出,藉由過濾及減壓乾燥得到丙烯酸聚合物(P-1)。所得之丙烯酸聚合物之Mn為6,500、Mw為11,000。<Synthesis of component A> <Synthesis example 1> Dissolve 15.0g of GMA and 0.8g of AIBN as a polymerization catalyst in 63.0g of tetrahydrofuran, and react under heating and reflux for 20 hours to obtain an acrylic acid polymer solution. The acrylic polymer solution was slowly dropped into 500.0 g of diethyl ether to precipitate a solid. The acrylic polymer (P-1) was obtained by filtration and drying under reduced pressure. The obtained acrylic polymer had an Mn of 6,500 and a Mw of 11,000.
<合成例2> 將合成例1所得到的具有環氧基之丙烯酸聚合物(P-1)10.0g、CIN1 8.4g、丙烯酸 0.8g、作為反應觸媒之乙基三苯基鏻溴化物 0.1g、作為聚合抑制劑之二丁基羥基甲苯 0.4g溶解於PM 46.1g中,於80℃反應20小時,得到含有30質量%之丙烯酸聚合物(PA-1)的溶液。測定所得聚合物之環氧價,確認到環氧基消失。<Synthesis example 2> 10.0 g of the acrylic polymer (P-1) having an epoxy group obtained in Synthesis Example 1, 8.4 g of CIN1, 0.8 g of acrylic acid, 0.1 g of ethyltriphenylphosphonium bromide as a reaction catalyst, and 0.1 g of ethyltriphenylphosphonium bromide as a polymerization inhibitor. 0.4 g of dibutylhydroxytoluene as an agent was dissolved in 46.1 g of PM, and the mixture was reacted at 80°C for 20 hours to obtain a solution containing 30% by mass of acrylic polymer (PA-1). The epoxy valency of the obtained polymer was measured, and it was confirmed that the epoxy group disappeared.
<合成例3~10> 除了使具有環氧基之聚合物(丙烯酸聚合物)、賦予光配向性基之化合物及賦予含聚合性雙鍵之基的化合物之種類、摻合量成為如下述表1所示以外,係與合成例2同樣地操作,得到含有30質量%之聚合物(PA-2)~(PA-9)的溶液。再者,表1中之空欄,表示未摻合該成分。<Synthesis Examples 3~10> In addition to making the types and blending amounts of the polymer having an epoxy group (acrylic polymer), the compound imparting a photo-alignment group, and the compound imparting a polymerizable double bond-containing group as shown in Table 1 below, The same operation was performed in Synthesis Example 2 to obtain a solution containing 30% by mass of polymers (PA-2) to (PA-9). Furthermore, empty columns in Table 1 indicate that the component is not blended.
<B成分之合成> <合成例11> 將BMAA 100.0g、作為聚合觸媒之AIBN 4.2g溶解於PM 193.5g中,於90℃反應20小時藉以得到丙烯酸聚合物溶液。所得之丙烯酸聚合物之Mn為2,700、Mw為3,900。將丙烯酸聚合物溶液慢慢滴下至己烷2000.0g中,使固體析出,藉由過濾及減壓乾燥,得到聚合物(PB-1)。<Synthesis of component B> <Synthesis Example 11> Dissolve 100.0g of BMAA and 4.2g of AIBN as a polymerization catalyst in 193.5g of PM, and react at 90°C for 20 hours to obtain an acrylic polymer solution. The obtained acrylic polymer had Mn of 2,700 and Mw of 3,900. The acrylic polymer solution was slowly dropped into 2000.0 g of hexane to precipitate a solid, which was filtered and dried under reduced pressure to obtain polymer (PB-1).
<聚合性液晶溶液之配製> 添加聚合性液晶LC242(BASF公司製)29.0g、作為聚合起始劑之Irgacure 907(BASF公司製)0.9g、作為整平劑之BYK-361N(BYK公司製)0.2g、作為溶劑之甲基異丁基酮,得到固體成分濃度30質量%之聚合性液晶溶液(RM-1)。<Preparation of polymerizable liquid crystal solution> 29.0g of polymerizable liquid crystal LC242 (manufactured by BASF Corporation), 0.9g of Irgacure 907 (manufactured by BASF Corporation) as a polymerization initiator, 0.2g of BYK-361N (manufactured by BYK Corporation) as a leveling agent, and methyl group as a solvent were added isobutyl ketone to obtain a polymerizable liquid crystal solution (RM-1) with a solid content concentration of 30% by mass.
<實施例1> 混合作為(A)成分之上述合成例2所得到的含有30質量%丙烯酸聚合物(PA-1)之溶液的換算為丙烯酸聚合物(PA-1)而言相當於100質量份之量、作為(B)成分之HMM 30質量份、作為(C)成分之PTSA 3質量份,於其中添加PM及EA,配製溶劑組成為PM:EA=100:30(質量比)、固體成分濃度為5.0質量%之硬化膜(配向材料)形成組成物(A-1)。<Example 1> The solution containing 30% by mass of the acrylic polymer (PA-1) obtained in the above synthesis example 2 as the component (A) was mixed in an amount equivalent to 100 parts by mass in terms of the acrylic polymer (PA-1), as 30 parts by mass of HMM as component (B) and 3 parts by mass of PTSA as component (C) were added to PM and EA to prepare a solvent composition of PM:EA=100:30 (mass ratio) and a solid content concentration of 5.0 mass. % of the cured film (alignment material) forms the composition (A-1).
<實施例2~12及比較例1~2> 除了使各成分之種類及量分別成為如表2所記載以外,係與實施例1同樣地實施,分別配製硬化膜(配向材料)形成組成物A-2~A-15。再者,表2中之空欄表示未摻合該成分。<Examples 2 to 12 and Comparative Examples 1 to 2> Except that the types and amounts of each component were as described in Table 2, the same procedure was carried out as in Example 1, and cured film (alignment material) forming compositions A-2 to A-15 were respectively prepared. Furthermore, empty columns in Table 2 indicate that the component is not blended.
<實施例13~24及比較例3~4> [配向性之評估] 將實施例1~12及比較例1~2之各硬化膜(配向材料)形成組成物,使用棒塗佈器以Wet膜厚4μm塗佈於TAC薄膜上。分別於溫度110℃於熱循環式烘箱中進行加熱乾燥60秒,於薄膜上分別形成硬化膜。對此各硬化膜以10mJ/cm2 之曝光量垂直照射313nm之直線偏光,形成配向材料。將聚合性液晶溶液(RM-1),使用棒塗佈器以Wet膜厚6μm塗佈於薄膜上之配向材料之上。將該塗膜於溫度90℃之加熱板上乾燥60秒後,以300mJ/cm2 曝光,製作相位差材料。將所製作之薄膜上的相位差材料以一對偏光板夾入,觀察相位差材料之相位差特性的表現狀況,將無缺陷地表現相位差者作為○、未表現相位差者作為×,記載於「配向性」之欄。評估結果一併示於後述表3。<Examples 13 to 24 and Comparative Examples 3 to 4> [Evaluation of Alignment] Each cured film (alignment material) of Examples 1 to 12 and Comparative Examples 1 to 2 was formed into a composition, using a bar coater with Wet The film thickness is 4 μm and is coated on the TAC film. Heat and dry in a thermal cycle oven at a temperature of 110° C. for 60 seconds to form a cured film on the film. Each cured film was vertically irradiated with linearly polarized light of 313 nm at an exposure dose of 10 mJ/cm 2 to form an alignment material. The polymerizable liquid crystal solution (RM-1) was coated on the alignment material on the film using a rod coater with a Wet film thickness of 6 μm. The coating film was dried on a hot plate at a temperature of 90° C. for 60 seconds, and then exposed to 300 mJ/cm 2 to produce a phase difference material. The retardation material on the produced film was sandwiched between a pair of polarizing plates, and the performance of the retardation characteristics of the retardation material was observed. Those that showed the retardation without defects were marked as ○, and those that did not show the retardation were marked as ×. in the "Orientation" column. The evaluation results are collectively shown in Table 3 described below.
[密合性之評估] 將實施例1~12及比較例1~2之各硬化膜(配向材料)形成組成物,使用棒塗佈器以Wet膜厚4μm塗佈於TAC薄膜上。分別於溫度110℃於熱循環式烘箱中進行加熱乾燥60秒,於薄膜上分別形成硬化膜。對此各硬化膜以10mJ/cm2 之曝光量垂直照射313nm之直線偏光,形成配向材料。將聚合性液晶溶液(RM-1),使用棒塗佈器以Wet膜厚6μm塗佈於薄膜上之配向材料之上。將該塗膜於溫度90℃之加熱板上乾燥60秒後,以300mJ/cm2 曝光,製作相位差材料。於該相位差材料,以縱橫1mm間隔以切割刀切出切口為5×5方格。於該切口上使用Scotch膠帶進行賽珞凡膠帶剝離試驗。評估結果作為「密合性」,而記載25方格中未剝離而殘留的方格數。例如若為25/25,則表示全部的方格未剝離而殘留,其係密合性高。評估結果一併示於後述表3。[Evaluation of Adhesion] Each cured film (alignment material) forming composition of Examples 1 to 12 and Comparative Examples 1 to 2 was applied on the TAC film with a Wet film thickness of 4 μm using a bar coater. Heat and dry in a thermal cycle oven at a temperature of 110° C. for 60 seconds to form a cured film on the film. Each cured film was vertically irradiated with linearly polarized light of 313 nm at an exposure dose of 10 mJ/cm 2 to form an alignment material. The polymerizable liquid crystal solution (RM-1) was coated on the alignment material on the film using a rod coater with a Wet film thickness of 6 μm. The coating film was dried on a hot plate at a temperature of 90° C. for 60 seconds, and then exposed to 300 mJ/cm 2 to produce a phase difference material. In this phase difference material, cut out a 5×5 square grid with a cutting knife at intervals of 1 mm in length and width. Use Scotch tape on this incision to perform a Cellophane tape peel test. The evaluation results are recorded as "adhesion", and the number of squares remaining without peeling out of the 25 squares is recorded. For example, if it is 25/25, it means that all the squares are not peeled off but remain, and the adhesion is high. The evaluation results are collectively shown in Table 3 described below.
如表3所示,實施例13~24所得到之相位差材料顯示良好的配向性與高的密合性。As shown in Table 3, the phase difference materials obtained in Examples 13 to 24 showed good alignment and high adhesion.
相對於此,比較例3所得到之相位差材料係顯示良好的配向性,但得不到充分的密合性。又,比較例4所得到之相位差材料係配向性與密合性均不充分。 [產業上之可利用性]On the other hand, the retardation material obtained in Comparative Example 3 showed good alignment, but sufficient adhesion was not obtained. In addition, the retardation material obtained in Comparative Example 4 had insufficient alignment and adhesion properties. [Industrial availability]
由本發明之硬化膜形成組成物所形成之硬化膜,非常有用於作為用以形成液晶顯示元件之液晶配向膜,或設於液晶顯示元件之內部或外部的光學各向異性薄膜之配向材料。特別地,本發明之硬化膜形成組成物,適合作為用於3D顯示器之圖型化相位差材料的硬化膜之形成材料。進一步地,本發明之硬化膜形成組成物,亦適合作為形成薄膜電晶體(TFT)型液晶顯示元件或有機EL元件等之各種顯示器中的保護膜、平坦膜及絕緣膜等之硬化膜的材料,特別是形成TFT型液晶顯示元件之層間絕緣膜、彩色濾光片之保護膜或有機EL元件之絕緣膜等的材料。The cured film formed from the cured film-forming composition of the present invention is very useful as an alignment material for a liquid crystal alignment film used to form a liquid crystal display element or an optically anisotropic film provided inside or outside a liquid crystal display element. In particular, the cured film-forming composition of the present invention is suitable as a material for forming a cured film of a patterned retardation material used in a 3D display. Furthermore, the cured film-forming composition of the present invention is also suitable as a material for forming cured films such as protective films, flat films, and insulating films in various displays such as thin film transistor (TFT) liquid crystal display elements or organic EL elements. , especially materials that form interlayer insulating films for TFT-type liquid crystal display elements, protective films for color filters, or insulating films for organic EL elements.
Claims (12)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018060706 | 2018-03-27 | ||
JP2018-060706 | 2018-03-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW202003672A TW202003672A (en) | 2020-01-16 |
TWI822746B true TWI822746B (en) | 2023-11-21 |
Family
ID=68061881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW108110676A TWI822746B (en) | 2018-03-27 | 2019-03-27 | Cured film forming composition, alignment material and retardation material |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP7492196B2 (en) |
KR (1) | KR20200135967A (en) |
CN (1) | CN112041713B (en) |
TW (1) | TWI822746B (en) |
WO (1) | WO2019189189A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7499673B2 (en) | 2020-10-22 | 2024-06-14 | 住友化学株式会社 | Polarizing plate and image display device |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015031823A (en) * | 2013-08-02 | 2015-02-16 | 大阪有機化学工業株式会社 | Photo-alignment film composition and novel polymer |
TW201529669A (en) * | 2013-10-17 | 2015-08-01 | Nissan Chemical Ind Ltd | Cured film forming composition, alignment material and retardation material |
TW201534629A (en) * | 2014-02-13 | 2015-09-16 | Dainippon Printing Co Ltd | Thermosetting composition having photoalignment properties, alignment layer, substrate with alignment layer, retardation plate, and device |
TW201726798A (en) * | 2012-03-28 | 2017-08-01 | 日產化學工業股份有限公司 | Cured film forming composition, alignment material and retardation material |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55165858A (en) | 1979-06-13 | 1980-12-24 | Toppan Printing Co Ltd | Center-bound bookbinding folding pagination and its processing method |
JPH1068816A (en) | 1996-08-29 | 1998-03-10 | Sharp Corp | Phase difference plate and circularly polarizing plate |
CN1211418C (en) | 1997-09-25 | 2005-07-20 | 罗列克股份公司 | Photocrosslinkable polyimides |
JP4207430B2 (en) | 2002-01-31 | 2009-01-14 | Jsr株式会社 | Liquid crystal aligning agent, method for forming liquid crystal aligning film, and liquid crystal display element |
JP2005049865A (en) | 2003-07-17 | 2005-02-24 | Arisawa Mfg Co Ltd | Manufacturing method of optical phase difference element |
TWI406061B (en) * | 2005-11-10 | 2013-08-21 | Dainippon Ink & Chemicals | Composition for photoalignment film, optically anisotropic body and method of producing same |
WO2008119426A1 (en) | 2007-03-30 | 2008-10-09 | Merck Patent Gmbh | Birefingent layer with negative optical dispersion |
JP5316740B2 (en) | 2007-08-30 | 2013-10-16 | Jsr株式会社 | Method for forming liquid crystal alignment film |
JP5076810B2 (en) * | 2007-10-31 | 2012-11-21 | Dic株式会社 | Composition for photo-alignment film, photo-alignment film, and optical anisotropic body |
JP5373293B2 (en) | 2008-01-29 | 2013-12-18 | 富士フイルム株式会社 | Compound, liquid crystal composition and anisotropic material |
EP2557119B1 (en) * | 2010-04-08 | 2015-12-09 | Nissan Chemical Industries, Ltd. | Composition forming heat-cured film having photo-alignment properties |
WO2014010688A1 (en) * | 2012-07-12 | 2014-01-16 | 日産化学工業株式会社 | Composition for forming cured film, alignment material, and phase difference material |
JP2015152745A (en) * | 2014-02-13 | 2015-08-24 | 大日本印刷株式会社 | Thermosetting composition having photo-aligning property, alignment layer, substrate with alignment layer, retardation plate, and device |
US10100201B2 (en) * | 2014-02-28 | 2018-10-16 | Nissan Chemical Industries, Ltd. | Cured film formation composition, orientation material and retardation material |
CN106459324B (en) * | 2014-06-30 | 2019-09-27 | 日产化学工业株式会社 | Cured film, which is formed, uses composition, oriented material and phase difference material |
JP6269952B2 (en) | 2014-07-02 | 2018-01-31 | Jnc株式会社 | Composition for photo-alignment film |
JP6698677B2 (en) | 2015-10-23 | 2020-05-27 | 富士フイルム株式会社 | Composition for photo-alignment film, photo-alignment film, optical laminate and image display device |
-
2019
- 2019-03-26 CN CN201980027755.1A patent/CN112041713B/en active Active
- 2019-03-26 JP JP2020510916A patent/JP7492196B2/en active Active
- 2019-03-26 WO PCT/JP2019/012873 patent/WO2019189189A1/en active Application Filing
- 2019-03-26 KR KR1020207027872A patent/KR20200135967A/en not_active Application Discontinuation
- 2019-03-27 TW TW108110676A patent/TWI822746B/en active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201726798A (en) * | 2012-03-28 | 2017-08-01 | 日產化學工業股份有限公司 | Cured film forming composition, alignment material and retardation material |
JP2015031823A (en) * | 2013-08-02 | 2015-02-16 | 大阪有機化学工業株式会社 | Photo-alignment film composition and novel polymer |
TW201529669A (en) * | 2013-10-17 | 2015-08-01 | Nissan Chemical Ind Ltd | Cured film forming composition, alignment material and retardation material |
TW201534629A (en) * | 2014-02-13 | 2015-09-16 | Dainippon Printing Co Ltd | Thermosetting composition having photoalignment properties, alignment layer, substrate with alignment layer, retardation plate, and device |
Also Published As
Publication number | Publication date |
---|---|
KR20200135967A (en) | 2020-12-04 |
WO2019189189A1 (en) | 2019-10-03 |
CN112041713B (en) | 2023-07-07 |
JP7492196B2 (en) | 2024-05-29 |
TW202003672A (en) | 2020-01-16 |
CN112041713A (en) | 2020-12-04 |
JPWO2019189189A1 (en) | 2021-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6032438B2 (en) | Cured film forming composition, alignment material and retardation material | |
US9529132B2 (en) | Cured film formation composition, orientation material, and retardation material | |
TWI633148B (en) | Cured film forming composition, alignment material and retardation material | |
JP6274442B2 (en) | Cured film forming composition, alignment material and retardation material | |
TWI608047B (en) | Film formed in cured coating, alignment material and retardation material | |
JP6260790B2 (en) | Alignment material manufacturing method, alignment material, retardation material manufacturing method, and retardation material | |
JP2020019964A (en) | Polymer containing repeating unit having n-alkoxymethyl group and repeating unit having side chain containing polymerizable c=c double bond | |
WO2013191251A1 (en) | Cured film-forming composition, oriented material, and phase difference material | |
WO2019189193A1 (en) | Cured film-forming composition, alignment material, and phase difference material | |
TWI822746B (en) | Cured film forming composition, alignment material and retardation material | |
JP7365003B2 (en) | Cured film forming composition, alignment material and retardation material | |
WO2023157934A1 (en) | Resin composition for thermosetting photo-alignment films | |
WO2024214830A1 (en) | Resin composition for thermosetting photo-alignment films | |
WO2020184463A1 (en) | Liquid crystal alignment agent for photoalignment, alignment material, and phase difference material | |
WO2023204281A1 (en) | Resin composition for thermosetting photo-alignment films |